DE4213338A1 - Treatment of impotence - Google Patents
Treatment of impotenceInfo
- Publication number
- DE4213338A1 DE4213338A1 DE19924213338 DE4213338A DE4213338A1 DE 4213338 A1 DE4213338 A1 DE 4213338A1 DE 19924213338 DE19924213338 DE 19924213338 DE 4213338 A DE4213338 A DE 4213338A DE 4213338 A1 DE4213338 A1 DE 4213338A1
- Authority
- DE
- Germany
- Prior art keywords
- sydnonimine
- methyl
- carbonyl
- phenylethyl
- sydnonimin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000001881 impotence Diseases 0.000 title claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 20
- 208000010228 Erectile Dysfunction Diseases 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 7
- 125000004663 dialkyl amino group Chemical group 0.000 claims abstract description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 4
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 3
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract description 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims abstract description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims abstract description 3
- 125000002098 pyridazinyl group Chemical group 0.000 claims abstract description 3
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims abstract description 3
- 125000000168 pyrrolyl group Chemical group 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 58
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- FKDHHVKWGRFRTG-UHFFFAOYSA-N linsidomine Chemical compound [N-]1OC(=N)C=[N+]1N1CCOCC1 FKDHHVKWGRFRTG-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 229960002006 linsidomine Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000005293 bicycloalkoxy group Chemical group 0.000 claims description 2
- 150000001602 bicycloalkyls Chemical group 0.000 claims description 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- -1 1,1-dioxo-tetrahydrothiophen-3-yl Chemical group 0.000 abstract description 338
- 125000005108 alkenylthio group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000005018 aryl alkenyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- GSKDBLIBBOYOFU-UHFFFAOYSA-N oxadiazol-5-amine Chemical compound NC1=CN=NO1 GSKDBLIBBOYOFU-UHFFFAOYSA-N 0.000 description 146
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 62
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 11
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 5
- SQTLUXJWUCHKMT-UHFFFAOYSA-N 4-bromo-n,n-diphenylaniline Chemical compound C1=CC(Br)=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 SQTLUXJWUCHKMT-UHFFFAOYSA-N 0.000 description 5
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 5
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- 229960001789 papaverine Drugs 0.000 description 5
- 230000000699 topical effect Effects 0.000 description 5
- ZTMXUHHBYAKUBR-UHFFFAOYSA-N 3-benzyl-4-(3-nitrophenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [O-][N+](=O)C1=CC=CC(C=2C(O[N-][N+]=2CC=2C=CC=CC=2)=N)=C1 ZTMXUHHBYAKUBR-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- QZVCTJOXCFMACW-UHFFFAOYSA-N Phenoxybenzamine Chemical compound C=1C=CC=CC=1CN(CCCl)C(C)COC1=CC=CC=C1 QZVCTJOXCFMACW-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229960003418 phenoxybenzamine Drugs 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 3
- TWXKVTRLQAMCKR-UHFFFAOYSA-N 3-(4-ethoxyphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(OCC)=CC=C1[N+]1=CC(=N)O[N-]1 TWXKVTRLQAMCKR-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 2
- ZSJNNLAFHYHEQJ-UHFFFAOYSA-N 2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)ethanol Chemical compound OCC[N+]1=CC(=N)O[N-]1 ZSJNNLAFHYHEQJ-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- KUCZYLMXMVPZNV-UHFFFAOYSA-N 3,4-diphenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound N=C1O[N-][N+](C=2C=CC=CC=2)=C1C1=CC=CC=C1 KUCZYLMXMVPZNV-UHFFFAOYSA-N 0.000 description 2
- DLYWRTWKXCETLP-UHFFFAOYSA-N 3-(1-phenylethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C=1C(=N)O[N-][N+]=1C(C)C1=CC=CC=C1 DLYWRTWKXCETLP-UHFFFAOYSA-N 0.000 description 2
- KLVFZOBIIFQANC-UHFFFAOYSA-N 3-(2-phenylethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CCC1=CC=CC=C1 KLVFZOBIIFQANC-UHFFFAOYSA-N 0.000 description 2
- NIVQCIFOVUCXFV-UHFFFAOYSA-N 3-(azepan-1-yl)-4-bromo-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(Br)=[N+]1N1CCCCCC1 NIVQCIFOVUCXFV-UHFFFAOYSA-N 0.000 description 2
- ULUDFOBJODHDCY-UHFFFAOYSA-N 3-benzyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CC1=CC=CC=C1 ULUDFOBJODHDCY-UHFFFAOYSA-N 0.000 description 2
- GTLJLXKSKMFYFY-UHFFFAOYSA-N 3-benzyl-4-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C=1C=CC=CC=1C=1C(=N)O[N-][N+]=1CC1=CC=CC=C1 GTLJLXKSKMFYFY-UHFFFAOYSA-N 0.000 description 2
- FOJGGBRECCJHME-UHFFFAOYSA-N 3-butan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CCC(C)[N+]1=CC(=N)O[N-]1 FOJGGBRECCJHME-UHFFFAOYSA-N 0.000 description 2
- AYVAGLGCDDRCAP-UHFFFAOYSA-N 3-cyclohexyl-4-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C)=[N+]1C1CCCCC1 AYVAGLGCDDRCAP-UHFFFAOYSA-N 0.000 description 2
- 125000004208 3-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C([H])C(*)=C1[H] 0.000 description 2
- MAPNYWAUFFMTDT-UHFFFAOYSA-N 3-nitroso-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound N=C1C=[N+](N=O)[N-]O1 MAPNYWAUFFMTDT-UHFFFAOYSA-N 0.000 description 2
- WNCAUPVVPFCLCG-UHFFFAOYSA-N 3-piperidin-1-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1N1CCCCC1 WNCAUPVVPFCLCG-UHFFFAOYSA-N 0.000 description 2
- PLIFLEVBVVPNLI-UHFFFAOYSA-N 3-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC(C)[N+]1=CC(=N)O[N-]1 PLIFLEVBVVPNLI-UHFFFAOYSA-N 0.000 description 2
- MLUAGQLGNWNSPI-UHFFFAOYSA-N 3-thiomorpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1N1CCSCC1 MLUAGQLGNWNSPI-UHFFFAOYSA-N 0.000 description 2
- SHTLKOXAVFKDDT-UHFFFAOYSA-N 4-(benzylsulfanylmethyl)-3-(2,6-dimethylpiperidin-1-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC1CCCC(C)N1[N+]1=C(CSCC=2C=CC=CC=2)C(=N)O[N-]1 SHTLKOXAVFKDDT-UHFFFAOYSA-N 0.000 description 2
- BWBVJKYATDIULO-UHFFFAOYSA-N 4-(chloromethyl)-3-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC(C)[N+]=1[N-]OC(=N)C=1CCl BWBVJKYATDIULO-UHFFFAOYSA-N 0.000 description 2
- MFYDFGAXZZKAMA-UHFFFAOYSA-N 4-bromo-3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(Br)=[N+]1N1CCOCC1 MFYDFGAXZZKAMA-UHFFFAOYSA-N 0.000 description 2
- LBFJGLFWBFWCKR-UHFFFAOYSA-N 4-bromo-3-piperidin-1-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(Br)=[N+]1N1CCCCC1 LBFJGLFWBFWCKR-UHFFFAOYSA-N 0.000 description 2
- DKAYFIXMSMZCAB-UHFFFAOYSA-N 4-bromo-5-imino-n,n-dimethyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound CN(C)[N+]=1[N-]OC(=N)C=1Br DKAYFIXMSMZCAB-UHFFFAOYSA-N 0.000 description 2
- DJVFMMOWYYDHJW-UHFFFAOYSA-N 4-chloro-3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(Cl)=[N+]1N1CCOCC1 DJVFMMOWYYDHJW-UHFFFAOYSA-N 0.000 description 2
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- IBTVVCDFLGVYGH-UHFFFAOYSA-N 4-methyl-3-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC(C)[N+]=1[N-]OC(=N)C=1C IBTVVCDFLGVYGH-UHFFFAOYSA-N 0.000 description 2
- DXMMUFNWRSDINK-UHFFFAOYSA-N 5-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)pentanoic acid Chemical compound OC(=O)CCCC[N+]1=CC(=N)O[N-]1 DXMMUFNWRSDINK-UHFFFAOYSA-N 0.000 description 2
- SWKBWJNRYLLLEY-UHFFFAOYSA-N 5-imino-n-methyl-n-(thiolan-3-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C(=N)O[N-][N+]=1N(C)C1CCSC1 SWKBWJNRYLLLEY-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000005225 erectile tissue Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- PFZDKKMHPJCGGR-UHFFFAOYSA-N ethyl 4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1[N+]1=CC(=N)O[N-]1 PFZDKKMHPJCGGR-UHFFFAOYSA-N 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- HFLCEELTJROKMJ-UHFFFAOYSA-N feprosidnine Chemical compound C1=C([NH-])ON=[N+]1C(C)CC1=CC=CC=C1 HFLCEELTJROKMJ-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007926 intracavernous injection Substances 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 230000001272 neurogenic effect Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 229920000151 polyglycol Polymers 0.000 description 2
- 239000010695 polyglycol Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical group CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000003087 receptor blocking agent Substances 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229960001722 verapamil Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- HJIXBPPSAUYOTM-UHFFFAOYSA-N (4-chlorophenyl)-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)[N+]1=CC(=N)O[N-]1 HJIXBPPSAUYOTM-UHFFFAOYSA-N 0.000 description 1
- KILBWUZDNSRWFM-UHFFFAOYSA-N (5-imino-4-propyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl) acetate Chemical compound CCCC1=[N+](OC(C)=O)[N-]OC1=N KILBWUZDNSRWFM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- CQDMOYLRZWVVAY-UHFFFAOYSA-N 1-[5-imino-3-(1-phenylpropan-2-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-4-yl]-N,N-dimethylmethanamine Chemical compound CN(C)CC1=[N+]([N-]OC1=N)C(CC1=CC=CC=C1)C CQDMOYLRZWVVAY-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- POOCLFZZJFCMIA-UHFFFAOYSA-N 2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n,n-dimethyl-1-phenylethanamine Chemical compound C=1C=CC=CC=1C(N(C)C)C[N+]1=CC(=N)O[N-]1 POOCLFZZJFCMIA-UHFFFAOYSA-N 0.000 description 1
- TWZHYXYBJQXPOP-UHFFFAOYSA-N 2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n,n-dimethylethanamine Chemical compound CN(C)CC[N+]1=CC(=N)O[N-]1 TWZHYXYBJQXPOP-UHFFFAOYSA-N 0.000 description 1
- QHCQQJXIBMXHEG-UHFFFAOYSA-N 2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)acetic acid Chemical compound OC(=O)C[N+]1=CC(=N)O[N-]1 QHCQQJXIBMXHEG-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- MMEJQYOFFRUJAG-UHFFFAOYSA-N 2-[(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)amino]cyclohexan-1-ol Chemical compound OC1CCCCC1N[N+]1=CC(=N)O[N-]1 MMEJQYOFFRUJAG-UHFFFAOYSA-N 0.000 description 1
- CBDSLFGKZQUJFY-UHFFFAOYSA-N 2-[(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)amino]ethanol Chemical compound OCCN[N+]1=CC(=N)O[N-]1 CBDSLFGKZQUJFY-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- NPOVZTPLNFJGIZ-UHFFFAOYSA-N 2-[4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)phenyl]acetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1[N+]1=CC(=N)O[N-]1 NPOVZTPLNFJGIZ-UHFFFAOYSA-N 0.000 description 1
- CIEPWKQWLNTZGU-UHFFFAOYSA-N 2-[tert-butyl-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)amino]ethanol Chemical compound OCCN(C(C)(C)C)[N+]1=CC(=N)O[N-]1 CIEPWKQWLNTZGU-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- PKRSYEPBQPFNRB-UHFFFAOYSA-N 2-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC1=CC=CC=C1 PKRSYEPBQPFNRB-UHFFFAOYSA-N 0.000 description 1
- NMKSAYKQLCHXDK-UHFFFAOYSA-N 3,3-diphenyl-N-(1-phenylethyl)-1-propanamine Chemical compound C=1C=CC=CC=1C(C)NCCC(C=1C=CC=CC=1)C1=CC=CC=C1 NMKSAYKQLCHXDK-UHFFFAOYSA-N 0.000 description 1
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- UPEGTPVPHPSONJ-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-ylmethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CC1=CC=C(OCO2)C2=C1 UPEGTPVPHPSONJ-UHFFFAOYSA-N 0.000 description 1
- UZHARDIIASWSRV-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-ylmethyl)-4-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C)=[N+]1CC1=CC=C(OCO2)C2=C1 UZHARDIIASWSRV-UHFFFAOYSA-N 0.000 description 1
- SBLUICGXGIQKAG-UHFFFAOYSA-N 3-(1,3-diphenylpropan-2-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1C(CC=1C=CC=CC=1)CC1=CC=CC=C1 SBLUICGXGIQKAG-UHFFFAOYSA-N 0.000 description 1
- BJXBIICFAXZYEO-UHFFFAOYSA-N 3-(1-adamantylmethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CC1(C2)CC(C3)CC2CC3C1 BJXBIICFAXZYEO-UHFFFAOYSA-N 0.000 description 1
- SXSPHQUSFSXJRM-UHFFFAOYSA-N 3-(2,2,2-trinitroethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [O-][N+](=O)C([N+]([O-])=O)([N+]([O-])=O)C[N+]1=CC(=N)O[N-]1 SXSPHQUSFSXJRM-UHFFFAOYSA-N 0.000 description 1
- BSWKWKKILWTZOK-UHFFFAOYSA-N 3-(2,2-diphenylethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CC(C=1C=CC=CC=1)C1=CC=CC=C1 BSWKWKKILWTZOK-UHFFFAOYSA-N 0.000 description 1
- VJMMLUQIJUHGQD-UHFFFAOYSA-N 3-(2,6-dimethylpiperidin-1-yl)-4-(prop-2-enylsulfanylmethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC1CCCC(C)N1[N+]1=C(CSCC=C)C(=N)O[N-]1 VJMMLUQIJUHGQD-UHFFFAOYSA-N 0.000 description 1
- AMHHZYPBFYRRMA-UHFFFAOYSA-N 3-(2,6-dimethylpiperidin-1-yl)-4-hexyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(CCCCCC)=[N+]1N1C(C)CCCC1C AMHHZYPBFYRRMA-UHFFFAOYSA-N 0.000 description 1
- XWBAHYOBPNEZBJ-UHFFFAOYSA-N 3-(2,6-dimethylpiperidin-1-yl)-4-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC1CCCC(C)N1[N+]1=C(C)C(=N)O[N-]1 XWBAHYOBPNEZBJ-UHFFFAOYSA-N 0.000 description 1
- OOYRXWHQFOMBRG-UHFFFAOYSA-N 3-(2-methoxyphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound COC1=CC=CC=C1[N+]1=CC(=N)O[N-]1 OOYRXWHQFOMBRG-UHFFFAOYSA-N 0.000 description 1
- NDZVFOLKWHIQNU-UHFFFAOYSA-N 3-(3,3,3-trinitropropyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [O-][N+](=O)C([N+]([O-])=O)([N+]([O-])=O)CC[N+]1=CC(=N)O[N-]1 NDZVFOLKWHIQNU-UHFFFAOYSA-N 0.000 description 1
- UYPWWIOFYNSARK-UHFFFAOYSA-N 3-(3,3-dimethylmorpholin-4-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC1(C)COCCN1[N+]1=CC(=N)O[N-]1 UYPWWIOFYNSARK-UHFFFAOYSA-N 0.000 description 1
- VYGFSPJMKHBQDZ-UHFFFAOYSA-N 3-(3,4-dihydro-1h-isoquinolin-2-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1N1CC2=CC=CC=C2CC1 VYGFSPJMKHBQDZ-UHFFFAOYSA-N 0.000 description 1
- KGKLNLGUPHPQMS-UHFFFAOYSA-N 3-(3-fluorophenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound FC1=CC=CC([N+]=2[N-]OC(=N)C=2)=C1 KGKLNLGUPHPQMS-UHFFFAOYSA-N 0.000 description 1
- JXJPDTQKXWKQFI-UHFFFAOYSA-N 3-(3-methylphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC1=CC=CC([N+]=2[N-]OC(=N)C=2)=C1 JXJPDTQKXWKQFI-UHFFFAOYSA-N 0.000 description 1
- XJNXCEQCDPGLBI-UHFFFAOYSA-N 3-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C12COCC(CC1)N2[N+]=1[N-]OC(C=1)=N XJNXCEQCDPGLBI-UHFFFAOYSA-N 0.000 description 1
- HJTPSWVNKXENPI-UHFFFAOYSA-N 3-(3-oxa-9-azabicyclo[3.3.1]nonan-9-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C12COCC(CCC1)N2[N+]=1[N-]OC(C=1)=N HJTPSWVNKXENPI-UHFFFAOYSA-N 0.000 description 1
- VHSLTSDORCOICY-UHFFFAOYSA-N 3-(3-piperidin-1-ylpropyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CCCN1CCCCC1 VHSLTSDORCOICY-UHFFFAOYSA-N 0.000 description 1
- VVHZTTMUSMQPKI-UHFFFAOYSA-N 3-(4-benzhydrylpiperazin-1-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1N1CCN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 VVHZTTMUSMQPKI-UHFFFAOYSA-N 0.000 description 1
- IBWZHPXTSRIXCY-UHFFFAOYSA-N 3-(4-benzylpiperazin-1-yl)-4-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C)=[N+]1N1CCN(CC=2C=CC=CC=2)CC1 IBWZHPXTSRIXCY-UHFFFAOYSA-N 0.000 description 1
- XCKKHKAVPOVQNR-UHFFFAOYSA-N 3-(4-fluorophenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(F)=CC=C1[N+]1=CC(=N)O[N-]1 XCKKHKAVPOVQNR-UHFFFAOYSA-N 0.000 description 1
- NFTYKNNCUMABTK-UHFFFAOYSA-N 3-(4-methylphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(C)=CC=C1[N+]1=CC(=N)O[N-]1 NFTYKNNCUMABTK-UHFFFAOYSA-N 0.000 description 1
- XZCRGKFHEDGTKX-UHFFFAOYSA-N 3-(4-methylphenyl)-4-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(C)=CC=C1[N+]1=C(C=2C=CC=CC=2)C(=N)O[N-]1 XZCRGKFHEDGTKX-UHFFFAOYSA-N 0.000 description 1
- JALMRIIJFAJDIO-UHFFFAOYSA-N 3-(4-methylsulfonylpiperazin-1-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1CN(S(=O)(=O)C)CCN1[N+]1=CC(=N)O[N-]1 JALMRIIJFAJDIO-UHFFFAOYSA-N 0.000 description 1
- GNYKUTZZWAADQN-UHFFFAOYSA-N 3-(4-morpholin-4-ylsulfonylphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound N1(CCOCC1)S(=O)(=O)C1=CC=C(C=C1)[N+]=1[N-]OC(C=1)=N GNYKUTZZWAADQN-UHFFFAOYSA-N 0.000 description 1
- FEJDLVAVXJMWLH-UHFFFAOYSA-N 3-(4-piperidin-1-ylsulfonylphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1C1=CC=C(S(=O)(=O)N2CCCCC2)C=C1 FEJDLVAVXJMWLH-UHFFFAOYSA-N 0.000 description 1
- OCHOTMORJQCVAF-UHFFFAOYSA-N 3-(4-pyrrolidin-1-ylsulfonylphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1C1=CC=C(S(=O)(=O)N2CCCC2)C=C1 OCHOTMORJQCVAF-UHFFFAOYSA-N 0.000 description 1
- AREOGORKHHFMQT-UHFFFAOYSA-N 3-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCC[N+]1=CC(=N)O[N-]1 AREOGORKHHFMQT-UHFFFAOYSA-N 0.000 description 1
- JJMQIJNYXQVIKP-UHFFFAOYSA-N 3-(azepan-1-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1N1CCCCCC1 JJMQIJNYXQVIKP-UHFFFAOYSA-N 0.000 description 1
- IQGMRVWUTCYCST-UHFFFAOYSA-N 3-Aminosalicylic acid Chemical compound NC1=CC=CC(C(O)=O)=C1O IQGMRVWUTCYCST-UHFFFAOYSA-N 0.000 description 1
- ONOFFZGBUIZZHS-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(Cl)=CC=C1C[N+]1=CC(=N)O[N-]1 ONOFFZGBUIZZHS-UHFFFAOYSA-N 0.000 description 1
- OTXMAMPIRYTICJ-UHFFFAOYSA-N 3-[(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)methyl]oxadiazol-3-ium-5-olate Chemical compound C([N+]=1[N-]OC(C=1)=N)[N+]=1[N-]OC(C=1)=O OTXMAMPIRYTICJ-UHFFFAOYSA-N 0.000 description 1
- YGJPYVUNRDSESQ-UHFFFAOYSA-N 3-[1-(4-nitrophenyl)propan-2-yl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C=1C(=N)O[N-][N+]=1C(C)CC1=CC=C([N+]([O-])=O)C=C1 YGJPYVUNRDSESQ-UHFFFAOYSA-N 0.000 description 1
- CURATKKXKRNSFB-UHFFFAOYSA-N 3-[1-hydroxy-2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)ethyl]phenol Chemical compound C=1C=CC(O)=CC=1C(O)C[N+]1=CC(=N)O[N-]1 CURATKKXKRNSFB-UHFFFAOYSA-N 0.000 description 1
- HZFTVPWQDIGUEK-UHFFFAOYSA-N 3-[2-(3,4-dimethoxyphenyl)ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=C(OC)C(OC)=CC=C1CC[N+]1=CC(=N)O[N-]1 HZFTVPWQDIGUEK-UHFFFAOYSA-N 0.000 description 1
- JDRJLSQBCOJYNC-UHFFFAOYSA-N 3-[2-(4-methoxyphenyl)ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(OC)=CC=C1CC[N+]1=CC(=N)O[N-]1 JDRJLSQBCOJYNC-UHFFFAOYSA-N 0.000 description 1
- IRPWKMBUJFIPIZ-UHFFFAOYSA-N 3-[2-(4-nitrophenyl)ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CC[N+]1=CC(=N)O[N-]1 IRPWKMBUJFIPIZ-UHFFFAOYSA-N 0.000 description 1
- RFKHWNJUJQYYPI-UHFFFAOYSA-N 3-[2-(4-pyridin-2-ylpiperazin-1-yl)ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CCN1CCN(C=2N=CC=CC=2)CC1 RFKHWNJUJQYYPI-UHFFFAOYSA-N 0.000 description 1
- FFNIMLWVUBIQEE-UHFFFAOYSA-N 3-[2-(4-pyrimidin-2-ylpiperazin-1-yl)ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CCN1CCN(C=2N=CC=CN=2)CC1 FFNIMLWVUBIQEE-UHFFFAOYSA-N 0.000 description 1
- OULODSJLFZFRFY-UHFFFAOYSA-N 3-[2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)ethyl]oxadiazol-3-ium-5-olate Chemical compound C(C[N+]=1[N-]OC(C=1)=N)[N+]=1[N-]OC(C=1)=O OULODSJLFZFRFY-UHFFFAOYSA-N 0.000 description 1
- IDCOTRUKYZIDQX-UHFFFAOYSA-N 3-[2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1CCN1CCN(CC=2C=C3OCOC3=CC=2)CC1 IDCOTRUKYZIDQX-UHFFFAOYSA-N 0.000 description 1
- IBTCMTQGTITHBE-UHFFFAOYSA-N 3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound COC1=CC=CC=C1N1CCN(CC[N+]=2[N-]OC(=N)C=2)CC1 IBTCMTQGTITHBE-UHFFFAOYSA-N 0.000 description 1
- JKHATEUPCPWZNW-UHFFFAOYSA-N 3-[2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound COC1=C(C=CC(=C1OC)OC)CN1CCN(CC1)CC[N+]=1[N-]OC(C=1)=N JKHATEUPCPWZNW-UHFFFAOYSA-N 0.000 description 1
- OIBFMRUBPSMTCR-UHFFFAOYSA-N 3-[4-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)piperazin-1-yl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [NH-]c1c[n+](no1)N1CCN(CC2COc3ccccc3O2)CC1 OIBFMRUBPSMTCR-UHFFFAOYSA-N 0.000 description 1
- MOWRJYJBZARFIJ-UHFFFAOYSA-N 3-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CCN([N+]=2[N-]OC(=N)C=2)CC1 MOWRJYJBZARFIJ-UHFFFAOYSA-N 0.000 description 1
- PVJXIOZQINBQFT-UHFFFAOYSA-N 3-[4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)phenyl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-one Chemical compound C1(=CC=C(C=C1)[N+]=1[N-]OC(C=1)=N)[N+]=1[N-]OC(C=1)=O PVJXIOZQINBQFT-UHFFFAOYSA-N 0.000 description 1
- WHXNGLKWUYRYGS-UHFFFAOYSA-N 3-[4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)piperazin-1-yl]oxadiazol-3-ium-5-olate Chemical compound N1(CCN(CC1)[N+]=1[N-]OC(C=1)=N)[N+]=1[N-]OC(C=1)=O WHXNGLKWUYRYGS-UHFFFAOYSA-N 0.000 description 1
- LWJWLZGROQOLLE-UHFFFAOYSA-N 3-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound COC1=C(OC)C(OC)=CC=C1CN1CCN([N+]=2[N-]OC(=N)C=2)CC1 LWJWLZGROQOLLE-UHFFFAOYSA-N 0.000 description 1
- MNIKOIMMJJUMQB-UHFFFAOYSA-N 3-[5-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-3,3-dinitropentyl]oxadiazol-3-ium-5-olate Chemical compound [N+](=O)([O-])C(CC[N+]=1[N-]OC(C=1)=O)(CC[N+]=1[N-]OC(C=1)=N)[N+](=O)[O-] MNIKOIMMJJUMQB-UHFFFAOYSA-N 0.000 description 1
- OGIYDFVHFQEFKQ-UHFFFAOYSA-N 3-[n-(4,5-dihydro-1h-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid Chemical compound CS(O)(=O)=O.C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 OGIYDFVHFQEFKQ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- MZHMSTDOJLNQDX-UHFFFAOYSA-N 3-benzyl-4-(4-methoxyphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(OC)=CC=C1C(C(O[N-]1)=N)=[N+]1CC1=CC=CC=C1 MZHMSTDOJLNQDX-UHFFFAOYSA-N 0.000 description 1
- CAJBSAIERRKKMS-UHFFFAOYSA-N 3-benzyl-4-(4-methylphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(C)=CC=C1C(C(O[N-]1)=N)=[N+]1CC1=CC=CC=C1 CAJBSAIERRKKMS-UHFFFAOYSA-N 0.000 description 1
- YXLDIGDBBMMMLJ-UHFFFAOYSA-N 3-benzyl-4-(4-propan-2-ylphenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(C(C)C)=CC=C1C(C(O[N-]1)=N)=[N+]1CC1=CC=CC=C1 YXLDIGDBBMMMLJ-UHFFFAOYSA-N 0.000 description 1
- KSVCVKAROZZZSY-UHFFFAOYSA-N 3-benzyl-4-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C)=[N+]1CC1=CC=CC=C1 KSVCVKAROZZZSY-UHFFFAOYSA-N 0.000 description 1
- ZYRXTFQJXOMBOD-UHFFFAOYSA-N 3-butyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CCCC[N+]1=CC(=N)O[N-]1 ZYRXTFQJXOMBOD-UHFFFAOYSA-N 0.000 description 1
- PBVUAMHUFQIZME-UHFFFAOYSA-N 3-cycloheptyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1C1CCCCCC1 PBVUAMHUFQIZME-UHFFFAOYSA-N 0.000 description 1
- IDBRSHLXQGUCED-UHFFFAOYSA-N 3-cyclohexyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1C1CCCCC1 IDBRSHLXQGUCED-UHFFFAOYSA-N 0.000 description 1
- SAWZVYHGXVUUOF-UHFFFAOYSA-N 3-cyclohexyl-4-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C(C)C)=[N+]1C1CCCCC1 SAWZVYHGXVUUOF-UHFFFAOYSA-N 0.000 description 1
- YPAXWBYOLSRXJU-UHFFFAOYSA-N 3-cyclopentyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1C1CCCC1 YPAXWBYOLSRXJU-UHFFFAOYSA-N 0.000 description 1
- AEOXHAVXKWHABH-UHFFFAOYSA-N 3-decyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CCCCCCCCCC[n+]1cc([NH-])on1 AEOXHAVXKWHABH-UHFFFAOYSA-N 0.000 description 1
- NCIGWPHMDJUFHR-UHFFFAOYSA-N 3-ethyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC[N+]1=CC(=N)O[N-]1 NCIGWPHMDJUFHR-UHFFFAOYSA-N 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- MFZMQSNKFZJPHM-UHFFFAOYSA-N 3-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C[N+]1=CC(=N)O[N-]1 MFZMQSNKFZJPHM-UHFFFAOYSA-N 0.000 description 1
- GUXAUMIOUISRNR-UHFFFAOYSA-N 3-methyl-4-nonyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CCCCCCCCCC1=[N+](C)[N-]OC1=N GUXAUMIOUISRNR-UHFFFAOYSA-N 0.000 description 1
- JGFVAOFJKTWXGI-UHFFFAOYSA-N 3-methyl-4-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC(C)C1=[N+](C)[N-]OC1=N JGFVAOFJKTWXGI-UHFFFAOYSA-N 0.000 description 1
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- WRWFNMXZZBFOLA-UHFFFAOYSA-N 3-octan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CCCCCCC(C)[N+]1=CC(=N)O[N-]1 WRWFNMXZZBFOLA-UHFFFAOYSA-N 0.000 description 1
- VLKLIBHTXNAMSD-UHFFFAOYSA-N 3-octyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CCCCCCCC[N+]1=CC(=N)O[N-]1 VLKLIBHTXNAMSD-UHFFFAOYSA-N 0.000 description 1
- HCGSLHKQCAPOGI-UHFFFAOYSA-N 3-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1C1=CC=CC=C1 HCGSLHKQCAPOGI-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JMYFMVSOXRRSKI-UHFFFAOYSA-N 3-piperidin-1-yl-4-propyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(CCC)=[N+]1N1CCCCC1 JMYFMVSOXRRSKI-UHFFFAOYSA-N 0.000 description 1
- OVPSWZPKCZYNJW-UHFFFAOYSA-N 3-pyrrolidin-1-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C=[N+]1N1CCCC1 OVPSWZPKCZYNJW-UHFFFAOYSA-N 0.000 description 1
- AEYQJUUYUXBTBJ-UHFFFAOYSA-N 4-(3-benzyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-4-yl)-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C(C(O[N-]1)=N)=[N+]1CC1=CC=CC=C1 AEYQJUUYUXBTBJ-UHFFFAOYSA-N 0.000 description 1
- AKMXMRIANVREFW-UHFFFAOYSA-N 4-(4-methylphenyl)-3-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C1=CC(C)=CC=C1C1=[N+](C=2C=CC=CC=2)[N-]OC1=N AKMXMRIANVREFW-UHFFFAOYSA-N 0.000 description 1
- HZIVJOVQLVOXHI-UHFFFAOYSA-N 4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n,n-dimethylpiperazine-1-sulfonamide Chemical compound C1CN(S(=O)(=O)N(C)C)CCN1[N+]1=CC(=N)O[N-]1 HZIVJOVQLVOXHI-UHFFFAOYSA-N 0.000 description 1
- ZKOLFBYNDOABSZ-UHFFFAOYSA-N 4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n-methyl-n-phenylbenzenesulfonamide Chemical compound C=1C=C([N+]=2[N-]OC(=N)C=2)C=CC=1S(=O)(=O)N(C)C1=CC=CC=C1 ZKOLFBYNDOABSZ-UHFFFAOYSA-N 0.000 description 1
- WWVQELUXYNIXFV-UHFFFAOYSA-N 4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)butanoic acid Chemical compound OC(=O)CCC[N+]1=CC(=N)O[N-]1 WWVQELUXYNIXFV-UHFFFAOYSA-N 0.000 description 1
- IEPUVDZBZDTJNN-UHFFFAOYSA-N 4-(5-imino-4-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound O=C1N(C=2C=CC=CC=2)N(C)C(C)=C1[N+]=1[N-]OC(=N)C=1C1=CC=CC=C1 IEPUVDZBZDTJNN-UHFFFAOYSA-N 0.000 description 1
- WGQDFKOMSXMGJC-UHFFFAOYSA-N 4-(5-imino-4-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound [N-]1OC(=N)C(C(C)C)=[N+]1C(C1=O)=C(C)N(C)N1C1=CC=CC=C1 WGQDFKOMSXMGJC-UHFFFAOYSA-N 0.000 description 1
- HBJGGGJANOSSIA-UHFFFAOYSA-N 4-(benzylsulfanylmethyl)-3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound C=1C=CC=CC=1CSCC=1C(=N)O[N-][N+]=1N1CCOCC1 HBJGGGJANOSSIA-UHFFFAOYSA-N 0.000 description 1
- BXVHRZKWEHQAKP-UHFFFAOYSA-N 4-(chloromethyl)-3-(2-methylpropyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC(C)C[N+]=1[N-]OC(=N)C=1CCl BXVHRZKWEHQAKP-UHFFFAOYSA-N 0.000 description 1
- VYBIZDIGLSKJOY-UHFFFAOYSA-N 4-[2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)ethyl]phenol Chemical compound C1=CC(O)=CC=C1CC[N+]1=CC(=N)O[N-]1 VYBIZDIGLSKJOY-UHFFFAOYSA-N 0.000 description 1
- BFOABEYUPWDKLI-UHFFFAOYSA-N 4-[4-(2-chlorophenyl)-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound ClC1=C(C=CC=C1)C1=[N+]([N-]OC1=N)C=1C(N(N(C=1C)C)C1=CC=CC=C1)=O BFOABEYUPWDKLI-UHFFFAOYSA-N 0.000 description 1
- BPMVCCYDTTZRLC-UHFFFAOYSA-N 4-[4-(furan-2-yl)-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound CN1N(C(C(=C1C)[N+]=1[N-]OC(C=1C=1OC=CC=1)=N)=O)C1=CC=CC=C1 BPMVCCYDTTZRLC-UHFFFAOYSA-N 0.000 description 1
- NCPKMYCWNDTXPC-UHFFFAOYSA-N 4-[4-[4-(dimethylamino)phenyl]-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound C1=CC(N(C)C)=CC=C1C1=[N+](C=2C(N(C=3C=CC=CC=3)N(C)C=2C)=O)[N-]OC1=N NCPKMYCWNDTXPC-UHFFFAOYSA-N 0.000 description 1
- LRZRHCQMDPGPGH-UHFFFAOYSA-N 4-[5-imino-4-(2-phenylethenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound O=C1N(C=2C=CC=CC=2)N(C)C(C)=C1[N+]=1[N-]OC(=N)C=1C=CC1=CC=CC=C1 LRZRHCQMDPGPGH-UHFFFAOYSA-N 0.000 description 1
- OACVWLUTKTXHKK-UHFFFAOYSA-N 4-[5-imino-4-(3-nitrophenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound O=C1N(C=2C=CC=CC=2)N(C)C(C)=C1[N+]=1[N-]OC(=N)C=1C1=CC=CC([N+]([O-])=O)=C1 OACVWLUTKTXHKK-UHFFFAOYSA-N 0.000 description 1
- DBIZDQPMYWIHTD-UHFFFAOYSA-N 4-[5-imino-4-(4-nitrophenyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl]-1,5-dimethyl-2-phenylpyrazol-3-one Chemical compound O=C1N(C=2C=CC=CC=2)N(C)C(C)=C1[N+]=1[N-]OC(=N)C=1C1=CC=C([N+]([O-])=O)C=C1 DBIZDQPMYWIHTD-UHFFFAOYSA-N 0.000 description 1
- GWZIXCJLKARJTH-UHFFFAOYSA-N 4-benzyl-3-(2,6-dimethylpiperidin-1-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound CC1CCCC(C)N1[N+]1=C(CC=2C=CC=CC=2)C(=N)O[N-]1 GWZIXCJLKARJTH-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 150000005168 4-hydroxybenzoic acids Chemical class 0.000 description 1
- VYLLBJRHMRJCGV-UHFFFAOYSA-N 4-methyl-3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C)=[N+]1N1CCOCC1 VYLLBJRHMRJCGV-UHFFFAOYSA-N 0.000 description 1
- NYUIUTKFXRLHQT-UHFFFAOYSA-N 4-methyl-3-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C)=[N+]1C1=CC=CC=C1 NYUIUTKFXRLHQT-UHFFFAOYSA-N 0.000 description 1
- JIJIAHVEIFABKD-UHFFFAOYSA-N 4-phenyl-3-(1-phenylpropan-2-yl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C=2C=CC=CC=2)=[N+]1C(C)CC1=CC=CC=C1 JIJIAHVEIFABKD-UHFFFAOYSA-N 0.000 description 1
- IECOYKQSCVNTCE-UHFFFAOYSA-N 4-phenyl-3-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine Chemical compound [N-]1OC(=N)C(C=2C=CC=CC=2)=[N+]1C(C)C IECOYKQSCVNTCE-UHFFFAOYSA-N 0.000 description 1
- QVZILVCJQMNOLN-UHFFFAOYSA-N 5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound N[N+]1=CC(=N)O[N-]1 QVZILVCJQMNOLN-UHFFFAOYSA-N 0.000 description 1
- ZOLCDOVNNRBTEF-UHFFFAOYSA-N 5-imino-n,n,4-trimethyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound CN(C)[N+]=1[N-]OC(=N)C=1C ZOLCDOVNNRBTEF-UHFFFAOYSA-N 0.000 description 1
- YBOQSVRDMSNIOX-UHFFFAOYSA-N 5-imino-n,n-dimethyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound CN(C)[N+]1=CC(=N)O[N-]1 YBOQSVRDMSNIOX-UHFFFAOYSA-N 0.000 description 1
- RXQPDCCAIPWBQH-UHFFFAOYSA-N 5-imino-n-methyl-n-(1-phenylethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C=CC=CC=1C(C)N(C)[N+]1=CC(=N)O[N-]1 RXQPDCCAIPWBQH-UHFFFAOYSA-N 0.000 description 1
- ZEKICWJLSAYDMG-UHFFFAOYSA-N 5-imino-n-methyl-n-(2-phenylethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C(=N)O[N-][N+]=1N(C)CCC1=CC=CC=C1 ZEKICWJLSAYDMG-UHFFFAOYSA-N 0.000 description 1
- PGXSUVNQQHFXNW-UHFFFAOYSA-N 5-imino-n-methyl-n-(piperidin-1-ylmethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C(=N)O[N-][N+]=1N(C)CN1CCCCC1 PGXSUVNQQHFXNW-UHFFFAOYSA-N 0.000 description 1
- JPUPYSQZMLXQFQ-UHFFFAOYSA-N 5-imino-n-methyl-n-(pyridin-2-ylmethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C(=N)O[N-][N+]=1N(C)CC1=CC=CC=N1 JPUPYSQZMLXQFQ-UHFFFAOYSA-N 0.000 description 1
- KWKPTCLZOOLMNH-UHFFFAOYSA-N 5-imino-n-methyl-n-prop-2-enyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=CCN(C)[N+]1=CC(=N)O[N-]1 KWKPTCLZOOLMNH-UHFFFAOYSA-N 0.000 description 1
- QGJATPMTUJZMRA-UHFFFAOYSA-N 5-imino-n-methyl-n-prop-2-ynyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C#CCN(C)[N+]1=CC(=N)O[N-]1 QGJATPMTUJZMRA-UHFFFAOYSA-N 0.000 description 1
- ZTRIBMSWYJUMDX-UHFFFAOYSA-N 6-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)hexanoic acid Chemical compound OC(=O)CCCCC[N+]1=CC(=N)O[N-]1 ZTRIBMSWYJUMDX-UHFFFAOYSA-N 0.000 description 1
- PKFQVULEYVTNBT-UHFFFAOYSA-N 6-(5-imino-4-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)hexanoic acid Chemical compound CC1=[N+](CCCCCC(O)=O)[N-]OC1=N PKFQVULEYVTNBT-UHFFFAOYSA-N 0.000 description 1
- QJECGEKMTPPJPB-UHFFFAOYSA-N 7-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)heptanoic acid Chemical compound OC(=O)CCCCCC[N+]1=CC(=N)O[N-]1 QJECGEKMTPPJPB-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- DKEBBCCHYGQGTJ-UHFFFAOYSA-N BrC=1C(=C(C=C(C=1)Br)C1=[N+]([N-]OC1=N)C1=CC=C(C=C1)C(=O)OCC)O Chemical compound BrC=1C(=C(C=C(C=1)Br)C1=[N+]([N-]OC1=N)C1=CC=C(C=C1)C(=O)OCC)O DKEBBCCHYGQGTJ-UHFFFAOYSA-N 0.000 description 1
- UUWHXPQSOKKRTB-UHFFFAOYSA-N BrC=1C(=C(C=C(C=1)Br)C1=[N+]([N-]OC1=N)C=1C(N(N(C=1C)C)C1=CC=CC=C1)=O)O Chemical compound BrC=1C(=C(C=C(C=1)Br)C1=[N+]([N-]OC1=N)C=1C(N(N(C=1C)C)C1=CC=CC=C1)=O)O UUWHXPQSOKKRTB-UHFFFAOYSA-N 0.000 description 1
- ISRQMRJUNQYPCX-UHFFFAOYSA-N BrC=1C(=C(C=CC=1)C1=[N+]([N-]OC1=N)C=1C(N(N(C=1C)C)C1=CC=CC=C1)=O)O Chemical compound BrC=1C(=C(C=CC=1)C1=[N+]([N-]OC1=N)C=1C(N(N(C=1C)C)C1=CC=CC=C1)=O)O ISRQMRJUNQYPCX-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- FHBRNLLRKOKOIV-UHFFFAOYSA-N C(=O)(O)C1=C(C=CC=C1)[N+]=1[N-]OC(C=1)=N Chemical compound C(=O)(O)C1=C(C=CC=C1)[N+]=1[N-]OC(C=1)=N FHBRNLLRKOKOIV-UHFFFAOYSA-N 0.000 description 1
- CNKXVARQUKLWJR-UHFFFAOYSA-N C(C)OC(=O)C1=[N+]([N-]OC1=N)N1CCN(CC1)S(=O)(=O)C Chemical compound C(C)OC(=O)C1=[N+]([N-]OC1=N)N1CCN(CC1)S(=O)(=O)C CNKXVARQUKLWJR-UHFFFAOYSA-N 0.000 description 1
- UAKTVZSXHXCJBW-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)C1=[N+]([N-]OC1=N)NCC1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)(=O)C1=[N+]([N-]OC1=N)NCC1=CC=CC=C1 UAKTVZSXHXCJBW-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- JIIOGGDKVMEINR-UHFFFAOYSA-N C1(=CC=CC=C1)NC(=O)O[N+]=1[N-]OC(C=1CCC)=N Chemical compound C1(=CC=CC=C1)NC(=O)O[N+]=1[N-]OC(C=1CCC)=N JIIOGGDKVMEINR-UHFFFAOYSA-N 0.000 description 1
- RMXMUKYMILSDAH-UHFFFAOYSA-N CN1N(C(C(=C1C)[N+]=1[N-]OC(C=1C1=CC=C(C=C1)O)=N)=O)C1=CC=CC=C1 Chemical compound CN1N(C(C(=C1C)[N+]=1[N-]OC(C=1C1=CC=C(C=C1)O)=N)=O)C1=CC=CC=C1 RMXMUKYMILSDAH-UHFFFAOYSA-N 0.000 description 1
- APWZMSUDKSJEMC-UHFFFAOYSA-N COC1=C(C=CC=C1)N1CCN(CC1)[N+]=1[N-]OC(C=1C(CC)=O)=N Chemical compound COC1=C(C=CC=C1)N1CCN(CC1)[N+]=1[N-]OC(C=1C(CC)=O)=N APWZMSUDKSJEMC-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- DJFBDFVYZPXSHI-UHFFFAOYSA-N ClC1=CC=C(CCCCN[N+]=2[N-]OC(C2)=N)C=C1 Chemical compound ClC1=CC=C(CCCCN[N+]=2[N-]OC(C2)=N)C=C1 DJFBDFVYZPXSHI-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- XQLWNAFCTODIRK-UHFFFAOYSA-N Gallopamil Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC(OC)=C(OC)C(OC)=C1 XQLWNAFCTODIRK-UHFFFAOYSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N Glycerol trihexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- KZBAXKKOXPLOBX-UHFFFAOYSA-N Kaempferol 7,4'-dimethyl ether Natural products C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(OC)C=C2O1 KZBAXKKOXPLOBX-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- KCKCUTJJNXEBDU-UHFFFAOYSA-N N-[(3-cyclohexyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-4-yl)methyl]-N-ethylethanamine Chemical compound C1(CCCCC1)[N+]=1[N-]OC(C=1CN(CC)CC)=N KCKCUTJJNXEBDU-UHFFFAOYSA-N 0.000 description 1
- DUBPGMPKDWTJNK-UHFFFAOYSA-N NC(=O)[N+]=1[N-]OC(C=1)=N Chemical compound NC(=O)[N+]=1[N-]OC(C=1)=N DUBPGMPKDWTJNK-UHFFFAOYSA-N 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- IFFPICMESYHZPQ-UHFFFAOYSA-N Prenylamine Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)CCNC(C)CC1=CC=CC=C1 IFFPICMESYHZPQ-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 206010052005 Psychogenic erectile dysfunction Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- ZIIQCSMRQKCOCT-YFKPBYRVSA-N S-nitroso-N-acetyl-D-penicillamine Chemical compound CC(=O)N[C@@H](C(O)=O)C(C)(C)SN=O ZIIQCSMRQKCOCT-YFKPBYRVSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000003048 aphrodisiac agent Substances 0.000 description 1
- 230000002509 aphrodisiac effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 1
- NZUPCNDJBJXXRF-UHFFFAOYSA-O bethanechol Chemical compound C[N+](C)(C)CC(C)OC(N)=O NZUPCNDJBJXXRF-UHFFFAOYSA-O 0.000 description 1
- 229960000910 bethanechol Drugs 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- ICXOQLLBLHMSTL-UHFFFAOYSA-N ethyl 2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-3-phenylpropanoate Chemical compound C=1C(=N)O[N-][N+]=1C(C(=O)OCC)CC1=CC=CC=C1 ICXOQLLBLHMSTL-UHFFFAOYSA-N 0.000 description 1
- BRNOTCWTLLEYSI-UHFFFAOYSA-N ethyl 4-(5-imino-4-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1[N+]1=C(C=2C=CC=CC=2)C(=N)O[N-]1 BRNOTCWTLLEYSI-UHFFFAOYSA-N 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960002602 fendiline Drugs 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229960000457 gallopamil Drugs 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 description 1
- 229960001587 hesperetin Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000012155 injection solvent Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 125000003217 leucino group Chemical group [H]OC(=O)C([H])(N([H])[*])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 229940024471 liquid plasters Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- DLTHXCKCQLGLQI-UHFFFAOYSA-N methyl 3-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)propanoate Chemical compound COC(=O)CC[N+]1=CC(=N)O[N-]1 DLTHXCKCQLGLQI-UHFFFAOYSA-N 0.000 description 1
- QSSJZLPUHJDYKF-UHFFFAOYSA-N methyl 4-methylbenzoate Chemical group COC(=O)C1=CC=C(C)C=C1 QSSJZLPUHJDYKF-UHFFFAOYSA-N 0.000 description 1
- LRFYGMKOKNIXPU-UHFFFAOYSA-N methyl 6-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)hexanoate Chemical compound COC(=O)CCCCC[N+]1=CC(=N)O[N-]1 LRFYGMKOKNIXPU-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XLFWDASMENKTKL-UHFFFAOYSA-N molsidomine Chemical compound O1C(N=C([O-])OCC)=C[N+](N2CCOCC2)=N1 XLFWDASMENKTKL-UHFFFAOYSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- KVAYHEPVYLJHTI-UHFFFAOYSA-N n'-tert-butyl-n'-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n,n-di(propan-2-yl)ethane-1,2-diamine Chemical compound CC(C)N(C(C)C)CCN(C(C)(C)C)[N+]1=CC(=N)O[N-]1 KVAYHEPVYLJHTI-UHFFFAOYSA-N 0.000 description 1
- XOTDYCNQYONAKQ-UHFFFAOYSA-N n'-tert-butyl-n'-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n,n-dimethylethane-1,2-diamine Chemical compound CN(C)CCN(C(C)(C)C)[N+]1=CC(=N)O[N-]1 XOTDYCNQYONAKQ-UHFFFAOYSA-N 0.000 description 1
- MORXEGQCAURULJ-UHFFFAOYSA-N n,n-bis(2-chloroethyl)-4-(5-imino-3-phenyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-4-yl)aniline Chemical compound C1=CC(N(CCCl)CCCl)=CC=C1C1=[N+](C=2C=CC=CC=2)[N-]OC1=N MORXEGQCAURULJ-UHFFFAOYSA-N 0.000 description 1
- NMAHYUUGFRBVHB-UHFFFAOYSA-N n,n-dibenzyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound [N-]1OC(=N)C=[N+]1N(CC=1C=CC=CC=1)CC1=CC=CC=C1 NMAHYUUGFRBVHB-UHFFFAOYSA-N 0.000 description 1
- FFHCBEXPBHAQDS-UHFFFAOYSA-N n,n-dibenzyl-5-imino-4-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound [N-]1OC(=N)C(C)=[N+]1N(CC=1C=CC=CC=1)CC1=CC=CC=C1 FFHCBEXPBHAQDS-UHFFFAOYSA-N 0.000 description 1
- UAGOFCQPDILSMU-UHFFFAOYSA-N n,n-dibutyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound CCCCN(CCCC)[N+]1=CC(=N)O[N-]1 UAGOFCQPDILSMU-UHFFFAOYSA-N 0.000 description 1
- ZHAUOJDXBXJOEX-UHFFFAOYSA-N n,n-diethyl-2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)ethanamine Chemical compound CCN(CC)CC[N+]1=CC(=N)O[N-]1 ZHAUOJDXBXJOEX-UHFFFAOYSA-N 0.000 description 1
- CLTFQSKUUZVONC-UHFFFAOYSA-N n,n-diethyl-4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(CC)CC)=CC=C1[N+]1=CC(=N)O[N-]1 CLTFQSKUUZVONC-UHFFFAOYSA-N 0.000 description 1
- PROIAHBAGLBNFM-UHFFFAOYSA-N n,n-diethyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound CCN(CC)[N+]1=CC(=N)O[N-]1 PROIAHBAGLBNFM-UHFFFAOYSA-N 0.000 description 1
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 1
- LIACIJSJPRYWAB-UHFFFAOYSA-N n-(1,3-benzodioxol-5-ylmethyl)-5-imino-n-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C=C2OCOC2=CC=1CN(C)[N+]1=CC(=N)O[N-]1 LIACIJSJPRYWAB-UHFFFAOYSA-N 0.000 description 1
- OIMSWFGSYBCICZ-UHFFFAOYSA-N n-(1-adamantyl)-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound [N-]1OC(=N)C=[N+]1NC1(C2)CC(C3)CC2CC3C1 OIMSWFGSYBCICZ-UHFFFAOYSA-N 0.000 description 1
- URIJYDUQCYHFJO-UHFFFAOYSA-N n-[2-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)ethyl]pyridine-3-carboxamide Chemical compound [N-]1OC(=N)C=[N+]1CCNC(=O)C1=CC=CN=C1 URIJYDUQCYHFJO-UHFFFAOYSA-N 0.000 description 1
- GUQXHMAJUGITSZ-UHFFFAOYSA-N n-benzyl-5-imino-n-methyl-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C(=N)O[N-][N+]=1N(C)CC1=CC=CC=C1 GUQXHMAJUGITSZ-UHFFFAOYSA-N 0.000 description 1
- ZLFVJRHXZBXAEB-UHFFFAOYSA-N n-cyclohexyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound [N-]1OC(=N)C=[N+]1NC1CCCCC1 ZLFVJRHXZBXAEB-UHFFFAOYSA-N 0.000 description 1
- GUAIBNSXIKSOHM-UHFFFAOYSA-N n-ethyl-4-(5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-yl)-n-phenylbenzenesulfonamide Chemical compound C=1C=C([N+]=2[N-]OC(=N)C=2)C=CC=1S(=O)(=O)N(CC)C1=CC=CC=C1 GUAIBNSXIKSOHM-UHFFFAOYSA-N 0.000 description 1
- QSZJLBWANGGKRD-UHFFFAOYSA-N n-ethyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound CCN[N+]1=CC(=N)O[N-]1 QSZJLBWANGGKRD-UHFFFAOYSA-N 0.000 description 1
- QZTWHKTUDXUJGX-UHFFFAOYSA-N n-ethyl-n-[(5-imino-3-propan-2-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-4-yl)methyl]ethanamine Chemical compound CCN(CC)CC1=[N+](C(C)C)[N-]OC1=N QZTWHKTUDXUJGX-UHFFFAOYSA-N 0.000 description 1
- YAIFHDLURHHLRI-UHFFFAOYSA-N n-tert-butyl-5-imino-n-(2-methoxyethyl)-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound COCCN(C(C)(C)C)[N+]1=CC(=N)O[N-]1 YAIFHDLURHHLRI-UHFFFAOYSA-N 0.000 description 1
- DXOSFWNDIRIOOR-UHFFFAOYSA-N n-tert-butyl-n-cyclohexyl-5-imino-1-oxa-3-azonia-2-azanidacyclopent-3-en-3-amine Chemical compound C=1C(=N)O[N-][N+]=1N(C(C)(C)C)C1CCCCC1 DXOSFWNDIRIOOR-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- VZWXXKDFACOXNT-UHFFFAOYSA-N niludipine Chemical compound CCCOCCOC(=O)C1=C(C)NC(C)=C(C(=O)OCCOCCC)C1C1=CC=CC([N+]([O-])=O)=C1 VZWXXKDFACOXNT-UHFFFAOYSA-N 0.000 description 1
- 229950000109 niludipine Drugs 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 229960005425 nitrendipine Drugs 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- BWORNNDZQGOKBY-UHFFFAOYSA-N ombuin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(OC)C(O)=C1 BWORNNDZQGOKBY-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- CYXKNKQEMFBLER-UHFFFAOYSA-N perhexiline Chemical compound C1CCCNC1CC(C1CCCCC1)C1CCCCC1 CYXKNKQEMFBLER-UHFFFAOYSA-N 0.000 description 1
- 229960000989 perhexiline Drugs 0.000 description 1
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 1
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 1
- 229960001999 phentolamine Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229960001989 prenylamine Drugs 0.000 description 1
- 201000011264 priapism Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- 235000012752 quinoline yellow Nutrition 0.000 description 1
- 239000004172 quinoline yellow Substances 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- BBBFJLBPOGFECG-UHFFFAOYSA-N salmon calcitonin Chemical compound C=1N=CNC=1CC(C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(C(C)O)C(=O)NC(CC=1C=CC(O)=CC=1)C(=O)N1C(CCC1)C(=O)NC(CCCNC(N)=N)C(=O)NC(C(C)O)C(=O)NC(CC(N)=O)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N1C(CCC1)C(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CCC(O)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C1CSSCC(N)C(=O)NC(CO)C(=O)NC(CC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)N1 BBBFJLBPOGFECG-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000050 smooth muscle relaxant Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940083618 sodium nitroprusside Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- RNVYQYLELCKWAN-UHFFFAOYSA-N solketal Chemical compound CC1(C)OCC(CO)O1 RNVYQYLELCKWAN-UHFFFAOYSA-N 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- UISARWKNNNHPGI-UHFFFAOYSA-N terodiline Chemical compound C=1C=CC=CC=1C(CC(C)NC(C)(C)C)C1=CC=CC=C1 UISARWKNNNHPGI-UHFFFAOYSA-N 0.000 description 1
- 229960005383 terodiline Drugs 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960003232 troxerutin Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1
- 229960000317 yohimbine Drugs 0.000 description 1
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Die Erfindung betrifft die Verwendung von Sydnoniminen bei der Behandlung erektiler Dysfunktionen.The invention relates to the use of sydnonimines in the Treatment of erectile dysfunctions.
Etwa 5% der Männer im 40. Lebensjahr und 20% im 60. Lebensjahr leiden an einer erektilen Dysfunktion. Durch den Verlust der Potenz wird das körperliche, seelische und soziale Selbstverständnis des Mannes, insbesondere des jungen Mannes, erschüttert. Patienten mit chronischer erektiler Dysfunktion sind in Ihrer Sexualität und Persönlichkeit verunsichert und als krank anzusehen.About 5% of men in their 40s and 20% in their 60s suffer from erectile dysfunction. By losing the Potency becomes the physical, mental and social Self-image of the man, especially the young man, shocked. Patients with chronic erectile dysfunction are unsettled in your sexuality and personality and to be regarded as sick.
Zur Behandlung von bis in die siebziger Jahre überwiegend auf psychische Ursachen zurückgeführten Potenzstörungen wurden neben psychotherapeutischen Maßnahmen Testosterone oder Aphrodisiaka von umstrittenem Wert eingesetzt. Erst durch die Erforschung der Physiologie des Erektionsablaufs wurde festgestellt, daß bei mehr als 60% der Patienten organische Ursachen die Erektionsstörung bewirken, wobei autonome Efferenzen aus dem parasympathischen Anteil des Sakralmarkes, Neurotransmitter, Dilatation der Penisarterien, Relaxation der cavernösen Räume und Konstriktion der Venen eine Rolle spielen. In über 70% der Fälle sind vaskuläre Faktoren ursächlich beteiligt, wie pathologische arterielle Blutversorgungen oder abnorm gesteigerter venöser Abfluß aus den kavernosen Räumen. Neurogene Störungen sind zu etwa 20% beteiligt.For the treatment of mainly up to the seventies Psychological causes were attributed to erectile dysfunction in addition to psychotherapy or testosterone Aphrodisiacs of controversial value used. Only through that Research into the physiology of the erection process has been done found that organic in more than 60% of patients Causes which cause erectile dysfunction, being autonomous Efferences from the parasympathetic part of the sacral marrow, Neurotransmitters, dilation of the penile arteries, relaxation of the cavernous spaces and constriction of the veins play a role. Vascular factors are the cause in over 70% of cases involved, such as pathological or arterial blood supplies abnormally increased venous drainage from the cavernous spaces. About 20% of neurogenic disorders are involved.
Die orale Therapie dieser organisch bedingten Dysfunktionen mit vasoaktiven Substanzen wie Yohimbin, Phenoxybenzamin, Terbutalin, Bethanechol, Levodopa, Verapamil oder Theophyllin erwies sich als erfolglos. Neben der Anwendung von Prothesenimplantationen oder Revaskularisierungsoperationen erwies sich eine intrakavernöse Injektion von Papaverin (Virag, Lancet, 2, 938, 1982), dem α-Rezeptorenblocker Phenoxybenzamin (Brindley, Br. J. Psychiatr., 143, 332, 1983) und eine Kombination von Papaverin und dem α-Rezeptorenblocker Phentolamin (Stief, Urologe A, 25, 63, 1986) als erfolgreich. Oral therapy with these organically related dysfunctions vasoactive substances such as yohimbine, phenoxybenzamine, Terbutaline, Bethanechol, Levodopa, Verapamil or Theophyllin proved unsuccessful. In addition to using Prosthetic implantation or revascularization surgery an intracavernous injection of papaverine (Virag, Lancet, 2, 938, 1982), the α-receptor blocker phenoxybenzamine (Brindley, Br. J. Psychiatr., 143, 332, 1983) and one Combination of papaverine and the α-receptor blocker Phentolamine (Stief, Urologist A, 25, 63, 1986) as successful.
Letztere Therapiemethode läßt sich vom Patienten selbständig durchführen und wird auch als Schwellkörper- Autoinjektionstherapie (SKAT) bezeichnet.The latter therapy method can be used independently by the patient perform and is also called erectile tissue Auto Injection Therapy (SKAT).
Nachteilig erwiesen sich jedoch eine teilweise unerwünscht verlängerte Erektion mit der Gefahr des Priapismus bei der Verwendung von Papaverin, unerwünschte Schmerzhaftigkeit bei der Anwendung von Phenoxybenzamin sowie eine mögliche Cancerogenität dieser Verbindung.A disadvantage, however, turned out to be partially undesirable prolonged erection with the risk of priapism at the Use of papaverine, unwanted painfulness the use of phenoxybenzamine as well as a possible one Cancerogenicity of this compound.
Im Tierexperiment (Cynomolgus) wurden zudem bei 1-2 Intracavernös-Injektionen Papaverin wöchentlich über 12 Monate ausgedehnte Fibrosierungen weiter Teile des Schwellkörpers festgestellt, was beim Menschen zu äußerst negativen Langzeitergebnissen führen würde, da bei einer Fibroisierung des corpus cavernosum keine Erektion mehr erfolgen kann.In animal experiments (cynomolgus), 1-2 Intra-cavernous papaverine injections weekly for 12 months extensive fibrosis of large parts of the erectile tissue found what is extremely negative in humans Long-term results would result from fibroization of the cavernous body can no longer be erected.
Die Anwendung von Acetylcholin ist bei nur kurzzeitiger Erektion mit starken systemischen Nebenwirkungen verbunden und die Injektion von Prostaglandin E1 wird von den Patienten wegen zu großer Schmerzhaftigkeit abgelehnt.The use of acetylcholine is associated with strong systemic side effects if the erection is short-lived and the injection of prostaglandin E 1 is rejected by the patient due to excessive pain.
Aufgabe der Erfindung war daher die Entwicklung und Herstellung von Arzneimitteln zur Behandlung von neurogenen, arteriellen, neurotransmitterbedingten, myopathischen, venösen oder psychogenen erektilen Dysfunktionen bei Säugetieren, bevorzugt beim Menschen, ohne die genannten Nebenwirkungen.The object of the invention was therefore to develop and manufacture of drugs for the treatment of neurogenic, arterial, neurotransmitter, myopathic, venous or psychogenic erectile dysfunction in mammals, preferred in humans without the side effects mentioned.
Überraschenderweise wurde nun gefunden, daß die intracavernöse Injektion von Sydnoniminen der Formel I,Surprisingly, it has now been found that the intracavernous Injection of sydnonimines of formula I,
worin
R1 Wasserstoff, C1-C5-Alkyl oder Halogen
R2 Wasserstoff, -NO, -COR4 oder SO2-R5,
R3 einen der Reste,wherein
R 1 is hydrogen, C 1 -C 5 alkyl or halogen
R 2 is hydrogen, -NO, -COR 4 or SO 2 -R 5 ,
R 3 is one of the residues,
bedeuten, wobei A für Sauerstoff oder eine der Gruppen
<S(O)m, <N-R11, <N-COOR8 oder <N-SO2R9 und
m für 0, 1 oder 2 und
n für 2, 3, 4, oder 5 stehen,
R4 Wasserstoff, einen aliphatischen Rest mit 1 bis 6 C-Atomen,
der auch durch Alkoxy 1 bis 6 C-Atomen oder Aryloxy mit 6 bis
12 C-Atomen substituiert sein kann, einen cycloaliphatischen
Rest mit 7 bis 14 C-Atomen, einen tricycloaliphatischen Rest
mit 7 bis 16 C-Atomen, Aryl mit 6 bis 12 C-Atomen, das auch
durch Halogen und/oder Alkyl mit 1 bis 4 C-Atomen und/oder
Alkoxy mit 1 bis 4 C-Atomen mono-, di- oder trisubstituiert sein
kann, Aralkyl oder Aralkenyl mit 7 bis 13 C-Atomen, Alkoxy mit
1 bis 6 C-Atomen, Cycloalkoxy mit 5 bis 8 C-Atomen,
Bicycloalkoxy mit 7 bis 12 C-Atomen, Tricycloalkoxy mit 7 bis
16 C-Atomen, Aryloxy mit 6 bis 12 C-Atomen, Pyridyl, Pyrrolyl,
Imidazolyl, Pyrazolyl, Pyrazinyl, Pyrimidinyl, Pyridazinyl,
Alkoxycarbonyl mit insgesamt 2 bis 7 C-Atomen,
R5 Alkyl mit 1 bis 6 C-Atomen, Aryl mit 6 bis 12 C-Atomen, das
auch durch Methyl oder Halogen substituiert sein kann, oder
eine Dialkylaminogruppe mit 1 bis 4 C-Atomen in jedem der
Alkylreste,
R6 und R7 unabhängig voneinander Alkyl mit 1 bis 6 C-Atomen,
Alkenyl mit 3 bis 6 C-Atomen, Cycloalkyl mit 5 bis 8 C-Atomen,
Bicycloalkyl mit 7 bis 14 C-Atomen, Tricycloalkyl mit 7 bis 16
C-Atomen, Aralkyl mit 7 bis 9 C-Atomen, wobei die Aralkylgruppe
durch Methyl oder Halogen substituiert sein kann, oder einen
über eine Alkylenkette an das Stickstoffatom der 3-Aminogruppe
gebundenen heterocyclischen Ring bedeuten und
R6 zusätzlich Wasserstoff und
R7 zusätzlich ein Rest der Formelmean, where A is oxygen or one of the groups
<S (O) m , <NR 11 , <N-COOR 8 or <N-SO 2 R 9 and
m for 0, 1 or 2 and
n stands for 2, 3, 4 or 5,
R 4 is hydrogen, an aliphatic radical with 1 to 6 C atoms, which can also be substituted by alkoxy 1 to 6 C atoms or aryloxy with 6 to 12 C atoms, a cycloaliphatic radical with 7 to 14 C atoms, one tricycloaliphatic radical with 7 to 16 carbon atoms, aryl with 6 to 12 carbon atoms, which is also mono-, di- by halogen and / or alkyl with 1 to 4 carbon atoms and / or alkoxy with 1 to 4 carbon atoms or can be trisubstituted, aralkyl or aralkenyl with 7 to 13 carbon atoms, alkoxy with 1 to 6 carbon atoms, cycloalkoxy with 5 to 8 carbon atoms, bicycloalkoxy with 7 to 12 carbon atoms, tricycloalkoxy with 7 to 16 carbon atoms Atoms, aryloxy with 6 to 12 carbon atoms, pyridyl, pyrrolyl, imidazolyl, pyrazolyl, pyrazinyl, pyrimidinyl, pyridazinyl, alkoxycarbonyl with a total of 2 to 7 carbon atoms,
R 5 is alkyl having 1 to 6 carbon atoms, aryl having 6 to 12 carbon atoms, which can also be substituted by methyl or halogen, or a dialkylamino group having 1 to 4 carbon atoms in each of the alkyl radicals,
R 6 and R 7 independently of one another alkyl with 1 to 6 C atoms, alkenyl with 3 to 6 C atoms, cycloalkyl with 5 to 8 C atoms, bicycloalkyl with 7 to 14 C atoms, tricycloalkyl with 7 to 16 C atoms Atoms, aralkyl having 7 to 9 carbon atoms, where the aralkyl group can be substituted by methyl or halogen, or a heterocyclic ring bonded via an alkylene chain to the nitrogen atom of the 3-amino group and
R 6 additionally hydrogen and
R 7 is additionally a radical of the formula
sein kann,
R8 Alkyl mit 1 bis 4 C-Atomen,
R9 Alkyl mit 1 bis 6 C-Atomen, Aryl mit 6 bis 12 C-Atomen, das
auch durch Methyl oder Halogen substituiert sein kann, oder
eine Dialkylaminogruppe mit 1 bis 4 C-Atomen in jedem der
Alkylreste,
R10 Alkyl mit 1 bis 4 C-Atomen und
R11 Alkyl mit 1 bis 6 C-Atomen bedeuten,
sowie deren pharmakologisch verträglichen Salze,
zu einer Erektion mit vollständiger Rigidität führen.can be,
R 8 alkyl with 1 to 4 carbon atoms,
R 9 is alkyl having 1 to 6 carbon atoms, aryl having 6 to 12 carbon atoms, which can also be substituted by methyl or halogen, or a dialkylamino group having 1 to 4 carbon atoms in each of the alkyl radicals,
R 10 alkyl with 1 to 4 carbon atoms and
R 11 is alkyl with 1 to 6 carbon atoms,
and their pharmacologically acceptable salts,
lead to an erection with complete rigidity.
Gegenstand der Erfindung ist daher die Verwendung von Sydnoniminen der allgemeinen Formel I zur Herstellung von Arzneimitteln zur Behandlung erektiler Dysfunktionen bei erektiler Dysfunktionen bei Säugetieren und Menschen mittels der Sydnonoimine der allgemeinen Formel I mit Ausnahme von 3-Morpholinosydnonimin.The invention therefore relates to the use of Sydnonimines of the general formula I for the preparation of Medicines used to treat erectile dysfunction erectile dysfunction in mammals and humans the Sydnonoimine of the general formula I with the exception of 3-morpholinosydnonimine.
Als Beispiele für die erfindungsgemäße Verwendbarkeit sind die
folgenden Verbindungen genannt:
3-(2,6-Dimethyl-1-piperidinyl)-sydnonimin;
N-((Butoxyacetyl)oxy)-3-(3,3-dimethyl-4-thiomorpholinyl)-
sydnonimin;
N-(Butoxycarbonyl)-3-(3,3-dimethyl-4-thiomorpholinyl)-
sydnonimin;
3-(3,3-Dimethyl-4-thiomorpholinyl)-N-(methoxycarbonyl)-
sydnonimin;
3-(3,3-Dimethyl-4-thiomorpholinyl)-N-(ethoxycarbonyl)-
sydnonimin;
3-(3,3-Dimethyl-4-thiomorpholinyl)-N-(4-methoxybenzoyl)-
sydnonimin;
3-(3,3-Dimethyl-4-thiomorpholinyl)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(3,3-dimethyl-4 -thiomorpholinyl)-
sydnonimin;
3-(3,3-Dimethyl-4-thiomorpholinyl)-N-(4-methoxybenzoyl)-
sydnonimin;
3-(3,3-Dimethyl-4-thiomorpholinyl)-N-(ethoxycarbonyl)-
sydnonimin;
3-(3,3-Dimethyl-4-thiomorpholinyl)-sydnonimin;
N-Benzoyl-3-(2,6-dimethyl1-piperidinyl)-4-(2-phenylethyl)-
sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-(2-phenylethyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-N-(ethoxycarbonyl)-4-
(phenylmethyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-(phenylmethyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-(1-methylethyl)-sydnonimin;
N-Benzoyl-3-(2,6-dimethyl-1-piperidinyl)-4-hexyl-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-hexyl-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-N-(ethoxycarbonyl)-4-methyl-
sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-methyl-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-N-(4-methoxybenzoyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-(phenoxymethyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-(((phenylmethyl)thio)methyl)-
sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-N-(ethoxycarbonyl)-4-
((phenylmethoxy)methyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-((phenylmethoxy)methyl)-
sydnonimin;
4-(1-Methyl-2-((phenylmethyl)thio)ethyl)-3-(4-morpholino)
sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-N-(4-methoxybenzoyl)-4-
(((phenylmethyl)thio)methyl)-sydnonimin;
N-Benzoyl-3-(2,6-dimethyl-1-piperidinyl)-4-
(((phenylmethyl)thio)methyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)tetra-N-(ethoxycarbonyl)-4-
(((phenylmethyl)thio)methyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-(((phenylmethyl)thio)methyl)-
sydnonimin;
3-(4-Morpholinyl)-4-(((phenylmethyl)thio)methyl)-sydnonimin;
N-Benzoyl-3-(2,6-dimethyl-1-piperidinyl)-4-
((phenylthio)methyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-((phenylthio)methyl)-
sydnonimine;
3-(2,6-Dimethyl-1-piperidinyl)-4-((2-propenylthio)methyl)-
sydnonimin;
N-Benzoyl-3-(2,6-dimethyl-1-piperidinyl)-4-((ethylthio)methyl)-
sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-N-(ethoxycarbonyl)-4-
((ethylthio)methyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-4-((ethylthio)methyl)-
sydnonimin;
3-(Cyclohexyl(1,1-dimethylethyl)amino)-sydnonimin;
3-(Tricyclo(3.3.1.13,7)dec-1-ylamino)-sydnonimin;
N-(Ethoxycarbonyl)-3-((2-hydroxycyclohexyl)amino)-sydnonimin;
N-(4-Chlorbenzoyl)-3-((2-hydroxycyclohexyl)amino)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-((2-hydroxycyclohexyl)amino)-
sydnonimin;
N-Benzoyl-3-((2-hydroxycyclohexyl)amino)-sydnonimin;
3-((2-Hydroxycyclohexyl)amino)-sydnonimin;
3-(Cyclohexylamino)-sydnonimin;
N-(Ethoxycarbonyl)-3-(ethylamino)-sydnonimin;
3-(Ethylamino)-sydnonimin;
3-((2-Hydroxyethyl)amino)-sydnonimin;
3-(2,2-Dimethyl-1-pyrrolidinyl)-sydnonimin;
3-(2,2-Dimethyl-4-(1-methylethyl)-1-piperazinyl)-N-(2-methyl-1-
oxopropyl)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(2,2-dimethyl-4-morpholinyl)-
sydnonimin;
3-(2,2-Dimethyl-1-piperidinyl)-N-(ethoxycarbonyl)-sydnonimin;
N-Acetyl-3-(2,2-dimethyl-1-piperidinyl)-sydnonimin;
3-(4-Chlorbenzoyl)-sydnonimin;
3-(2,2-Dimethyl-4-(1-methylethyl)-1-piperazinyl)-sydnonimin;
3-(2,2-Dimethyl-1-piperidinyl)-sydnonimin;
3-(3,3-Dimethyl-4-morpholinyl)-sydnonimin;
3-((2-(bis(1-Methylethyl)amino)ethyl)(1,1-dimethylethyl)amino)-
N-(2,2-dimethyl-1-oxopropyl)-sydnonimin;
N-Acetyl-3-((2-(dimethylamino)ethyl)(1,1-dimethylethyl)amino)-
sydnonimin;
N-(Cyclohexylcarbonyl)-3-((1,1-dimethylethyl)(2-(1-
methylethoxy)ethyl)amino)-sydnonimin;
N-Benzoyl-3-((1,1-dimethylethyl)(2-methoxyethyl)amino)-
sydnonimin;
3-((1,1-Dimethylethyl)(2-(4-morpholinyl)ethyl)amino)-
sydnonimin;
3-((2-(bis(1-Methylethyl)amino)ethyl)(1,1-dimethylethyl)amino)-
sydnonimin;
3-((2-(Dimethylamino)ethyl)(1,1-dimethylethyl)amino)-
sydnonimin;
3-((1,1-Dimethylethyl)(2-(1-methylethoxy)ethyl)amino)-
sydnonimin;
3-((1,1-Dimethylethyl)(2-methoxyethyl)amino)-sydnonimin;
3-((1,1-Dimethylethyl)(2-hydroxyethyl)amino)-N-
(ethoxycarbonyl)-sydnonimin;
3-((1,1-Dimethylethyl)(2-hydroxyethyl)amino)-sydnonimin;
3-(4-Ethoxyphenyl)-sydnonimin;
3-(2,6-Dimethyl-1-piperidinyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(2,2,6,6-tetramethyl-1-piperidinyl)-
sydnonimin;
3-(2,2,6,6-Tetramethyl-1-piperidinyl)-sydnonimin;
4-Benzoyl-3-((phenylmethyl)amino)-sydnonimin;
N-(Ethoxycarbonyl)-3-(4-morpholinyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-sydnonimin;
N-((2-Propenylthio)acetyl)-3-(1-pyrrolidinyl)-sydnonimin;
3-(1-Piperidinyl)-N-((2-propenylthio)acetyl)-sydnonimin;
3-(Dimethylamino)-N-((2-propenylthio)acetyl)-sydnonimin;
3-(Methyl(tetrahydro-3-thienyl)amino)-N-((2-
propenylthio)acetyl)-sydnonimin;
N-((2-Propenylthio)acetyl)-3-(4-thiomorpholinyl)-sydnonimin;
3-(4-((Dimethylamino)sulfonyl)-1-piperazinyl)-N-((2-
propenylthio)acetyl)-sydnonimin;
3-(4-(Methylsulfonyl)-1-piperazinyl)-N-((2-
propenylthio)acetyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-((2-
propenylthio)acetyl)-sydnonimin;
3-(4-Morpholinyl)-N-((2-propenylthio)acetyl)-sydnonimin;
3-Methyl-4-(1-methylethyl)-sydnonimin;
N-(((4-((2-(Diethylamino)ethoxy)carbonyl)phenyl)amino)-
carbonyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
N-(((4-Aminophenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-(((4-sulfophenyl)amino)carbonyl)-
sydnonimin;
N-(((4-Chlor-3-hydroxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-(((4-nitrophenyl)amino)carbonyl)-
sydnonimin;
N-(((3-Chlor-4-methylphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-(((2,4,6-trimethylphenyl)amino)-
carbonyl)-sydnonimin;
N-(((2,6-Dimethylphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((2-Methylphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-1,3,2-Dioxaphospholan-2-yl-3-(1-methyl-2-phenylethyl)-
sydnonimin;
4-(4-Chlorphenyl)-3-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-
1H-pyrazol-4-yl)-sydnonimin;
4-(2-Chlorphenyl)-3-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-
1H-pyrazol-4-yl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(1-methylethyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(2-phenylethenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(2-furanyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-
(4-methoxyphenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(4-nitrophenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(3-nitrophenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(4-(dimethylamino)phenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(4-hydroxy-3-methoxyphenyl)-sydnonimin;
4-(3,5-Dibrom-2-hydroxyphenyl)-3-(2,3-dihydro-1,5-dimethyl-3-
oxo-2-phenyl-1H-pyrazol-4-yl)-sydnonimin;
4-(3-Brom-2-hydroxyphenyl)-3-(2,3-dihydro-1,5-dimethyl-3-oxo-2-
phenyl-1H-pyrazol-4-yl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(4-hydroxyphenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(3-hydroxyphenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
(2-hydroxyphenyl)-sydnonimin;
3-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-4-
phenyl-sydnonimin;
N-(Dichlorphosphinothioyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-(Methyl(tetrahydro-3-thienyl)amino)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-((2,6,6,7,7-
pentamethylbicyclo(3.1.1)hept-3-yl)carbonyl)-sydnonimin;
N-(3-Chlorbenzoyl)-3-(4-morpholinyl)-sydnonimin;
N-((Cyclohexyloxy)carbonyl)-3-(4-morpholinyl)-sydnonimin;
N-Acetyl-3-(methyl(tetrahydro-3-thienyl)amino)-sydnonimin;
N-Acetyl-3-(bis(2-hydroxyethyl)amino)-sydnonimin;
3-(bis(2-Hydroxyethyl)amino)-N-((phenylmethoxy)carbonyl)-
sydnonimin;
3-(Dimethylamino)-N-(((5-methyl-2-(1-methylethyl)cyclohexyl)
oxy)carbonyl)-sydnonimin;
N-(3-Methyl-1-oxopentyl)-3-(1-piperidinyl)-sydnonimin;
3-(Dimethylamino)-N-((2-methylbutoxy)carbonyl)-sydnonimin;
N-(((5-Methyl-2-(1-methylethyl)cyclohexyl)oxy)carbonyl)-3-(1-
piperidinyl)-sydnonimin-;
3-(Methyl(tetrahydro-3-thienyl)amino)N-(((1,7,7-
trimethylbicyclo(2.2.1)hept-2-yl)oxy)carbonyl)-sydnonimin;
N-(2-Methoxy-1-oxopropyl)-3-(4-morpholinyl)-sydnonimin;
N-((Acetyloxy)phenylacetyl)-3-(4-(ethoxycarbonyl)-1-
piperazinyl)-sydnonimin;
N-((Acetyloxy)phenylacetyl)-3-(4-morpholinyl)-sydnonimin;
N-(2-Methoxy-1-oxopropyl)-3-(4-(methylsulfonyl)-1-piperazinyl)-
sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-(2-methoxy-1-oxopropyl)-
sydnonimin;
N-(((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)carbonyl)-3-(4-
(ethoxycarbonyl)-1-piperazinyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-(((1,7,7-
trimethylbicyclo(2.2.1)hept-2-yl)oxy)carbonyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-(((2,6,6-
trimethylbicyclo(3.1.1)hept-3-yl)oxy)carbonyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-(((5-methyl-2-(1-
methylethyl)cyclohexyl)oxy)carbonyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-((2-ethoxy-1-methyl-2-
oxoethoxy)carbonyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-((2-
methylbutoxy)carbonyl)-sydnonimin;
3-(4-Morpholinyl)-N-(((2,6,6-trimethylbicyclo(3.1.1)hept-3-
yl)oxy)carbonyl)-sydnonimin;
3-(4-Morpholinyl)-N-(((1,7,7-trimethylbicyclo(2.2.1)hept-2-
yl)oxy)carbonyl)-sydnonimin;
N-(((5-Methyl-2-(1-methylethyl)cyclohexyl)oxy)carbonyl)-3-(4-
morpholinyl)-sydnonimin;
N-((2-Ethoxy-1-methyl-2-oxoethoxy)carbonyl)-3-(4-morpholinyl)-
sydnonimin;
N-((2-Methylbutoxy)carbonyl)-3-(4-morpholinyl)-sydnonimin;
3-(4-(Methylsulfonyl)-1-piperazinyl)-N-(((2,6,6-
trimethylbicyclo(3.1.1)hept-3-yl)oxy)carbonyl)-sydnonimin;
N-(((5-Methyl-2-(1-methylethyl)cyclohexyl)oxy)carbonyl)-3-(4-
(methylsulfonyl)-1-piperazinyl)-sydnonimin;
N-(((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)carbonyl)-3-(4-
morpholinyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-(2-methoxy-1-oxopropyl)-
sydnonimin;
N-((2-Methylbutoxy)carbonyl)-3-(4-(methylsulfonyl)-1-
piperazinyl)-sydnonimin;
3-(bis(2-Hydroxyethyl)amino)-N-(ethoxycarbonyl)-sydnonimin;
N-(4-Methyl-1,3,2-dioxaphosphorinan-2-yl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
4-(3-Nitrophenyl)-3-(phenylmethyl)-sydnonimin;
4-(4-(bis(2-Chlorethyl)amino)phenyl)-3-phenyl-sydnonimin;
3-(4-((Diethylamino)sulfonyl)phenyl)-sydnonimin;
3-(4-(1-Pyrrolidinylsulfonyl)phenyl)-sydnonimin;
3-(4-(1-Piperidinylsulfonyl)phenyl)-sydnonimin;
3-(4-(4-Morpholinylsulfonyl)phenyl)-sydnonimin;
3-(4-((Ethylphenylamino)sulfonyl)phenyl)-sydnonimin;
3-(4-((Methylphenylamino)sulfonyl)phenyl)-sydnonimin;
3-(3-Oxa-9-azabicyclo(3.3.1)non-9-yl)-sydnonimin;
3-(3-Oxa-8-azabicyclo(3.2.1)oct-8-yl)-sydnonimin;
3-(2-((3-Pyridinylcarbonyl)amino)ethyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(3-oxa-9-azabicyclo(3.3.1) non-9-yl)-
sydnonimin;
N-(Ethoxycarbonyl)-3-(3-oxa-8-azabicyclo(3.2.1)oct-8-yl)-
sydnonimin;
3-(4-Thiomorpholinyl)-sydnonimin;
3-(2-Hydroxy-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-(((Diethylamino)acetyl)oxy)-2-phenylethyl )-N-
((phenylamino)carbonyl)-sydnonimin;
3-(2-((Chloracetyl)oxy)-2-phenylethyl)-N-
((phenylamino)carbonyl)-sydnonimin;
3-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-sydnonimin;
N-(4-(Chlormethyl)tetrahydro-7,7-dimethyl-4H-
(1,3)dioxolo(4,5)furo( 3,2-d)-1,3,2-dioxaphosphoran-2-yl)-3-(1-
methyl-2-phenylethyl)-sydnonimin;
N-(Diethoxyphosphinyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
N-(Dipropoxyphosphinyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
N-1,3,2-Benzodioxaphosphol-2-yl-3-(1-met hyl-2-phenylethyl)-
sydnonimin;
N-(5,5-Dimethyl-1,3,2-dioxaphosphorinan-2-yl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(4-Methyl-1,3,2-dioxaphosphorinan-2-yl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(4-(5-oxo-5-phenylpentyl)-1-piperazinyl)-
sydnonimine;
N-Benzoyl-3-(4-(4-benzoyl-6-methylheptyl)-1-piperazinyl)-
N-(Ethoxycarbonyl)-3-(4-(9-oxo-9-phenylnonyl)-1-piperazinyl)-
sydnonimin;
N-(Ethoxycarbonyl)-3-(4-(2-oxo-2-phenylethyl)-1-piperazinyl)-
sydnonimin;
N-Benzoyl-3-(4-(2-oxo-2-phenylethyl)-1-piperazinyl)-sydnonimin;
N-Acetyl-3-(4-(2-oxo-2-phenylethyl)-1-piperazinyl)-sydnonimin;
3-(4-(4-Benzoyl-6-methylheptyl)-1-piperazinyl)-sydnonimin;
3-(4-(9-Oxo-9-phenylnonyl)-1-piperazinyl)-sydnonimin;
3-(4-(7-Oxo-7-phenylheptyl)-1-piperazinyl)-sydnonimin;
3-(4-(6-Oxo-6-phenylhexyl)-1-piperazinyl)-sydnonimin;
3-(4-(4-Oxo-4-phenylbutyl)-1-piperazinyl)-sydnonimin;
3-Methyl-N-(trimethylsilyl)-sydnonimin;
3-(1-(Hydroxymethyl)-2-phenylethyl)-sydnonimin;
3-(1-(hydroxymethyl)-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(1-(hydroxymethyl)-2-
phenylethyl)-sydnonimin, (.PM.)-;
3-(Methyl(phenylmethyl)amino)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(2-methylpropyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(2-furanylmethyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(4-methoxy phenyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(3-phenyl-2-propenyl)-
sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(4-hydroxy-3-methoxyphenyl)-
sydnonimin;
4-(3,5-Dibrom-2-hydroxyphenyl)-3-(4-(ethoxycarbonyl)phenyl)-
sydnonimin;
4-(3-Brom -2-hydroxyphenyl)-3-(4-(ethoxycarbonyl)phenyl)-
sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(4-hydroxyphenyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(3-hydroxyphenyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)phenyl)-4-(2-hydroxyphenyl)-sydnonimin ;
3-(4-(Ethoxycarbonyl)phenyl)-4-phenyl-sydnonimin;
N-(4-Methyl-1,3,2-dioxaphosphorinan-2-yl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
3-(4-(5-Oxo-5-phenylpentyl)-1-piperazinyl)-sydnonimin;
N-(Methoxyacetyl)-3-(methyl(tetrahydro-3-thienyl)amino)-
sydnonimin;
N-Acetyl-3-(4-(ethoxycarbonyl)-1-piperazinyl)-sydnonimin;
N-(4-Methoxybenzoyl)-3-(methyl(tetrahydro-3-thienyl)amino)-
sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-((2,6,6-
trimethylbicyclo(3.1.1)hept-3-yl)carbonyl)-sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-
(tricyclo(3.3.1.13,7)dec-1-ylcarbonyl)-sydnonimin;
N-(2,2-Dimethyl-1-oxopropyl)-3-(4-(ethoxycarbonyl)-1-
piperazinyl)-sydnonimin;
N-(4-Chlorbenzoyl)-3-(4-(ethoxycarbonyl)-1-piperazinyl)-
sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-N-(ethoxyoxoacetyl)-
sydnonimin;
N-Benzoyl-3-(4-(ethoxycarbonyl)-1-piperazinyl)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(4-(ethoxycarbonyl)-1-piperazinyl)-
sydnonimin;
N-(Ethoxycarbonyl)-3-(4-(etho xycarbonyl)-1-piperazinyl)-
sydnonimin;
N-(4-Methylbenzoyl)-3-(methyl(tetrahydro-3-thienyl)amino)-
sydnonimin;
N-(Cyclohexylcarbonyl)-3-(methyl(tetrahydro-3-thienyl)amino)-
sydnonimin;
3-(Methyl(tetrahydro-3-thienyl)amino)-N-(4-nitrobenzoyl)-
sydnonimin;
N-Benzoyl-3-(methyl(tetrahydro-3-thienyl)amino)-sydnonimin;
N-(Ethoxycarbonyl)-3-(methyl(tetrahydro-3-thienyl)amino)-
sydnonimin;
3-(4-(Ethoxycarbonyl)-1-piperazinyl)-sydnonimin;
3-(Methyl(tetrahydro-3-thienyl)amino)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-hydroxy-2-phenylethyl)-
sydnonimin;
3-(2-((4-Morpholinylacetyl)oxy)-2-phenylethyl)-N-
((phenylamino)carbonyl)-sydnonimin;
3-(2-((Chloracetyl)oxy)-2-phenylethyl)-N-((phenylamino)-
carbonyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-
(((diethylamino)acetyl)oxy)-2-phenylethyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-
(((diethylamino)acetyl)oxy)-2-phenylethyl)-sydnonimin;
N-(2-(((4-Methyl-1-piperazinyl)acetyl)oxy)-2-phenylethyl)-N-
((phenylamino)carbonyl)-sydnonimin;
3-(2-((Chloracetyl)oxy)-2-phenylethyl)-N-(((4-
chlorphenyl)amino)carbonyl)-sydnonimin;
3-(2-(((Diethylamino)acetyl)oxy)-2-phenylethyl)-N-
((phenylamino)carbonyl)-sydnonimin;
3-(2-(((4-Methyl-1-piperazinyl)acetyl)oxy)-2-phenylethyl)-N-
((phenylamino)carbonyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl )-3-(2-phenyl-2-
((trimethylsilyl)oxy)ethyl)-sydnonimin;
3-(2-(Acetyloxy)-2-phenylethyl)-N-(((4-
chlorphenyl)amino)carbonyl)-sydnonimin;
3-(2-(Dimethylamino)-2-phenylethyl)-sydnonimin;
N-(4-Methyl-1,3,2-dioxaphosphorinan-2-yl)-3-(1-methyl-1-
phenylethyl)-sydnonimin;
N-1,3,2-Benzodioxaphosphol-2-yl-3-(1-methyl-1-phenylethyl)-
sydnonimin;
3-(1-(((4-Morpholinylacetyl)oxy)methyl)-2-phenylethyl)-N-
((phenylamino)carbonyl)-sydnonimin;
3-(1-((((4-Methyl-1-piperazinyl)acetyl)oxy)methyl)-2-
phenylethyl)-N-((phenylamino)carbonyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(1-(((4-
morpholinylacetyl)oxy)methyl)-2-phenylethyl)-sydnonimin;
3-(1-(((Chloracetyl)oxy)methyl)-2-phenylethyl)-N-
((phenylamino)carbonyl)-sydnonimin;
3-(1-(Hydroxymethyl)-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(1-(hydroxymethyl)-2-
phenylethyl)-sydnonimin;
3-(1-((Acetyloxy)methyl)-2-phenylethyl)-N-(((4-
chlorphenyl)amino)carbonyl)-sydnonimin;
N-(((4-(Methoxycarbonyl)phenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((4-Carboxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-((Dimethylamino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-(Dimethylamino)-2-
phenylethyl)-sydnonimin;
3-(2-(Dimethylamino)-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3,3′-Methylenebis-sydnonimin;
3-(2-Hydroxy-1-methyl-2-phenylethyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-hydroxy-2-
phenylpropyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-(((phenylmethyl)amino)carbonyl)-
sydnonimin;
N-((((4-(Methoxycarbonyl)phenyl)methyl)amino)carbonyl)-3-(1-
methyl-2-phenylethyl)-sydnonimin;
N-((((4-Carboxyphenyl)methyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-((((4-(Ethoxycarbonyl)phenyl)methyl)amino)carbonyl)-3-(1-
methyl-2-phenylethyl)-sydnonimin;
N-(((2-Hydroxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((2-Carboxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((3-Carboxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((4-(Methoxycarbonyl)phenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((4-Carboxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((4-(Ethoxycarbonyl)phenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-(Cyclohexylcarbonyl)-3-(4-(methylsulfonyl)-1-piperazinyl)-
sydnonimin;
N-Formyl-3-(4-thiomorpholinyl)-sydnonimin;
3-(4-((Dimethylamino)sulfonyl)-1-piperazinyl)-sydnonimin;
3-(4-((4-Methylphenyl)sulfonyl)-1-piperazinyl)-sydnonimin;
3-(4-(Methylsulfonyl)-1-piperazinyl)-sydnonimin;
3-(4-Thiomorpholinyl)-sydnonimin;
4-Brom-N-(ethoxycarbonyl)-3-(4-thiomorpholinyl)-sydnonimin;
4-Brom-N-(ethoxycarbonyl)-3-(4-(methylsulfonyl)-1-piperazinyl)-
sydnonimin;
N-nitroso-3-(4-thiomorpholinyl)-sydnonimin;
N-((4-Methylphenyl)sulfonyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-((4-Methylphenyl)sulfonyl)-3-(4-(methylsulfonyl)-1-
piperazinyl)-sydnonimin;
N-(Butoxyacetyl)-3-(4-((4-methylphenyl)sulfonyl)-1-
piperazinyl)-sydnonimin;
3-(4-((4-Methylphenyl)sulfonyl)-1-piperazinyl)-N-
(phenylacetyl)-sydnonimin;
N-Benzoyl-3-(4-((dimethylamino)sulfonyl)-1-piperazinyl)-
sydnonimin;
N-(Ethoxyoxoacetyl)-3-(4-(methylsulfonyl)-1-piperazinyl)-
sydnonimin;
N-(2,4-Dichlorbenzoyl)-3-(4-((dimethylamino)sulfonyl)-1-
piperazinyl)-sydnonimin;
N-(3-Pyridinylcarbonyl)-3-(4-thiomorpholinyl)-sydnonimin;
3-(4-(Methylsulfonyl)-1-piperazinyl)-N-(3-pyridinylcarbonyl)-
sydnonimin;
3-(4-((Dimethylamino)sulfonyl)-1-piperazinyl)-N-
(ethoxycarbonyl)-sydnonimin;
N-(3,3-Dimethyl-1-oxobutyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-(Ethoxyoxoacetyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(4-(methylsulfonyl)-1-piperazinyl)-
sydnonimin;
3-(4-Thiomorpholinyl)-N-(3,4,5-trimethoxybenzoyl)-sydnonimin;
N-(2,2-Dimethyl-1-oxopropyl)-3-(4-thiomorpholinyl)-sydnonimin;
3-(4-((4-Methylphenyl)sulfonyl)-1-piperazinyl)-N-
(phenoxyacetyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(4-((4-methylphenyl)sulfonyl)-1-
piperazinyl)-sydnonimin;
N-Benzoyl-3-(4-thiomorpholinyl)-sydnonimin;
3-(4-((Dimethylamino)sulfonyl)-1-piperazinyl)-N-(1-oxo-3-
phenyl-2-propenyl)-sydnonimin;
N-(Phenoxycarbonyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-(4-Chlorbenzoyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-Benzoyl-3-(4-(methylsulfonyl)-1-piperazinyl)-sydnonimin;
N-(2,2-Dimethyl-1-oxopropyl)-3-(4-(methylsulfonyl)-1-
piperazinyl)-sydnonimin;
3-(4-((Dimethylamino)sulfonyl)-1-piperazinyl)-N-(1-oxopropyl)-
sydnonimin;
N-Acetyl-3-(4-(methylsulfonyl)-1-piperazinyl)-sydnonimin;
N-Acetyl-3-(4-((dimethylamino)sulfonyl)-1-piperazinyl)-
sydnonimin;
N-(Methoxyacetyl)-3-(4-thiomorpholinyl)-sydnonimin;
N-Acetyl-3-(4-thiomorpholinyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-hydroxy-2-phenylethyl)-
sydnonimin;
N-(((4-Acetylphenyl)amino)carbonyl)-3-(2-hydroxy-2-
phenylethyl)-sydnonimin;
3-(2Hydroxy-2-phenylethyl)-N-(((4-nitrophenyl)amino)carbonyl)-
sydnonimin;
N-(((3,4-Dichlorphenyl)amino)carbonyl)-3-(2-hydroxy-2-
phenylethyl)-sydnonimin;
N-(((4-Fluorphenyl)amino)carbonyl)-3-(2-hydroxy-2-phenylethyl)-
sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-hydroxy-1-methyl-2-
phenylethyl)-sydnonimin;
3-(2-Hydroxy-1-methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-Hydroxy-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-Hydroxy-2-phenylethyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-hydroxy-2-
phenylpropyl)-sydnonimin;
3-(2-hydroxy-2-phenylpropyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-Hydroxy-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-(((4-Methylphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-(((3-
(trifluormethyl)phenyl)amino)carbonyl)-sydnonimin;
N-(((3,4-Dichlorphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-Acetyl-3-(1-methyl-2-phenylethyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(2-phenylethyl)-
sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(1-Methyl-1-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-Hydroxy-1-methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-Hydroxy-1-methyl-2-phenylethyl)-N-(((4-
hydroxyphenyl)amino)carbonyl)-sydnonimin;
N-(((4-Hydroxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-((Cyclohexylamino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-((phenylamino)acetyl)-sydnonimin;
N-((Methylamino)acetyl)-N-(1-methyl-2-phenylethyl)-sydnonimin;
N-(2-Amino-1-oxopropyl)-N-(1-methyl-2-phenylethyl)-sydnonimin;
N-(Aminoacetyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
N-(((1-Carboxypentyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((1-Carboxy-3-methylbutyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(2-(((1,1-Dimethylethoxy)carbonyl)amino)-3-(1H-indol-3-yl)-1-
oxopropyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
N-(((Carboxymethyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-((((Carboxyphenyl)methyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((Carboxyphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-Acetyl-3-cyclohexyl-4-methyl-sydnonimin;
3-Cyclohexyl-4-methyl-sydnonimin;
4-Brom-3-methyl-N-((methylamino)carbonyl)-sydnonimin;
N-Acetyl-3-cyclohexyl-4-methyl-sydnonimin;
N-Acetyl-3-cyclohexyl-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-(((3-
(trifluormethyl)phenyl)amino)carbonyl)-sydnonimin;
N-(((3,4-Dichlorphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((4-Chlorphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-Acetyl-3-(1-methyl-2-phenylethyl)-sydnonimin;
N-(((4-Methylphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-(2-Phenylethyl )-N-(((3-(trifluormethyl)phenyl)amino)-
carbonyl)-sydnonimin;
N-(((3,4-Dichlorphenyl)amino)carbonyl)-3-(2-phenylethyl)-
sydnonimin;
N-(Chlor(dimethyliminio)methyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-((Dimethylamino)carbonyl)-3-(1-meth yl-2-phenylethyl)-
sydnonimin;
N-((Dimethylamino)(phenylimino)methyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-((Dimethylamino)((phenylmethyl)imino)methyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-((Dimethylamino)iminomethyl)-3-(1-methyl -2-phenylethyl)-
sydnonimin;
3-Tricyclo(3.3.1.13,7)dec-1-yl-sydnonimin;
3-Cyclohexyl-N-(((3,4-dichlorphenyl)amino)carbonyl)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(4-morpholinyl)-sydnonimin;
N-((Phenylamino)carbonyl)-3-(tricyclo(3.3.1.13,7)de c-1-
ylmethyl)-sydnonimin;
N-((Phenylamino)carbonyl)-3-tricyclo(3.3.1.13,7)dec-1-yl
sydnonimin;
3-Cyclohexyl-N-((phenylamino)carbonyl)-sydnonimin;
N-((Methylamino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-Methyl-N-((methylamino)carbonyl)-sydnonimin;
N-(((4-Ethoxyphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-(Tricyclo(3.3.1.13,7)dec-1-ylmethyl)-sydnonimin;
N-(((4-Methoxyphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-Acetyl-3-(1-methylethyl)-sydnonimin;
N-Acetyl-3-ethyl-sydnonimin;
N-Acetyl-3-methyl-sydnonimin;
N-Acetyl-3-propyl-sydnonimin;
4-(4-Methoxyphenyl)-3-(phenylmethyl)-sydnonimin,
4-(4-Methylphenyl)-3-(phenylmethyl)-sydnonimin;
4-(4-Hydroxyphenyl)-3-(phenylmethyl)-sydnonimin;
4-(2-Hydroxyphenyl)-3-(phenylmethyl)-sydnonimin;
4-(3,4-Dimethoxyphenyl)-3-(phenylmethyl)-sydnonimin;
3-(2,2,2-Trinitroethyl)-sydnonimin;
3-(4-Ethoxyphenyl)-4-(4-methylphenyl)-sydnonimin;
3-(3-Ethoxyphenyl)-4-(4-methylphenyl)-sydnonimin;
3-(2-Ethoxyphenyl)-4-(4-methylphenyl)-sydnonimin;
3-(4-Methoxyphenyl)-4-(4-methylphenyl)-sydnonimin;
3-(3-Methoxyphenyl)-4-(4-methylphenyl)-sydnonimin;
3-(2-Methoxyphenyl)-4-(4-methylphenyl)-sydnonimin;
3,4-bis(4-Methylphenyl)-sydnonimin;
3-(3-Methylphenyl)-4-(4-methylphenyl)-sydnonimin;
3-(2-Methylphenyl)-4-(4-methylphenyl)-sydnonimin;
4-(4-Methylphenyl)-3-phenyl-sydnonimin;
3-(3-Ethoxy-3-oxo-1-phenylpropyl)-sydnonimin;
3-(2-(4-Aminophenyl)ethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-(4-Nitrophenyl)ethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(1-Methyl-2-(4-nitrophenyl)ethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-((Phenylamino)carbonyl)-3-(2-phenylethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-(2-(4-Nitrophenyl)ethyl)-sydnonimin;
3-(1-Methyl-2-(4-nitrophenyl)ethyl)-sydnonimin;
3-(2-(4-Aminophenyl)ethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-(((4-Bromphenyl)amino)carbonyl)-3-methyl-sydnonimin;
N-(((4-Bromphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
4-Brom-N-((methylamino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
N-(((2,4-Dinitrophenyl)amino)carbonyl)-3-methyl-sydnonimin;
N-((Methylamino)carbonyl)-3-(1-methyl-2-(4-nitrophenyl)ethyl)-
sydnonimin;
N-(((2,4-dinitrophenyl)amino)carbonyl)-3-(1-methyl-2-(4-
nitrophenyl)ethyl)-sydnonimin;
4-Brom-N-(((2,4-dibromphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
4-Brom-N-(((4-bromphenyl)amino)carbonyl)-3-methyl-sydnonimin;
4-Brom-N-(((4-bromphenyl)amino)carbonyl)-3-(1-methyl-2-
phenylethyl)-sydnonimin;
N-(((4-Bromphenyl)amino)carbonyl)-3-methyl-sydnonimin;
N-(((4-Bromphenyl)amino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
4-Brom-N-((methylamino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-Methyl-N-((phenylamino)carbonyl)-sydnonimin;
N-((Methylamino)carbonyl)-3-(1-methyl-2-phenylethyl)-
sydnonimin;
3-(7-Methoxy-7-oxoheptyl)-sydnonimin;
3-(4-(Carboxymethyl)phenyl)-sydnonimin;
3-(3-Ethoxy-3-oxo-2-phenylpropyl)-sydnonimin;
3-(2-Ethoxy-2-oxo-1-(phenylmethyl)ethyl)-sydnonimin;
3-(2-Ethoxy-1-methyl-2-oxoethyl)-sydnonimin;
3-(6-Methoxy-6-oxohexyl)-sydnonimin;
3-(4-Ethoxy-4-oxobutyl)-sydnonimin;
3-(2-Carboxyethyl)-sydnonimin;
4-Brom-3-(1-piperidinyl)-sydnonimin;
4-Chlor-N-(ethoxycarbonyl)-3-(1-piperidinyl)-sydnonimin;
4-Chlor-3-(dimethylamino)-N-(3-pyridinylcarbonyl)-sydnonimin;
4-Chlor-3-(4-morpholinyl)-sydnonimin;
4-Chlor-N-(cyclohexylcarbonyl)-3-(4-morpholinyl)-sydnonimin;
4-Brom-N-(ethoxycarbonyl)-3-(1-piperidinyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(1-piperidinyl)-sydnonimin;
N-Acetyl-3-(hexahydro-1H-azepin-1-yl)-sydnonimin;
4-Brom-3-(hexahydro-1H-azepin-1-yl)-sydnonimin;
4-Brom-3-(dimethylamino)-N-(3-pyridinylcarbonyl)-sydnonimin;
3-(Dimethylamino)-N-(3-pyridinylcarbonyl)-sydnonimin;
4-Brom-3-(4-morpholinyl)-sydnonimin;
4-Brom-N-(cyclohexylcarbonyl)-3-(4-morpholinyl)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(4-morpholinyl)-sydnonimin;
4-Brom-3-(dimethylamino)-sydnonimin;
N-Acetyl-3-(dimethylamino)-sydnonimin;
4-Methyl-3-(4-(2-(nitrooxy)ethyl)-1-piperazinyl)-sydnonimin;
N-(Ethoxycarbonyl)-3-(4-(2-(nitrooxy)ethyl)-1-piperazinyl)-
sydnonimin;
N-(2-Ethoxy-2-oxoethyl)-4-methyl-3-(4-(2-(nitrooxy)-ethyl)-1-
piperazinyl)-sydnonimin;
N-Nitro-3-(3,3,3-trinitropropyl)-sydnonimin;
N-Nitroso-3-(3,3,3-trinitropropyl)-sydnonimin;
3-(3,3,3-Trinitropropyl)-sydnonimine;
3,3′-(3,3-Dinitro-1,5pentanediyl)bis(N-nitroso)-sydnonimin;
N-Acetyl-1-butyl-sydnonimin;
1-((4-Carboxyphenyl)methyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-Benzoyl-1-(6-carboxypentyl)-sydnonimin;
N-Benzoyl-1-(6-carboxyhexyl)-sydnonimin;
1-(5-Carboxypentyl)-N-((phenylamino)carbonyl)-sydnonimin;
N-(Aminocarbonyl)-1-(5-carboxypentyl)-sydnonimin;
N-Benzoyl-1-(5-carboxypentyl)-sydnonimin;
N-Benzoyl-1-(5-carboxyhexyl)-sydnonimin;
N-Acetyl-1-(5-carboxypentyl)-sydnonimin;
N-Acetyl-1-(5-carboxyhexyl)sydnonimin;
1-(6-Carboxyhexyl)-sydnonimin;
3-(4-Carboxybutyl)-sydnonimin;
1-((4-Carboxyphenyl)methyl)-sydnonimin;
3-(6-Carboxyhexyl)-sydnonimin;
3-(4-Carboxybutyl)-sydnonimin;
4-(2-Methoxy-2-oxoethyl)-N-((methylamino)carbonyl)-3-phenyl-
sydnonimin;
3-(2-Carboxy-1-piperidinyl)-N-nitroso-sydnonimin;
N-Benzoyl-3-(dibutylamino)-sydnonimin;
N-Benzoyl-3-(2-carboxy-1-piperidinyl)-sydnonimin;
N-Benzoyl-3-(diethylamino)-sydnonimin;
Sydnonimin;
4-Brom-3-(4-methyl-1-piperazinyl)-N-(phenoxycarbonyl)-
sydnonimin;
4-Chlor-N-(ethoxycarbonyl)-3-(4-morpholinyl)-sydnonimin;
3-Octyl-sydnonimin;
4-(4-Methoxyphenyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
4-((Diethylamino)methyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
3-(4-Ethoxyphenyl)-sydnonimin;
N-Acetyl-3-(1-piperidinyl)-sydnonimin;
4-Methyl-3-(1-piperidinyl)-sydnonimin;
3-(2-Carboxyethyl)-sydnonimin;
3-(Methyl-2-propenylamino)-sydnonimin;
3-(Aminocarbonyl)-sydnonimin;
N-Benzoyl-3,4-diphenyl-sydnonimin;
3-(4-(4,4-bis(4-Fluorphenyl)butyl)-1-piperazinyl)-N-(1-
oxopropyl)-sydnonimin;
3-(4-(2-Methoxyphenyl)-1-piperazinyl)-N-(3,4,5-
trimethoxybenzoyl)-sydnonimin;
3-(4-(Diphenylmethyl)-1-piperazinyl)-N-(1-oxopropyl)-
sydnonimin;
N-(1,3-Benzodioxol-5-ylcarbonyl)-3-(4-(2-methoxyphenyl)-1-
piperazinyl)-sydnonimin;
3-(4-(2-Pyrimidinyl)-1-piperazinyl)-N-(3,4,5-
trimethoxybenzoyl)-sydnonimin;
3-(4-(2-Methoxyphenyl)-1-piperazinyl)-N-
((phenylamino)carbonyl)-sydnonimin;
N-(1-Oxopropyl)-3-((4-(2,3,4-trimethoxyphenyl)methyl)-1-
piperazinyl)-sydnonimin;
3-(4-(Diphenylmethyl)-1-piperazinyl)-sydnonimin;
N-(2,2-Dimethyl-1-oxopropyl)-3-(4-(2-methoxyphenyl)-1-
piperazinyl)-sydnonimin;
3-(2-(4-((2,3,4-Trimethoxyphenyl)methyl)-1-piperazinyl)ethyl)-
sydnonimin;
N-(1,3-Benzodioxol-5-ylcarbonyl)-3-(4-(2-pyrimidinyl)-1-
piperazinyl)-sydnonimin;
3-(4-((2,3-Dihydro-1,4-benzodioxin-2-yl)methyl)-1-piperazinyl)-
N-(1-oxopropyl)-sydnonimin;
3-(4-(2-Methoxyphenyl)-1-piperazinyl)-(1-oxopropyl)-sydnonimin;
3-(2-(4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl)ethyl)-
sydnonimin;
3-(4-((2,3,4-Trimethoxyphenyl)methyl)-1-piperazinyl)-
sydnonimin;
N-((Phenylamino)carbonyl)-3-(4-(2-pyrimidinyl)-1-piperazinyl)-
sydnonimin;
3-(4-(2-Methoxyphenyl)-1-piperazinyl)-(1-oxybutyl)sydnonimin;
N-(1-Oxopropyl)-3-(4-(2-pyridinyl)-1-piperazinyl)-sydnonimin;
N-(1-Oxobutyl)-3-(4-(2-pyrimidinyl)-1-piperazinyl)-sydnonimin;
3-(4-((2,3-Dihydro-1,4-benzodioxin-2-yl)methyl)-1-piperazinyl)-
sydnonimin;
3-(2-(4-(2-Methoxyphenyl)-1-piperazinyl)ethyl)-sydnonimin;
N-(2,2-Dimethyl-1-oxopropyl)-3-(4-(2-pyrimidinyl)-1-
piperazinyl)-sydnonimin;
3-(4-(1,3-Benzodioxol-5-yl)-1-piperazinyl)-N-(1-oxopropyl)
sydnonimin;
3-(4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl)-sydnonimin;
3-(2-(4-(2-Pyridinyl)-1-piperazinyl)ethyl)-sydnonimin;
N-(1-Oxopropyl)-3-(4-(2-pyrimidinyl)-1-piperazinyl)-sydnonimin;
3-(4-(2-Methoxyphenyl)-1-piperazinyl)-sydnonimin;
3-(2-(4-(2-pyrimidinyl)-1-piperazinyl)ethyl)-sydnonimin;
3-(4-(2-Pyridinyl)-1-piperazinyl)-sydnonimin;
3-(4-(2-Pyrimidinyl)-1-piperazinyl)-sydnonimin;
3-Phenyl-N-(trichloracetyl)-sydnonimin;
3-(2-(3,4-Dimethoxyphenyl)ethyl)-sydnonimin;
3-(2-(4-Methoxyphenyl)ethyl)-sydnonimin;
3-(2-(4-Hydroxyphenyl)ethyl)-sydnonimin;
3-(2-(4-Hydroxyphenyl)methyl)-sydnonimin;
N-Benzoyl-3-(2-phenylethyl)-sydnonimin;
3-(3-Phenylpropyl)-N-(2,3,4-trimethoxybenzoyl)-sydnonimin;
3-(2-Phenylethyl)-N-(2,3,4-trimethoxybenzoyl)-sydnonimin;
3-(2-(3,4-Dimethoxyphenyl)ethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
N-Acetyl-3-(2-(3,4-dimethoxyphenyl)ethyl)-sydnonimin;
4-Phenyl-3-(2-phenylethyl)-sydnonimin;
4-Methyl-3-(2-phenylethyl)-sydnonimin;
3-(2-Ethoxy-2-oxoethyl)-N-(1-oxopropyl)-sydnonimin;
N-Acetyl-3-(2-ethoxy-2-oxoethyl)-sydnonimin;
3-(2-Phenyl-1-(phenylmethyl)ethyl)-sydnonimin;
N,N′-Diformyl-3,3′-dimethyl-4,4′-bisydnonimin;
N,N′-Dicarboxy-3,3′-diphenyl-4,4′-bisydnonimin;
N,N′-Dicarboxy-3,3′-dimethyl-4,4′-bisydnonimin;
N,N′-Dibenzoyl-3,3′-dimethyl-4,4′-bisydnonimin;
3-(5-Carboxypentyl)-sydnonimin;
3-(5-Carboxypentyl)-4-methyl-sydnonimin;
3-(5-Carboxypentyl)-N-nitroso-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-((phenylamino)carbonyl)-
sydnonimin;
3-Acetoxy-4-propyl-sydnonimin;
3-Acetoxy-N-methyl-4-propyl-sydnonimin;
N-(Phenylcarbamoyl)-3-((phenylcarbamoyl)oxy)-4-propyl-
sydnonimin;
3-((Phenylcarbamoyl)oxy)-4-propyl-sydnonimin;
3-Acetoxy-N-acetyl-4-propyl-sydnonimin;
4-(Carboxymethyl)-N-(methylcarbamoyl)-3-phenyl-sydnonimin-
ethylester;
3-(m-((Cyanomethyl)nitrosamino)phenyl)-sydnonimin;
3-Benzyl-4-(m-nitrophenyl)-sydnonimin;
3,3′-p-Phenylenedisydnonimin;
3,3′-(1,2-Ethanediyl)bis-sydnonimin;
3-Morpholino-N-(3,4,5-trimethoxybenzoyl)-sydnonimin;
3-(Dibenzylamino)-4-methyl-sydnonimin;
3-(Dimethylamino)-4-methyl-sydnonimin;
N-Benzoyl-3-(2-methyl-1-piperidinyl)-sydnonimin;
N-Benzoyl-3-(1-piperidinyl)-sydnonimin;
3-(Dimethylamino)-N-nitroso-sydnonimin;
3-(Dimethylamino)-N-(ethoxycarbonyl)-sydnonimin;
N-Carboxy-3-morpholino-sydnonimin-3,3,5-trimethylcyclohexyl
ester;
N-Carboxy-3-morpholino-sydnonimin-2-(p-tolylsulfonyl)ethyl
ester;
N-Carboxy-3-morpholino-sydnonimin-ethylester;
N-(N-Carboxyalanyl)-3-morpholino-sydnonimin-benzylester;
3-(4-Morpholinyl)-N-(phenoxyacetyl)-sydnonimin;
N-Acetyl-3-(4-morpholinyl)-sydnonimin;
3-(Carboxymethyl)-4-phenyl-sydnonimin-ethylester;
N-Acetyl-3-butyl-4-phenyl-sydnonimin;
N-Acetyl-3-phenyl-sydnonimin;
N-Acetyl-3-benzyl-sydnonimin;
3-Benzyl-4-phenyl-sydnonimin;
3-Phenyl-sydnonimin;
3-Benzyl-sydnonimin;
3-(((2-Carboxy-3,3-dimethyl-7-oxo-4-thia-1-
azabicyc1o(3.2.0)hept-6-yl)carbamoyl)methyl)-N-((o-
chlorphenyl)carbamoyl)-sydnonimin;
N-Acetyl-3-(carbamoylmethyl)-sydnonimin;
4-(Carbamoylmethyl)-3-methyl-N-(phenylcarbamoyl)-sydnonimin;
4-(Carboxymethyl)-3-methyl-N-(phenylcarbamoyl)-sydnonimin-
ethylester;
N-(Benzylcarbamoyl)-3-(carboxymethyl)-sydnonimin-ethylester;
3-(Carboxymethyl)-N-(methylcarbamoyl)-4-phenyl-sydnonimin-
ethylester;
3-(α-Methylphenethyl)-sydnonimin;
3,3′-(3,3-Dinitro-1,5-pentanediyl)bis-sydnonimin;
N-Benzoyl-3-(carboxymethyl)-sydnonimin-ethylester;
3-Isopropyl-4-phenyl-sydnonimin;
N-Benzoyl-3-(carbamoylmethyl)-4-phenyl-sydnonimin;
3-(Carbamoylmethyl)-4-phenyl-N-(phenylthiocarbamoyl)-
sydnonimin;
3-(α-Carbamoyl-p-tolyl)-N-(methylcarbamoyl)-sydnonimin;
N-(Benzylcarbamoyl)-3-(carbamoylmethyl)-sydnonimin;
4-(Carbamoylmethyl)-3-methyl-N-(methylcarbamoyl)-sydnonimin;
3-(((2-Hydroxyethyl)carbamoyl)methyl)-4-phenyl-N-
(phenylcarbamoyl)-sydnonimin;
3-(Carbamoylmethyl)-N-((o-chlorphenyl)carbamoyl)-sydnonimin;
3-(Carbamoylmethyl)-4-methyl-N-(phenylthiocarbamoyl)-
sydnonimin;
3-(Carbamoylmethyl)-4-phenyl-N-(phenylcarbamoyl)-sydnonimin;
3-(Carbamoylmethyl)-N-(methyl carbamoyl)-4-phenyl-sydnonimin;
3-(α-Carboxy-p-tolyl)-N-((o-chlorphenyl)carbamoyl)-sydnonimin-
ethylester;
3-(α-Carboxy-p-tolyl)-N-(methylcarbamoyl)-sydnonimin-
ethylester;
3-(o-Carboxyphenyl)-N-(methylcarbamoyl)-sydnonimin;
3-Benzyl-4(carboxymethyl)-N-(methylcarbamoyl)-sydnonimin-
ethylester;
4-(2-Ethoxy-2-oxoethyl)-3-methyl-N-((methylamino)carbonyl)-
sydnonimin;
3-(Carboxymethyl)-4-methyl-N-(phenylthiocarbamoyl)-sydnonimin-
ethylester;
3-(Carboxymethyl)-4-phenyl-N-(phenylthiocarbamoyl)-sydnonimin-
ethylester;
3-(Carboxymethyl)-4-phenyl-N-(phenylcarbamoyl)-sydnonimin-
ethylester;
3-(Carboxymethyl)-N-(methylcarbamoyl)-sydnonimin-ethylester;
3-(Carboxymethyl)-N-((o-chlorphenyl)carbamoyl)-sydnonimin-
ethylester;
N-Benzoyl-3-(carboxymethyl)-4-phenyl-sydnonimin-ethylester;
N-Benzoyl-3-(carboxymethyl)-sydnonimin;
3-(Carboxymethyl)-sydnonimin;
4-(Carboxymethyl)-3-methyl -N-(phenylcarbamoyl)-sydnonimin;
3-(α-Carboxy-p-tolyl)-N-((o-chlorphenyl)carbamoyl)-sydnonimin;
3-(α-Carboxy-p-tolyl)-N-(methylcarbamoyl)-sydnonimin;
4-(Carboxymethyl)-3-methyl-N-(methylcarbamoyl)-sydnonimin;
N-(Benzylcarbamoyl)-3-(carboxymethyl)-sydnonimin;
3-(Carboxymethyl)-4-phenyl-N-(phenylthiocarbamoyl)-sydnonimin;
3-(Carboxymethyl)-4-phenyl-N-(phenylcarbamoyl)-sydnonimin;
3-(Carboxymethyl)-N-((o-chlorphenyl)carbamoyl)-sydnonimin;
3-(α-Carboxy-p-tolyl)-sydnonimin-ethylester;
3-(o-Carboxyphenyl)-sydnonimin;
3-Benzyl-4-(carboxymethyl)-sydnonimin-ethylester;
4-(Carboxymethyl)-3-methyl-sydnonimin-ethylester;
3-(2-Ethoxy-2-oxoethyl)-sydnonimin;
3-(Methoxyphenyl)-sydnonimin;
N-Acetyl-3-cyclohexyl-sydnonimin;
N-Formyl-3-morpholino-sydnonimin;
3-Cyclohexyl-4-isopropyl-sydnonimin;
4-Methyl-3-morpholino-sydnonimin;
4-Methyl-3-(1-methyl-2-phenylethyl)-sydnonimin;
3-(3-Piperidinopropyl)-sydnonimin;
3-(3-(Dimethylamino)propyl)-sydnonimin;
3-(2-(Diethylamino)ethyl)-sydnonimin;
3-(2-(Dimethylamino)ethyl)-sydnonimin;
3-Cyclohexyl-4-methyl-sydnonimin;
4-Brom-N-carboxy-3-morpholino-sydnonimin-phenylester;
N-Carboxy-3-(dimethylamino)-sydnonimin-benzylester;
4-Brom-N-(methoxycarbonyl)-3-(methyl(1-phenylethyl)amino)-
sydnonimin;
N-Carboxy-4-chlor-3-(dimethylamino)-sydnonimin-allylester;
N-Carboxy-3-(dimethylamino)-sydnonimin-allylester;
N-Carboxy-3-(methyl(α-methylbenzyl)amino)-sydnonimin-
methylester;
4-Brom-N-(butoxycarbonyl)-3-(hexahydro-1H-azepin-1-yl)
sydnonimin;
N-Carboxy-3-(hexahydro-1H-azepin-1-yl)-sydnonimin-butylester;
4-Brom-N-carboxy-3-(4-methyl-1-piperazinyl)-sydnonimin-
phenylester;
N-Carboxy-3-(4-methyl-1-piperazinyl)-sydnonimin-phenylester;
N-Carboxy-4-chlor-3-(dimethylamino)-sydnonimin-benzylester;
4-Brom-N-carboxy-3-(dimethylamino)-sydnonimin-benzylester;
N-(Ethoxycarbonyl)-4-iodo-3-(4-morpholinyl)-sydnonimin;
4-Brom-N-carboxy-3-morpholino-sydnonimin-ethylester;
4-Brom-N-(ethoxycarbonyl)-3-(4-morpholinyl)-sydnonimin;
N-Carboxy-4-chlor-3-morpholino-sydnonimin-ethylester;
N-Acetyl-4-brom-3-(methyl(α-methylbenzyl)amino)-sydnonimin;
N-Acetyl-4-brom-3-(3,4-dihydro-2(1H)-isoquinolyl)-sydnonimin;
3-(Methylpiperonylamino)-sydnonimin;
3-Acetyl-N-morpholino-sydnonimin;
N-nitroso-3-(1-piperidinyl)-sydnonimin;
3-(4-Morpholinyl)-N-((phenylamino)carbonyl)-sydnonimin;
3-(4-Methyl-1-piperazinyl)-N-nitroso-sydnonimin;
3-(bis(Phenylmethyl)amino)-4-methyl-N-nitroso-sydnonimin;
3,3′-(1,4-piperazinediyl)bis(N-nitroso-sydnonimin);
3-(2-Methyl-1-piperidinyl)-N-nitroso-sydnonimin;
N-Nitroso-3-(1-pyrrolidinyl)-sydnonimin;
3-(Dibutylamino)-N-nitroso-sydnonimin;
N-((4-(Acetylamino)phenyl)sulfonyl)-3-(4-morpholinyl)-
sydnonimin;
3-(4-Morpholinyl)-N-(3-pyridinylcarbonyl)-sydnonimin;
3-(4Morpholinyl)-N-(1-oxo-2-(((phenylmethoxy)carbonyl)-
amino)propyl)-sydnonimin;
N-(1,3-dioxobutyl)-3-(4-morpholinyl)-sydnonimin;
N-Benzoyl-3-(dimethylamino)-4-methyl-sydnonimin;
3-(4-Morpholinyl)-N-((phenylmethoxy)carbonyl)-sydnonimin;
N-Benzoyl-3-(dimethylamino)-sydnonimin;
3-(4-Morpholinyl)-N-(1-oxo-3-phenyl-2-propenyl)-sydnonimin;
3-(4-Morpholinyl)-N-(1-oxo-3-phenylpropyl)-sydnonimin;
3-(4-Morpholinyl)-N-(1-oxopropyl)-sydnonimin;
3-(4-Morpholinyl)-N-(trichloracetyl)-sydnonimin;
N-(dichloracetyl)-3-(4-morpholinyl)-sydnonimin;
N-(Chloracetyl)-3-(4-morpholinyl)-sydnonimin;
N-Formyl-3-(4-morpholinyl)-sydnonimin;
3-(4-Morpholinyl)-N-(trifluoracetyl)-sydnonimin;
3-(4-Morpholinyl)-N-nitroso-sydnonimin;
3-(4-Morpholinyl)-N-((phenylamino)carbonyl)-sydnonimin;
N-((4-Chlorphenyl)sulfonyl)-3-(4-morpholinyl)-sydnonimin;
N-Benzoyl-3-(4-morpholinyl)-sydnonimin;
3-(((2-Carboxy-3-(hydroxymethyl)-8-oxo-5-thia-1-
azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)methyl)N-((o-
chlorphenyl)carbamoyl)-sydnoniminacetat;
N-Benzoyl-3-(((2-carboxy-3-(hydroxymethyl)-8-oxo-5-thia-1-
azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)methyl)-
sydnoniminacetat;
3-(((2-Carboxy-3-(hydroxymethyl)-8-oxo-5-thia-1-
azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)methyl)-N-
(methylcarbamoyl)-sydnoniminacetat;
3-sec-Octyl-sydnonimin;
4-Chlor-3-(dimethylamino)-N-nicotinoyl-sydnonimin;
4-Chlor-N-(cyclohexylcarbonyl)-3-(4-morpholinyl)-sydnonimin;
4-Brom-N-(2-chlorbenzoyl)-3-(methyl(phenylmethyl)amino)-
sydnonimin;
N-Acetyl-4-brom-3-(3,4-dihydro-2(1H)-isoquinolinyl)-sydnonimin;
N-Acetyl-4-brom-3-(1-piperidinyl)-sydnonimin;
N-(Cyclohexylcarbonyl)-4-iodo-3-(4-morpholinyl)-sydnonimin;
4-Chlor-N-(ethoxycarbonyl)-3-(1-piperidinyl)-sydnonimin;
N-Acetyl-4-chlor-3-(hexahydro-1H-azepin-1-yl)-sydnonimin;
4-Chlor-3-(4-morpholinyl)-sydnonimin;
4-Brom-N-(ethoxycarbonyl)-3-(1-piperidinyl)-sydnonimin;
N-Benzoyl-4-brom-3-(dimethylamino)-sydnonimin;
4-Brom-3-(hexahydro-1H-azepin-1-yl)-sydnonimin;
N-Acetyl-4-brom-3-(methyl(1-phenylethyl)amino)-sydnonimin;
4-Brom-3-(dimethylamino)-N-(3-pyridinylcarbonyl)-sydnonimin;
4-Brom-3-(4-morpholinyl)-sydnonimin;
4-Brom-N-(cyclohexylcarbonyl)-3-(4-morpholinyl)-sydnonimin;
N-Acetyl-3-(3,4-dihydro-2(1H)-isoquinolyl)-sydnonimin;
4-Brom-3-(1-piperidinyl)-sydnonimin;
4-Brom-3-(dimethylamino)-sydnonimin;
3-Piperidino-4-propyl-sydnonimin;
3-Amino-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(4-morpholinyl)-sydnonimin;
3-(Allylmethylamino)-sydnonimin;
N-(2-Chlorbenzoyl)-3-(hexahydro-lH-azepin-1-yl)-sydnonimin;
3-(di-2-Propenylamino)-4-methyl-N-((5-nitro-2-
thienyl)carbonyl)-sydnonimin;
N-(2-Chlorbenzoyl)-3-(methyl(phenylmethyl)amino)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(methyl(phenylmethyl)amino)-
sydnonimin;
N-(Cyclohexylcarbonyl)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-
sydnonimin;
N-(o-Chlorbenzoyl)-3-(3,4-dihydro-2(1H)-isoquinolyl)-
sydnonimin;
N-(2-Methylbenzoyl)-3-(4-morpholinyl)-sydnonimin;
N-(2-Chlorbenzoyl)-3-(4-morpholinyl)-sydnonimin;
N-Acetyl-3-(hexahydro-lH-azepin-1-yl)-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(hexahydro-1H-azepin-1-yl)-sydnonimin;
3-(Hexahydro-1H-azepin-1-yl)-N-(2-methylbenzoyl)-sydnonimin;
3-(Dimethylamino)-N-(5-nitro-2-furoyl)-sydnonimin;
3-(Dimethylamino)-N-((5-nitro-2-thienyl)carbonyl)-sydnonimin;
3-(Methyl(2-pyridylmethyl)amino)-sydnonimin;
N-(Ethoxycarbonyl)-3-(4-morpholinyl)-sydnonimin;
3-(Diallylamino)-4-ethyl-sydnonimin;
3-(Diallylamino)-4-methyl-sydnonimin;
3-(Diallylamino)-4-phenethyl-sydnonimin;
3-(Methyl(2-propynyl)amino)-sydnonimin;
3-(Methyl(phenylmethyl)amino)-sydnonimin;
3-(Diallylamino)-sydnonimin;
N-(Cyclopropylcarbonyl)-3-(dimethylamino)-sydnonimin;
N-Carboxy-3-(dimethylamino)-sydnoniminethylester;
3-(Diethylamino)-sydnonimin;
3-((p-Chlorbenzyl)propylamino)-sydnonimin;
3-(Methylphenethylamino)-sydnonimin;
3-(Methyl(piperidinomethyl)amino)-sydnonimin;
3-(Methyl(α-methylbenzyl)amino)-sydnonimin;
3-(2-Phenylpiperidino)-sydnonimin;
3-(bis(Phenylmethyl)amino)-sydnonimin;
3-(Hexahydro-1H-azepin-1-yl)-sydnonimin;
3-(4-Methyl-1-piperazinyl)-sydnonimin;
3-(3,4-Dihydro-2(1H)-isoquinolinyl)-sydnonimin;
N-Acetyl-3-(dimethylamino)-sydnonimin;
3-(Dimethylamino)-N-(3,3-dimethylbutyryl)-sydnonimin;
3-(Dimethylamino)-N-nicotinoyl-sydnonimin;
N-(Cyclohexylcarbonyl)-3-(dimethylamino)-sydnonimin;
3-(Dimethylamino)-N-o-toluoyl-sydnonimin;
N-(p-Chlorbenzoyl)-3-(dimethylamino)-sydnonimin;
N-(o-Chlorbenzoyl)-3-(dimethylamino)-sydnonimin;
N-Benzoyl-3-(dimethylamino)-sydnonimin;
N-Acetyl-3-(4-acetylhexahydro-1H-1,4-diazepin-1-yl)-sydnonimin;
N-Acetyl-3-piperidino-sydnonimin;
N-Carboxy-3-(diallylamino)-4-ethyl-sydnonimin-ethylester;
N-Carboxy-3-piperidino-sydnonimin-ethylester;
3-(Dimethylamino)-N-hydrocinnamoyl-sydnonimin;
3-(Methyl(α-methylbenzyl)amino)-N-nicotinoyl-sydnonimin;
N-Benzoyl-3-(hexahydro-1H-azepin-1-yl)-sydnonimin;
N-Acetyl-3-(diallylamino)-sydnonimin;
3-(Dimethylamino)-N-(5-nitro-2-furoyl)-sydnonimin;
3-(4-Benzyl-3-phenyl-1-piperazinyl)-sydnonimin;
3-(4-Benzyl-1-piperazinyl)-4-methyl-sydnonimin;
3-(4-Benzyl-1-piperazinyl)-sydnonimin;
3-(4-Methyl-1-piperazinyl)-sydnonimin;
3-(4-(p-Chlorphenyl)-1-piperazinyl)-sydnonimin;
3-(2-Phenoxyethyl)-sydnonimin;
3-(2-Hydroxyethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-sydnonimin;
3-Phenethyl-sydnonimin;
3-(α-Methylbenzyl)-sydnonimin;
3-(2-Methylpropyl)-sydnonimin;
4-Ethyl-3-(2-methylpropyl)-N-nitroso-sydnonimin;
3-(3-Chlorphenyl)-N-nitroso-sydnonimin;
3-(2-hydroxyethyl)-sydnoniminacetat;
3-(3-Carboxypropyl)-sydnonimin;
3-Methyl-4-nonyl-sydnonimin;
3-(2,2-Diphenylethyl)-N-((phenylamino)carbonyl)-sydnonimin;
3-(2,2-Diphenylethyl)-N-nitroso-sydnonimin;
N-(methoxycarbonyl)-3-phenyl-sydnonimin;
3-Benzyl-5-(carboxyamino)-1,2,3-oxadiazoliumhydroxid
methylester;
3-Butyl-N-(methoxycarbonyl)-sydnonimin;
N-Benzoyl-3-butyl-sydnonimin;
N-Acetyl-3-butyl-sydnonimin;
N-Acetyl-3-(1-methylethyl)-sydnonimin;
3-sec-Butyl-sydnonimin;
3-(1-Methylheptyl)-sydnonimin;
3-m-Tolyl-sydnonimin;
3-(2-Phenylethyl)-sydnonimin;
3-(1-Methylpropyl)-sydnonimin;
3-(1-Methyl-2,2-diphenylethyl)-sydnonimin;
3-(2,2-Diphenylethyl)-sydnonimin;
3-(2-Hydroxy-1-methyl-2-phenylethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-nitroso-4-phenyl-sydnonimin;
3-Cyclohexyl-4-((diethylamino)methyl)-N-nitroso-sydnonimin;
3-(1-Methylethyl)-N-nitroso-sydnonimin;
3-Ethyl-N-nitroso-sydnonimin;
3-Methyl-N-nitroso-sydnonimin;
3-(α-Methylphenethyl)-sydnonimin;
3-(p-Ethoxyphenyl)-N-nitroso-sydnonimin;
3-(p-Ethoxyphenyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-nitroso-4-(1-piperidinylmethyl)-
sydnonimin;
4-((Dimethylamino)methyl)-3-(1-methyl-2-phenylethyl)-N-nitroso-
sydnonimin;
N-Benzoyl-3-(α-methylphenethyl)-4-(piperidinomethyl)-
sydnonimin;
N-Benzoyl-3-cyclohexyl-4-((diethylamino)methyl)-sydnonimin;
4-((Diethylamino)methyl)-3-(α-methylphenethyl)-sydnonimin;
4-((Dimethylamino)methyl)-3-(αmethylphenethyl)-sydnonimin;
4-((Diethylamino)methyl)-3-isopropyl-sydnonimin;
3-Cyclohexyl-4-((diethylamino)methyl)-sydnonimin;
3-Cyclohexyl-4-(nitromethyl)-N-nitroso-sydnonimin;
4-(Nitromethyl)-N-nitroso-3-(phenylmethyl)-sydnonimin;
3-Cyclohexyl-4-(nitromethyl)-N-nitroso-sydnonimin;
3-(1-Methylethyl)-4-(nitromethyl)-N-nitroso-sydnonimin;
4-(Chlormethyl)-3-isobutyl-sydnonimin;
3-Benzyl-4-(chlormethyl)-sydnonimin;
3-(α-Methylphenethyl)-N-(phenylthiocarbamoyl)-sydnonimin;
N-((m-Chlorphenyl)carbamoyl)-3-(α-methylphenethyl)-sydnonimin;
3-(2-(Diethylamino)ethyl)-N-(phenylcarbamoyl)-sydnonimin;
N-((Phenylamino)carbonyl)-3-(2-phenylethyl)-sydnonimin;
3-(α-Methylbenzyl)-N-(phenylcarbamoyl)-sydnonimin;
3-Benzyl-N-(phenylcarbamoyl)-sydnonimin;
N-(Aminocarbonyl)-3-(1-methyl-2-phenylethyl)-sydnonimin;
3-(α-Methylphenethyl)-N-nicotinoyl-sydnonimin;
3-(α-Methylphenethyl)-N-(phenylacetyl)-sydnonimin;
3-Phenethyl-N-(phenylacetyl)-sydnonimin;
N-Carboxy-3-(α-methylphenethyl)-sydnonimin-methylester;
N-Carboxy-3-phenethyl-sydnonimin-methylester;
N-Carboxy-3-methyl-sydnonimin-methylester;
4-(p-Methoxyphenyl)-3-(α-methylphenethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-4-phenyl-sydnonimin;
3-(2-Hydroxy-1-methyl-2-phenylethyl)-sydnonimin;
3-(2-Phenoxyethyl)-sydnonimin;
3,3′-(1,2-Ethanediyl)bis(N-nitroso-)sydnonimin;
4-Methyl-N-nitroso-3-(phenylmethyl)-sydnonimin;
4-Brom-N-nitroso-3-phenyl-sydnonimin;
3-(4-Chlorphenyl)-N-nitroso-sydnonimin;
3-(4-Ethoxyphenyl)-N-nitroso-sydnonimin;
3-(4-Methoxyphenyl)-N-nitroso-sydnonimin;
N-Nitroso-3-phenyl-sydnonimin;
3-Cyclohexyl-N-nitroso-sydnonimin;
N-Nitroso-3-(phenylmethyl)-sydnonimin;
N-Nitroso-3-(2-phenylethyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-nitroso-sydnonimin;
3-Cycloheptyl-sydnonimin;
3-Cyclopentyl-sydnonimin;
3-(Allylmethylamino)-sydnonimin;
3,3′-(1,4-piperazinediyl)disydnonimin;
4-Methyl-3-(1-piperidinyl)-sydnonimin;
3-(Dibutylamino)-sydnonimin;
3-(2-Methyl-1-piperidinyl)-sydnonimin;
3-(Dimethylamino)-sydnonimin;
3-(1-Pyrrolidinyl)-sydnonimin;
3-(1-Piperidinyl)-sydnonimin;
3-(p-Fluorphenyl)-sydnonimin;
3-(m-Fluorphenyl)-sydnonimin;
4-Methyl-3-piperonyl-sydnonimin;
N-Carbamoyl-3-phenyl-sydnonimin;
N-Benzoyl-4-brom-3-(2-methylpropyl)-sydnonimin;
N-(Ethoxycarbonyl)-3,4-diphenyl-sydnonimin;
N-Acetyl-3,4-diphenyl-sydnonimin;
3-p-Tolyl-sydnonimin;
4-(4-(1-Methylethyl)phenyl)-N-nitroso-3-(phenylmethyl)-
sydnonimin;
3-(1-Methyl-2-phenylethyl)-N-(phenylsulfonyl)-sydnonimin;
4-(3-Nitrophenyl)-N-nitroso-3-(phenylmethyl)-sydnonimin;
4-(Chlormethyl)-3-isopropyl-sydnonimin;
3-Benzyl-4-(p-(dimethylamino)phenyl)-sydnonimin;
3-Isopropyl-4-methyl-sydnonimin;
3-(1-Methylethyl)-sydnonimin;
4-Brom-3-(α-methylphenethyl)-N-(phenylsulfonyl)-sydnonimin;
N-Nitroso-4-phenyl-3-(phenylmethyl)-sydnonimin;
3-Benzyl-4-(4-hydroxy-3-methoxyphenyl)-sydnonimin;
3-Benzyl-4-p-cumenyl-sydnonimin;
4-(4-Methoxyphenyl)-N-nitroso-3-(phenylmethyl)-sydnonimin;
4-(4-(Dimethylamino)phenyl)-N-nitroso-3-(phenylmethyl)-
sydnonimin;
3-Benzyl-4-(m-nitrophenyl)-sydnonimin;
4-(3-Nitrophenyl)-3-(phenylmethyl)-sydnonimin;
3-Benzyl-4-(4-hydroxy-3-methoxyphenyl)-sydnonimin;
4-(4-Methoxyphenyl)-N-nitroso-3-(phenylmethyl)-sydnonimin;
N-Acetyl-3-benzyl-4-phenyl-sydnonimin;
N-Benzoyl-3-benzyl-4-phenyl-sydnonimin;
3-(1,3-Benzodioxol-5-ylmethyl)-sydnonimin;
N-(N-Acetylsulfanilyl)-3-piperonyl-sydnonimin;
3,4-Diphenyl-sydnonimin;
3-Isopropyl-4-methyl-sydnonimin;
3-(2-Chlorethyl)-sydnonimin;
3-(1-Methylethyl)-sydnonimin;
4-(Chlormethyl)-3-isopropyl-sydnonimin;
3-Cyclohexyl-sydnonimin;
3-Methyl-sydnonimin;
3-Ethyl-sydnonimin;
3-Butyl-sydnonimin;
4-Methyl-3-(α-methylphenethyl)-sydnonimin;
3,4-Diphenyl-sydnonimin;
4-Methyl-3-phenyl-sydnonimin;
3-(2-Carboxyethyl)-sydnonimin;
4-Phenyl-3-p-tolyl-sydnonimin;
3-(o-Methoxyphenyl)-sydnonimin;
3-(1-Methyl-2-phenylethyl)-sydnonimin;
3-(2-Methylpropyl)-sydnonimin;
3-(2-Hydroxyethyl)-sydnonimin;
3-(3-Methoxy-3-oxopropyl)-sydnonimin;
N-Benzoyl-3-(2-methylpropyl)-sydnonimin;
N-Benzoyl-4-methyl-3-(phenylmethyl)-sydnonimin;
N-(Dichlorphosphinyl)-3-(1-methylethyl)-sydnonimin;
N-(Dichlorphosphinyl)-4-methyl-3-phenyl-sydnonimin;
3-(1-Phenylethyl)-sydnonimin;
4-Phenyl-3-(phenylmethyl)-sydnonimin;
4-Methyl-3-(phenylmethyl)-sydnonimin;
3-((4-Chlorphenyl)methyl)-sydnonimin;
3-(Phenylmethyl)-sydnonimin;
N-Carboxy-3-(p-ethoxyphenyl)-sydnonimin-methylester;
N-Carboxy-3-(p-methoxyphenyl)-sydnonimin-methylester;
N-Carboxy-3-(p-chlorphenyl)-sydnonimin-methylester;
N-Carboxy-3-p-tolyl-sydnonimin-methylester;
N-Carboxy-3-(m-chlorphenyl)-sydnonimin-methylester;
sowie deren pharmakologisch verträglichen Salze.These are examples of the usability according to the invention
called the following connections:
3- (2,6-dimethyl-1-piperidinyl) sydnonimine;
N - ((Butoxyacetyl) oxy) -3- (3,3-dimethyl-4-thiomorpholinyl) -
sydnonimin;
N- (butoxycarbonyl) -3- (3,3-dimethyl-4-thiomorpholinyl) -
sydnonimin;
3- (3,3-dimethyl-4-thiomorpholinyl) -N- (methoxycarbonyl) -
sydnonimin;
3- (3,3-dimethyl-4-thiomorpholinyl) -N- (ethoxycarbonyl) -
sydnonimin;
3- (3,3-dimethyl-4-thiomorpholinyl) -N- (4-methoxybenzoyl) -
sydnonimin;
3- (3,3-dimethyl-4-thiomorpholinyl) sydnonimine;
N- (cyclohexylcarbonyl) -3- (3,3-dimethyl-4-thiomorpholinyl) -
sydnonimin;
3- (3,3-dimethyl-4-thiomorpholinyl) -N- (4-methoxybenzoyl) -
sydnonimin;
3- (3,3-dimethyl-4-thiomorpholinyl) -N- (ethoxycarbonyl) -
sydnonimin;
3- (3,3-dimethyl-4-thiomorpholinyl) sydnonimine;
N-benzoyl-3- (2,6-dimethyl1-piperidinyl) -4- (2-phenylethyl) -
sydnonimin;
3- (2,6-dimethyl-1-piperidinyl) -4- (2-phenylethyl) sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -N- (ethoxycarbonyl) -4-
(phenylmethyl) sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4- (phenylmethyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4- (1-methylethyl) -sydnonimine;
N-benzoyl-3- (2,6-dimethyl-1-piperidinyl) -4-hexyl-sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4-hexyl-sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -N- (ethoxycarbonyl) -4-methyl-
sydnonimin;
3- (2,6-dimethyl-1-piperidinyl) -4-methyl-sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -N- (4-methoxybenzoyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4- (phenoxymethyl) sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4 - (((phenylmethyl) thio) methyl) -
sydnonimin;
3- (2,6-dimethyl-1-piperidinyl) -N- (ethoxycarbonyl) -4-
((phenylmethoxy) methyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4 - ((phenylmethoxy) methyl) -
sydnonimin;
4- (1-methyl-2 - ((phenylmethyl) thio) ethyl) -3- (4-morpholino)
sydnonimin;
3- (2,6-dimethyl-1-piperidinyl) -N- (4-methoxybenzoyl) -4-
(((phenylmethyl) thio) methyl) -sydnonimine;
N-benzoyl-3- (2,6-dimethyl-1-piperidinyl) -4-
(((phenylmethyl) thio) methyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) tetra-N- (ethoxycarbonyl) -4-
(((phenylmethyl) thio) methyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4 - (((phenylmethyl) thio) methyl) -
sydnonimin;
3- (4-morpholinyl) -4 - (((phenylmethyl) thio) methyl) -sydnonimine;
N-benzoyl-3- (2,6-dimethyl-1-piperidinyl) -4-
((phenylthio) methyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4 - ((phenylthio) methyl) -
sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4 - ((2-propenylthio) methyl) -
sydnonimin;
N-benzoyl-3- (2,6-dimethyl-1-piperidinyl) -4 - ((ethylthio) methyl) -
sydnonimin;
3- (2,6-dimethyl-1-piperidinyl) -N- (ethoxycarbonyl) -4-
((ethylthio) methyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) -4 - ((ethylthio) methyl) -
sydnonimin;
3- (cyclohexyl (1,1-dimethylethyl) amino) -sydnonimine;
3- (tricyclo (3.3.1.13,7) dec-1-ylamino) -sydnonimine;
N- (ethoxycarbonyl) -3 - ((2-hydroxycyclohexyl) amino) -sydnonimine;
N- (4-chlorobenzoyl) -3 - ((2-hydroxycyclohexyl) amino) -sydnonimine;
N- (cyclohexylcarbonyl) -3 - ((2-hydroxycyclohexyl) amino) -
sydnonimin;
N-benzoyl-3 - ((2-hydroxycyclohexyl) amino) -sydnonimine;
3 - ((2-Hydroxycyclohexyl) amino) -sydnonimine;
3- (cyclohexylamino) -sydnonimine;
N- (ethoxycarbonyl) -3- (ethylamino) -sydnonimine;
3- (ethylamino) -sydnonimine;
3 - ((2-Hydroxyethyl) amino) -sydnonimine;
3- (2,2-dimethyl-1-pyrrolidinyl) sydnonimine;
3- (2,2-dimethyl-4- (1-methylethyl) -1-piperazinyl) -N- (2-methyl-1-
oxopropyl) -sydnonimine;
N- (cyclohexylcarbonyl) -3- (2,2-dimethyl-4-morpholinyl) -
sydnonimin;
3- (2,2-dimethyl-1-piperidinyl) -N- (ethoxycarbonyl) -sydnonimine;
N-acetyl-3- (2,2-dimethyl-1-piperidinyl) sydnonimine;
3- (4-chlorobenzoyl) -sydnonimine;
3- (2,2-dimethyl-4- (1-methylethyl) -1-piperazinyl) sydnonimine;
3- (2,2-dimethyl-1-piperidinyl) sydnonimine;
3- (3,3-dimethyl-4-morpholinyl) -sydnonimine;
3 - ((2- (bis (1-methylethyl) amino) ethyl) (1,1-dimethylethyl) amino) -
N- (2,2-dimethyl-1-oxopropyl) -sydnonimine;
N-acetyl-3 - ((2- (dimethylamino) ethyl) (1,1-dimethylethyl) amino) -
sydnonimin;
N- (cyclohexylcarbonyl) -3 - ((1,1-dimethylethyl) (2- (1-
methylethoxy) ethyl) amino) -sydnonimine;
N-Benzoyl-3 - ((1,1-dimethylethyl) (2-methoxyethyl) amino) -
sydnonimin;
3 - ((1,1-dimethylethyl) (2- (4-morpholinyl) ethyl) amino) -
sydnonimin;
3 - ((2- (bis (1-methylethyl) amino) ethyl) (1,1-dimethylethyl) amino) -
sydnonimin;
3 - ((2- (dimethylamino) ethyl) (1,1-dimethylethyl) amino) -
sydnonimin;
3 - ((1,1-dimethylethyl) (2- (1-methylethoxy) ethyl) amino) -
sydnonimin;
3 - ((1,1-dimethylethyl) (2-methoxyethyl) amino) -sydnonimine;
3 - ((1,1-dimethylethyl) (2-hydroxyethyl) amino) -N-
(ethoxycarbonyl) -sydnonimine;
3 - ((1,1-dimethylethyl) (2-hydroxyethyl) amino) -sydnonimine;
3- (4-ethoxyphenyl) -sydnonimine;
3- (2,6-dimethyl-1-piperidinyl) sydnonimine;
N- (ethoxycarbonyl) -3- (2,2,6,6-tetramethyl-1-piperidinyl) -
sydnonimin;
3- (2,2,6,6-tetramethyl-1-piperidinyl) sydnonimine;
4-benzoyl-3 - ((phenylmethyl) amino) -sydnonimine;
N- (ethoxycarbonyl) -3- (4-morpholinyl) -sydnonimine;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -sydnonimine;
N - ((2-propenylthio) acetyl) -3- (1-pyrrolidinyl) -sydnonimine;
3- (1-piperidinyl) -N - ((2-propenylthio) acetyl) -sydnonimine;
3- (dimethylamino) -N - ((2-propenylthio) acetyl) -sydnonimine;
3- (methyl (tetrahydro-3-thienyl) amino) -N - ((2-
propenylthio) acetyl) -sydnonimine;
N - ((2-propenylthio) acetyl) -3- (4-thiomorpholinyl) -sydnonimine;
3- (4 - ((Dimethylamino) sulfonyl) -1-piperazinyl) -N - ((2-
propenylthio) acetyl) -sydnonimine;
3- (4- (methylsulfonyl) -1-piperazinyl) -N - ((2-
propenylthio) acetyl) -sydnonimine;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -N - ((2-
propenylthio) acetyl) -sydnonimine;
3- (4-morpholinyl) -N - ((2-propenylthio) acetyl) -sydnonimine;
3-methyl-4- (1-methylethyl) -sydnonimine;
N - (((4 - ((2- (diethylamino) ethoxy) carbonyl) phenyl) amino) -
carbonyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
N - (((4-aminophenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3- (1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (1-methyl-2-phenylethyl) -N - (((4-sulfophenyl) amino) carbonyl) -
sydnonimin;
N - (((4-chloro-3-hydroxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
3- (1-methyl-2-phenylethyl) -N - (((4-nitrophenyl) amino) carbonyl) -
sydnonimin;
N - (((3-chloro-4-methylphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
3- (1-methyl-2-phenylethyl) -N - (((2,4,6-trimethylphenyl) amino) -
carbonyl) -sydnonimine;
N - (((2,6-dimethylphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((2-methylphenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N-1,3,2-dioxaphospholan-2-yl-3- (1-methyl-2-phenylethyl) -
sydnonimin;
4- (4-chlorophenyl) -3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-
1H-pyrazol-4-yl) -sydnonimine;
4- (2-chlorophenyl) -3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-
1H-pyrazol-4-yl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(1-methylethyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(2-phenylethenyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(2-furanyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -3-
(4-methoxyphenyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(4-nitrophenyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(3-nitrophenyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(4- (dimethylamino) phenyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(4-hydroxy-3-methoxyphenyl) -sydnonimine;
4- (3,5-dibromo-2-hydroxyphenyl) -3- (2,3-dihydro-1,5-dimethyl-3-
oxo-2-phenyl-1H-pyrazol-4-yl) -sydnonimine;
4- (3-bromo-2-hydroxyphenyl) -3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-
phenyl-1H-pyrazol-4-yl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(4-hydroxyphenyl) -sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(3-hydroxyphenyl) sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
(2-hydroxyphenyl) sydnonimine;
3- (2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl) -4-
phenyl-sydnonimine;
N- (dichlorophosphinothioyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3- (methyl (tetrahydro-3-thienyl) amino) -sydnonimine;
3- (4- (Ethoxycarbonyl) -1-piperazinyl) -N - ((2,6,6,7,7-
pentamethylbicyclo (3.1.1) hept-3-yl) carbonyl) -sydnonimine;
N- (3-chlorobenzoyl) -3- (4-morpholinyl) -sydnonimine;
N - ((Cyclohexyloxy) carbonyl) -3- (4-morpholinyl) -sydnonimine;
N-acetyl-3- (methyl (tetrahydro-3-thienyl) amino) -sydnonimine;
N-acetyl-3- (bis (2-hydroxyethyl) amino) -sydnonimine;
3- (bis (2-hydroxyethyl) amino) -N - ((phenylmethoxy) carbonyl) -
sydnonimin;
3- (dimethylamino) -N - (((5-methyl-2- (1-methylethyl) cyclohexyl)
oxy) carbonyl) -sydnonimine;
N- (3-methyl-1-oxopentyl) -3- (1-piperidinyl) sydnonimine;
3- (dimethylamino) -N - ((2-methylbutoxy) carbonyl) -sydnonimine;
N - (((5-methyl-2- (1-methylethyl) cyclohexyl) oxy) carbonyl) -3- (1-
piperidinyl) -sydnonimine;
3- (methyl (tetrahydro-3-thienyl) amino) N - (((1,7,7-
trimethylbicyclo (2.2.1) hept-2-yl) oxy) carbonyl) -sydnonimine;
N- (2-methoxy-1-oxopropyl) -3- (4-morpholinyl) -sydnonimine;
N - ((acetyloxy) phenylacetyl) -3- (4- (ethoxycarbonyl) -1-
piperazinyl) -sydnonimine;
N - ((acetyloxy) phenylacetyl) -3- (4-morpholinyl) -sydnonimine;
N- (2-methoxy-1-oxopropyl) -3- (4- (methylsulfonyl) -1-piperazinyl) -
sydnonimin;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -N- (2-methoxy-1-oxopropyl) -
sydnonimin;
N - (((2,2-Dimethyl-1,3-dioxolan-4-yl) methoxy) carbonyl) -3- (4-
(ethoxycarbonyl) -1-piperazinyl) -sydnonimine;
3- (4- (Ethoxycarbonyl) -1-piperazinyl) -N - (((1,7,7-
trimethylbicyclo (2.2.1) hept-2-yl) oxy) carbonyl) -sydnonimine;
3- (4- (Ethoxycarbonyl) -1-piperazinyl) -N - (((2,6,6-
trimethylbicyclo (3.1.1) hept-3-yl) oxy) carbonyl) -sydnonimine;
3- (4- (Ethoxycarbonyl) -1-piperazinyl) -N - (((5-methyl-2- (1-
methylethyl) cyclohexyl) oxy) carbonyl) -sydnonimine;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -N - ((2-ethoxy-1-methyl-2-
oxoethoxy) carbonyl) -sydnonimine;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -N - ((2-
methylbutoxy) carbonyl) -sydnonimine;
3- (4-Morpholinyl) -N - (((2,6,6-trimethylbicyclo (3.1.1) hept-3-
yl) oxy) carbonyl) -sydnonimine;
3- (4-morpholinyl) -N - (((1,7,7-trimethylbicyclo (2.2.1) hept-2-
yl) oxy) carbonyl) -sydnonimine;
N - (((5-methyl-2- (1-methylethyl) cyclohexyl) oxy) carbonyl) -3- (4-
morpholinyl) -sydnonimine;
N - ((2-ethoxy-1-methyl-2-oxoethoxy) carbonyl) -3- (4-morpholinyl) -
sydnonimin;
N - ((2-methylbutoxy) carbonyl) -3- (4-morpholinyl) -sydnonimine;
3- (4- (Methylsulfonyl) -1-piperazinyl) -N - (((2,6,6-
trimethylbicyclo (3.1.1) hept-3-yl) oxy) carbonyl) -sydnonimine;
N - (((5-methyl-2- (1-methylethyl) cyclohexyl) oxy) carbonyl) -3- (4-
(methylsulfonyl) -1-piperazinyl) -sydnonimine;
N - (((2,2-Dimethyl-1,3-dioxolan-4-yl) methoxy) carbonyl) -3- (4-
morpholinyl) -sydnonimine;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -N- (2-methoxy-1-oxopropyl) -
sydnonimin;
N - ((2-methylbutoxy) carbonyl) -3- (4- (methylsulfonyl) -1-
piperazinyl) -sydnonimine;
3- (bis (2-hydroxyethyl) amino) -N- (ethoxycarbonyl) -sydnonimine;
N- (4-methyl-1,3,2-dioxaphosphorinan-2-yl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
4- (3-nitrophenyl) -3- (phenylmethyl) -sydnonimine;
4- (4- (bis (2-chloroethyl) amino) phenyl) -3-phenyl-sydnonimine;
3- (4 - ((Diethylamino) sulfonyl) phenyl) -sydnonimine;
3- (4- (1-pyrrolidinylsulfonyl) phenyl) -sydnonimine;
3- (4- (1-piperidinylsulfonyl) phenyl) -sydnonimine;
3- (4- (4-morpholinylsulfonyl) phenyl) -sydnonimine;
3- (4 - ((Ethylphenylamino) sulfonyl) phenyl) -sydnonimine;
3- (4 - ((Methylphenylamino) sulfonyl) phenyl) -sydnonimine;
3- (3-oxa-9-azabicyclo (3.3.1) non-9-yl) -sydnonimine;
3- (3-oxa-8-azabicyclo (3.2.1) oct-8-yl) -sydnonimine;
3- (2 - ((3-Pyridinylcarbonyl) amino) ethyl) -sydnonimine;
N- (ethoxycarbonyl) -3- (3-oxa-9-azabicyclo (3.3.1) non-9-yl) -
sydnonimin;
N- (ethoxycarbonyl) -3- (3-oxa-8-azabicyclo (3.2.1) oct-8-yl) -
sydnonimin;
3- (4-thiomorpholinyl) -sydnonimine;
3- (2-hydroxy-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2 - (((Diethylamino) acetyl) oxy) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
3- (2 - ((chloroacetyl) oxy) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
3- (2-Hydroxy-2- (3-hydroxyphenyl) ethyl) -sydnonimine;
N- (4- (chloromethyl) tetrahydro-7,7-dimethyl-4H-
(1,3) dioxolo (4,5) furo (3,2-d) -1,3,2-dioxaphosphoran-2-yl) -3- (1-
methyl-2-phenylethyl) -sydnonimine;
N- (diethoxyphosphinyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
N- (dipropoxyphosphinyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
N-1,3,2-benzodioxaphosphol-2-yl-3- (1-methyl-2-phenylethyl) -
sydnonimin;
N- (5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N- (4-methyl-1,3,2-dioxaphosphorinan-2-yl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N- (ethoxycarbonyl) -3- (4- (5-oxo-5-phenylpentyl) -1-piperazinyl) -
sydnonimine;
N-benzoyl-3- (4- (4-benzoyl-6-methylheptyl) -1-piperazinyl) -
N- (ethoxycarbonyl) -3- (4- (9-oxo-9-phenylnonyl) -1-piperazinyl) -
sydnonimin;
N- (ethoxycarbonyl) -3- (4- (2-oxo-2-phenylethyl) -1-piperazinyl) -
sydnonimin;
N-benzoyl-3- (4- (2-oxo-2-phenylethyl) -1-piperazinyl) -sydnonimine;
N-acetyl-3- (4- (2-oxo-2-phenylethyl) -1-piperazinyl) -sydnonimine;
3- (4- (4-Benzoyl-6-methylheptyl) -1-piperazinyl) sydnonimine;
3- (4- (9-oxo-9-phenylnonyl) -1-piperazinyl) sydnonimine;
3- (4- (7-Oxo-7-phenylheptyl) -1-piperazinyl) sydnonimine;
3- (4- (6-oxo-6-phenylhexyl) -1-piperazinyl) sydnonimine;
3- (4- (4-oxo-4-phenylbutyl) -1-piperazinyl) sydnonimine;
3-methyl-N- (trimethylsilyl) -sydnonimine;
3- (1- (hydroxymethyl) -2-phenylethyl) sydnonimine;
3- (1- (hydroxymethyl) -2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N - (((4-chlorophenyl) amino) carbonyl) -3- (1- (hydroxymethyl) -2-
phenylethyl) -sydnonimine, (.PM.) -;
3- (methyl (phenylmethyl) amino) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (4- (ethoxycarbonyl) phenyl) -4- (2-methylpropyl) sydnonimine;
3- (4- (ethoxycarbonyl) phenyl) -4- (2-furanylmethyl) sydnonimine;
3- (4- (ethoxycarbonyl) phenyl) -4- (4-methoxyphenyl) -sydnonimine;
3- (4- (ethoxycarbonyl) phenyl) -4- (3-phenyl-2-propenyl) -
sydnonimin;
3- (4- (ethoxycarbonyl) phenyl) -4- (4-hydroxy-3-methoxyphenyl) -
sydnonimin;
4- (3,5-dibromo-2-hydroxyphenyl) -3- (4- (ethoxycarbonyl) phenyl) -
sydnonimin;
4- (3-bromo -2-hydroxyphenyl) -3- (4- (ethoxycarbonyl) phenyl) -
sydnonimin;
3- (4- (ethoxycarbonyl) phenyl) -4- (4-hydroxyphenyl) sydnonimine;
3- (4- (ethoxycarbonyl) phenyl) -4- (3-hydroxyphenyl) sydnonimine;
3- (4- (ethoxycarbonyl) phenyl) -4- (2-hydroxyphenyl) sydnonimine;
3- (4- (ethoxycarbonyl) phenyl) -4-phenyl-sydnonimine;
N- (4-methyl-1,3,2-dioxaphosphorinan-2-yl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
3- (4- (5-oxo-5-phenylpentyl) -1-piperazinyl) sydnonimine;
N- (methoxyacetyl) -3- (methyl (tetrahydro-3-thienyl) amino) -
sydnonimin;
N-acetyl-3- (4- (ethoxycarbonyl) -1-piperazinyl) -sydnonimine;
N- (4-methoxybenzoyl) -3- (methyl (tetrahydro-3-thienyl) amino) -
sydnonimin;
3- (4- (Ethoxycarbonyl) -1-piperazinyl) -N - ((2,6,6-
trimethylbicyclo (3.1.1) hept-3-yl) carbonyl) -sydnonimine;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -N-
(tricyclo (3.3.1.13,7) dec-1-ylcarbonyl) -sydnonimine;
N- (2,2-dimethyl-1-oxopropyl) -3- (4- (ethoxycarbonyl) -1-
piperazinyl) -sydnonimine;
N- (4-chlorobenzoyl) -3- (4- (ethoxycarbonyl) -1-piperazinyl) -
sydnonimin;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -N- (ethoxyoxoacetyl) -
sydnonimin;
N-benzoyl-3- (4- (ethoxycarbonyl) -1-piperazinyl) -sydnonimine;
N- (cyclohexylcarbonyl) -3- (4- (ethoxycarbonyl) -1-piperazinyl) -
sydnonimin;
N- (ethoxycarbonyl) -3- (4- (ethoxycarbonyl) -1-piperazinyl) -
sydnonimin;
N- (4-methylbenzoyl) -3- (methyl (tetrahydro-3-thienyl) amino) -
sydnonimin;
N- (cyclohexylcarbonyl) -3- (methyl (tetrahydro-3-thienyl) amino) -
sydnonimin;
3- (methyl (tetrahydro-3-thienyl) amino) -N- (4-nitrobenzoyl) -
sydnonimin;
N-benzoyl-3- (methyl (tetrahydro-3-thienyl) amino) -sydnonimine;
N- (ethoxycarbonyl) -3- (methyl (tetrahydro-3-thienyl) amino) -
sydnonimin;
3- (4- (ethoxycarbonyl) -1-piperazinyl) -sydnonimine;
3- (methyl (tetrahydro-3-thienyl) amino) -sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-hydroxy-2-phenylethyl) -
sydnonimin;
3- (2 - ((4-Morpholinylacetyl) oxy) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
3- (2 - ((Chloroacetyl) oxy) -2-phenylethyl) -N - ((phenylamino) -
carbonyl) -sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-
(((diethylamino) acetyl) oxy) -2-phenylethyl) -sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-
(((diethylamino) acetyl) oxy) -2-phenylethyl) -sydnonimine;
N- (2 - (((4-methyl-1-piperazinyl) acetyl) oxy) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
3- (2 - ((Chloroacetyl) oxy) -2-phenylethyl) -N - (((4-
chlorphenyl) amino) carbonyl) -sydnonimine;
3- (2 - (((Diethylamino) acetyl) oxy) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
3- (2 - (((4-Methyl-1-piperazinyl) acetyl) oxy) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-phenyl-2-
((trimethylsilyl) oxy) ethyl) -sydnonimine;
3- (2- (acetyloxy) -2-phenylethyl) -N - (((4-
chlorphenyl) amino) carbonyl) -sydnonimine;
3- (2- (dimethylamino) -2-phenylethyl) -sydnonimine;
N- (4-methyl-1,3,2-dioxaphosphorinan-2-yl) -3- (1-methyl-1-
phenylethyl) sydnonimine;
N-1,3,2-benzodioxaphosphol-2-yl-3- (1-methyl-1-phenylethyl) -
sydnonimin;
3- (1 - (((4-Morpholinylacetyl) oxy) methyl) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
3- (1 - ((((4-Methyl-1-piperazinyl) acetyl) oxy) methyl) -2-
phenylethyl) -N - ((phenylamino) carbonyl) -sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (1 - (((4-
morpholinylacetyl) oxy) methyl) -2-phenylethyl) -sydnonimine;
3- (1 - (((chloroacetyl) oxy) methyl) -2-phenylethyl) -N-
((phenylamino) carbonyl) -sydnonimine;
3- (1- (hydroxymethyl) -2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N - (((4-chlorophenyl) amino) carbonyl) -3- (1- (hydroxymethyl) -2-
phenylethyl) sydnonimine;
3- (1 - ((Acetyloxy) methyl) -2-phenylethyl) -N - (((4-
chlorphenyl) amino) carbonyl) -sydnonimine;
N - (((4- (methoxycarbonyl) phenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((4-carboxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - ((dimethylamino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2- (dimethylamino) -2-
phenylethyl) sydnonimine;
3- (2- (dimethylamino) -2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3,3'-methylenebis-sydnonimine;
3- (2-hydroxy-1-methyl-2-phenylethyl) sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-hydroxy-2-
phenylpropyl) -sydnonimine;
3- (1-methyl-2-phenylethyl) -N - (((phenylmethyl) amino) carbonyl) -
sydnonimin;
N - ((((4- (methoxycarbonyl) phenyl) methyl) amino) carbonyl) -3- (1-
methyl-2-phenylethyl) -sydnonimine;
N - ((((4-carboxyphenyl) methyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - ((((4- (ethoxycarbonyl) phenyl) methyl) amino) carbonyl) -3- (1-
methyl-2-phenylethyl) -sydnonimine;
N - (((2-hydroxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((2-carboxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((3-carboxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((4- (methoxycarbonyl) phenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((4-carboxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((4- (ethoxycarbonyl) phenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
3- (1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N- (cyclohexylcarbonyl) -3- (4- (methylsulfonyl) -1-piperazinyl) -
sydnonimin;
N-formyl-3- (4-thiomorpholinyl) -sydnonimine;
3- (4 - ((Dimethylamino) sulfonyl) -1-piperazinyl) -sydnonimine;
3- (4 - ((4-Methylphenyl) sulfonyl) -1-piperazinyl) -sydnonimine;
3- (4- (methylsulfonyl) -1-piperazinyl) -sydnonimine;
3- (4-thiomorpholinyl) -sydnonimine;
4-bromo-N- (ethoxycarbonyl) -3- (4-thiomorpholinyl) -sydnonimine;
4-bromo-N- (ethoxycarbonyl) -3- (4- (methylsulfonyl) -1-piperazinyl) -
sydnonimin;
N-nitroso-3- (4-thiomorpholinyl) -sydnonimine;
N - ((4-methylphenyl) sulfonyl) -3- (4-thiomorpholinyl) -sydnonimine;
N - ((4-methylphenyl) sulfonyl) -3- (4- (methylsulfonyl) -1-
piperazinyl) -sydnonimine;
N- (butoxyacetyl) -3- (4 - ((4-methylphenyl) sulfonyl) -1-
piperazinyl) -sydnonimine;
3- (4 - ((4-Methylphenyl) sulfonyl) -1-piperazinyl) -N-
(phenylacetyl) -sydnonimine;
N-benzoyl-3- (4 - ((dimethylamino) sulfonyl) -1-piperazinyl) -
sydnonimin;
N- (ethoxyoxoacetyl) -3- (4- (methylsulfonyl) -1-piperazinyl) -
sydnonimin;
N- (2,4-dichlorobenzoyl) -3- (4 - ((dimethylamino) sulfonyl) -1-
piperazinyl) -sydnonimine;
N- (3-pyridinylcarbonyl) -3- (4-thiomorpholinyl) -sydnonimine;
3- (4- (methylsulfonyl) -1-piperazinyl) -N- (3-pyridinylcarbonyl) -
sydnonimin;
3- (4 - ((Dimethylamino) sulfonyl) -1-piperazinyl) -N-
(ethoxycarbonyl) -sydnonimine;
N- (3,3-dimethyl-1-oxobutyl) -3- (4-thiomorpholinyl) -sydnonimine;
N- (ethoxyoxoacetyl) -3- (4-thiomorpholinyl) -sydnonimine;
N- (ethoxycarbonyl) -3- (4- (methylsulfonyl) -1-piperazinyl) -
sydnonimin;
3- (4-thiomorpholinyl) -N- (3,4,5-trimethoxybenzoyl) -sydnonimine;
N- (2,2-dimethyl-1-oxopropyl) -3- (4-thiomorpholinyl) -sydnonimine;
3- (4 - ((4-Methylphenyl) sulfonyl) -1-piperazinyl) -N-
(phenoxyacetyl) -sydnonimine;
N- (ethoxycarbonyl) -3- (4 - ((4-methylphenyl) sulfonyl) -1-
piperazinyl) -sydnonimine;
N-benzoyl-3- (4-thiomorpholinyl) sydnonimine;
3- (4 - ((Dimethylamino) sulfonyl) -1-piperazinyl) -N- (1-oxo-3-
phenyl-2-propenyl) -sydnonimine;
N- (phenoxycarbonyl) -3- (4-thiomorpholinyl) -sydnonimine;
N- (4-chlorobenzoyl) -3- (4-thiomorpholinyl) -sydnonimine;
N- (ethoxycarbonyl) -3- (4-thiomorpholinyl) -sydnonimine;
N- (cyclohexylcarbonyl) -3- (4-thiomorpholinyl) -sydnonimine;
N-benzoyl-3- (4- (methylsulfonyl) -1-piperazinyl) sydnonimine;
N- (2,2-dimethyl-1-oxopropyl) -3- (4- (methylsulfonyl) -1-
piperazinyl) -sydnonimine;
3- (4 - ((Dimethylamino) sulfonyl) -1-piperazinyl) -N- (1-oxopropyl) -
sydnonimin;
N-acetyl-3- (4- (methylsulfonyl) -1-piperazinyl) -sydnonimine;
N-acetyl-3- (4 - ((dimethylamino) sulfonyl) -1-piperazinyl) -
sydnonimin;
N- (methoxyacetyl) -3- (4-thiomorpholinyl) -sydnonimine;
N-acetyl-3- (4-thiomorpholinyl) -sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-hydroxy-2-phenylethyl) -
sydnonimin;
N - (((4-acetylphenyl) amino) carbonyl) -3- (2-hydroxy-2-
phenylethyl) sydnonimine;
3- (2-Hydroxy-2-phenylethyl) -N - (((4-nitrophenyl) amino) carbonyl) -
sydnonimin;
N - (((3,4-dichlorophenyl) amino) carbonyl) -3- (2-hydroxy-2-
phenylethyl) sydnonimine;
N - (((4-fluorophenyl) amino) carbonyl) -3- (2-hydroxy-2-phenylethyl) -
sydnonimin;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-hydroxy-1-methyl-2-
phenylethyl) sydnonimine;
3- (2-hydroxy-1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2-hydroxy-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2-hydroxy-2-phenylethyl) sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-hydroxy-2-
phenylpropyl) -sydnonimine;
3- (2-hydroxy-2-phenylpropyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2-hydroxy-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N - (((4-methylphenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3- (1-methyl-2-phenylethyl) -N - (((3-
(trifluoromethyl) phenyl) amino) carbonyl) -sydnonimine;
N - (((3,4-dichlorophenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N-acetyl-3- (1-methyl-2-phenylethyl) sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (2-phenylethyl) -
sydnonimin;
3- (1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (1-methyl-1-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2-hydroxy-1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2-Hydroxy-1-methyl-2-phenylethyl) -N - (((4-
hydroxyphenyl) amino) carbonyl) -sydnonimine;
N - (((4-hydroxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
3- (1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N - ((Cyclohexylamino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3- (1-methyl-2-phenylethyl) -N - ((phenylamino) acetyl) -sydnonimine;
N - ((methylamino) acetyl) -N- (1-methyl-2-phenylethyl) sydnonimine;
N- (2-amino-1-oxopropyl) -N- (1-methyl-2-phenylethyl) -sydnonimine;
N- (aminoacetyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
N - (((1-carboxypentyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((1-carboxy-3-methylbutyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N- (2 - (((1,1-dimethylethoxy) carbonyl) amino) -3- (1H-indol-3-yl) -1-
oxopropyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
N - (((carboxymethyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N - ((((carboxyphenyl) methyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((carboxyphenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N-acetyl-3-cyclohexyl-4-methyl-sydnonimine;
3-cyclohexyl-4-methyl-sydnonimine;
4-bromo-3-methyl-N - ((methylamino) carbonyl) -sydnonimine;
N-acetyl-3-cyclohexyl-4-methyl-sydnonimine;
N-acetyl-3-cyclohexyl-sydnonimine;
3- (1-methyl-2-phenylethyl) -N - (((3-
(trifluoromethyl) phenyl) amino) carbonyl) -sydnonimine;
N - (((3,4-dichlorophenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((4-chlorophenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N-acetyl-3- (1-methyl-2-phenylethyl) sydnonimine;
N - (((4-methylphenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3- (2-phenylethyl) -N - (((3- (trifluoromethyl) phenyl) amino) -
carbonyl) -sydnonimine;
N - (((3,4-dichlorophenyl) amino) carbonyl) -3- (2-phenylethyl) -
sydnonimin;
N- (chlorine (dimethyliminio) methyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N - ((Dimethylamino) carbonyl) -3- (1-meth yl-2-phenylethyl) -
sydnonimin;
N - ((Dimethylamino) (phenylimino) methyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - ((Dimethylamino) ((phenylmethyl) imino) methyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - ((dimethylamino) iminomethyl) -3- (1-methyl -2-phenylethyl) -
sydnonimin;
3-tricyclo (3.3.1.13.7) dec-1-yl-sydnonimine;
3-cyclohexyl-N - (((3,4-dichlorophenyl) amino) carbonyl) -sydnonimine;
N- (cyclohexylcarbonyl) -3- (4-morpholinyl) -sydnonimine;
N - ((phenylamino) carbonyl) -3- (tricyclo (3.3.1.13,7) de c-1-
ylmethyl) -sydnonimine;
N - ((Phenylamino) carbonyl) -3-tricyclo (3.3.1.13,7) dec-1-yl
sydnonimin;
3-cyclohexyl-N - ((phenylamino) carbonyl) -sydnonimine;
N - ((methylamino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3-methyl-N - ((methylamino) carbonyl) -sydnonimine;
N - (((4-ethoxyphenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3- (tricyclo (3.3.1.13,7) dec-1-ylmethyl) -sydnonimine;
N - (((4-methoxyphenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N-acetyl-3- (1-methylethyl) -sydnonimine;
N-acetyl-3-ethyl-sydnonimine;
N-acetyl-3-methyl-sydnonimine;
N-acetyl-3-propyl-sydnonimine;
4- (4-methoxyphenyl) -3- (phenylmethyl) -sydnonimine,
4- (4-methylphenyl) -3- (phenylmethyl) -sydnonimine;
4- (4-hydroxyphenyl) -3- (phenylmethyl) sydnonimine;
4- (2-hydroxyphenyl) -3- (phenylmethyl) sydnonimine;
4- (3,4-dimethoxyphenyl) -3- (phenylmethyl) sydnonimine;
3- (2,2,2-trinitroethyl) sydnonimine;
3- (4-ethoxyphenyl) -4- (4-methylphenyl) sydnonimine;
3- (3-ethoxyphenyl) -4- (4-methylphenyl) sydnonimine;
3- (2-ethoxyphenyl) -4- (4-methylphenyl) sydnonimine;
3- (4-methoxyphenyl) -4- (4-methylphenyl) sydnonimine;
3- (3-methoxyphenyl) -4- (4-methylphenyl) sydnonimine;
3- (2-methoxyphenyl) -4- (4-methylphenyl) sydnonimine;
3,4-bis (4-methylphenyl) hydnonimine;
3- (3-methylphenyl) -4- (4-methylphenyl) sydnonimine;
3- (2-methylphenyl) -4- (4-methylphenyl) sydnonimine;
4- (4-methylphenyl) -3-phenyl-sydnonimine;
3- (3-ethoxy-3-oxo-1-phenylpropyl) sydnonimine;
3- (2- (4-aminophenyl) ethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2- (4-nitrophenyl) ethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (1-methyl-2- (4-nitrophenyl) ethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N - ((phenylamino) carbonyl) -3- (2-phenylethyl) -sydnonimine;
3- (1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3- (2- (4-nitrophenyl) ethyl) -sydnonimine;
3- (1-methyl-2- (4-nitrophenyl) ethyl) -sydnonimine;
3- (2- (4-aminophenyl) ethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N - (((4-bromophenyl) amino) carbonyl) -3-methyl-sydnonimine;
N - (((4-bromophenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
4-bromo-N - ((methylamino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
N - (((2,4-dinitrophenyl) amino) carbonyl) -3-methyl-sydnonimine;
N - ((Methylamino) carbonyl) -3- (1-methyl-2- (4-nitrophenyl) ethyl) -
sydnonimin;
N - (((2,4-dinitrophenyl) amino) carbonyl) -3- (1-methyl-2- (4-
nitrophenyl) ethyl) -sydnonimine;
4-bromo-N - (((2,4-dibromophenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
4-bromo-N - (((4-bromophenyl) amino) carbonyl) -3-methyl-sydnonimine;
4-bromo-N - (((4-bromophenyl) amino) carbonyl) -3- (1-methyl-2-
phenylethyl) sydnonimine;
N - (((4-bromophenyl) amino) carbonyl) -3-methyl-sydnonimine;
N - (((4-bromophenyl) amino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
4-bromo-N - ((methylamino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3-methyl-N - ((phenylamino) carbonyl) -sydnonimine;
N - ((methylamino) carbonyl) -3- (1-methyl-2-phenylethyl) -
sydnonimin;
3- (7-methoxy-7-oxoheptyl) sydnonimine;
3- (4- (carboxymethyl) phenyl) -sydnonimine;
3- (3-ethoxy-3-oxo-2-phenylpropyl) sydnonimine;
3- (2-ethoxy-2-oxo-1- (phenylmethyl) ethyl) -sydnonimine;
3- (2-ethoxy-1-methyl-2-oxoethyl) sydnonimine;
3- (6-methoxy-6-oxohexyl) -sydnonimine;
3- (4-ethoxy-4-oxobutyl) sydnonimine;
3- (2-carboxyethyl) sydnonimine;
4-bromo-3- (1-piperidinyl) -sydnonimine;
4-chloro-N- (ethoxycarbonyl) -3- (1-piperidinyl) -sydnonimine;
4-chloro-3- (dimethylamino) -N- (3-pyridinylcarbonyl) -sydnonimine;
4-chloro-3- (4-morpholinyl) -sydnonimine;
4-chloro-N- (cyclohexylcarbonyl) -3- (4-morpholinyl) -sydnonimine;
4-bromo-N- (ethoxycarbonyl) -3- (1-piperidinyl) -sydnonimine;
N- (ethoxycarbonyl) -3- (1-piperidinyl) -sydnonimine;
N-acetyl-3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
4-bromo-3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
4-bromo-3- (dimethylamino) -N- (3-pyridinylcarbonyl) -sydnonimine;
3- (dimethylamino) -N- (3-pyridinylcarbonyl) -sydnonimine;
4-bromo-3- (4-morpholinyl) -sydnonimine;
4-bromo-N- (cyclohexylcarbonyl) -3- (4-morpholinyl) -sydnonimine;
N- (cyclohexylcarbonyl) -3- (4-morpholinyl) -sydnonimine;
4-bromo-3- (dimethylamino) -sydnonimine;
N-acetyl-3- (dimethylamino) -sydnonimine;
4-methyl-3- (4- (2- (nitrooxy) ethyl) -1-piperazinyl) sydnonimine;
N- (ethoxycarbonyl) -3- (4- (2- (nitrooxy) ethyl) -1-piperazinyl) -
sydnonimin;
N- (2-ethoxy-2-oxoethyl) -4-methyl-3- (4- (2- (nitrooxy) ethyl) -1-
piperazinyl) -sydnonimine;
N-nitro-3- (3,3,3-trinitropropyl) -sydnonimine;
N-nitroso-3- (3,3,3-trinitropropyl) sydnonimine;
3- (3,3,3-trinitropropyl) -sydnonimine;
3,3 '- (3,3-dinitro-1,5pentanediyl) bis (N-nitroso) -sydnonimine;
N-acetyl-1-butyl-sydnonimine;
1 - ((4-carboxyphenyl) methyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N-benzoyl-1- (6-carboxypentyl) -sydnonimine;
N-benzoyl-1- (6-carboxyhexyl) -sydnonimine;
1- (5-carboxypentyl) -N - ((phenylamino) carbonyl) -sydnonimine;
N- (aminocarbonyl) -1- (5-carboxypentyl) -sydnonimine;
N-benzoyl-1- (5-carboxypentyl) -sydnonimine;
N-benzoyl-1- (5-carboxyhexyl) -sydnonimine;
N-acetyl-1- (5-carboxypentyl) -sydnonimine;
N-acetyl-1- (5-carboxyhexyl) sydnonimine;
1- (6-carboxyhexyl) -sydnonimine;
3- (4-carboxybutyl) -sydnonimine;
1 - ((4-carboxyphenyl) methyl) -sydnonimine;
3- (6-carboxyhexyl) -sydnonimine;
3- (4-carboxybutyl) -sydnonimine;
4- (2-methoxy-2-oxoethyl) -N - ((methylamino) carbonyl) -3-phenyl-
sydnonimin;
3- (2-carboxy-1-piperidinyl) -N-nitroso-sydnonimine;
N-benzoyl-3- (dibutylamino) -sydnonimine;
N-benzoyl-3- (2-carboxy-1-piperidinyl) sydnonimine;
N-benzoyl-3- (diethylamino) -sydnonimine;
Sydnonimin;
4-bromo-3- (4-methyl-1-piperazinyl) -N- (phenoxycarbonyl) -
sydnonimin;
4-chloro-N- (ethoxycarbonyl) -3- (4-morpholinyl) -sydnonimine;
3-octyl-sydnonimine;
4- (4-methoxyphenyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
4 - ((diethylamino) methyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
3- (4-ethoxyphenyl) -sydnonimine;
N-acetyl-3- (1-piperidinyl) -sydnonimine;
4-methyl-3- (1-piperidinyl) sydnonimine;
3- (2-carboxyethyl) sydnonimine;
3- (methyl-2-propenylamino) -sydnonimine;
3- (aminocarbonyl) -sydnonimine;
N-benzoyl-3,4-diphenyl-sydnonimine;
3- (4- (4,4-bis (4-fluorophenyl) butyl) -1-piperazinyl) -N- (1-
oxopropyl) -sydnonimine;
3- (4- (2-methoxyphenyl) -1-piperazinyl) -N- (3,4,5-
trimethoxybenzoyl) -sydnonimine;
3- (4- (Diphenylmethyl) -1-piperazinyl) -N- (1-oxopropyl) -
sydnonimin;
N- (1,3-benzodioxol-5-ylcarbonyl) -3- (4- (2-methoxyphenyl) -1-
piperazinyl) -sydnonimine;
3- (4- (2-pyrimidinyl) -1-piperazinyl) -N- (3,4,5-
trimethoxybenzoyl) -sydnonimine;
3- (4- (2-methoxyphenyl) -1-piperazinyl) -N-
((phenylamino) carbonyl) -sydnonimine;
N- (1-oxopropyl) -3 - ((4- (2,3,4-trimethoxyphenyl) methyl) -1-
piperazinyl) -sydnonimine;
3- (4- (Diphenylmethyl) -1-piperazinyl) -sydnonimine;
N- (2,2-dimethyl-1-oxopropyl) -3- (4- (2-methoxyphenyl) -1-
piperazinyl) -sydnonimine;
3- (2- (4 - ((2,3,4-Trimethoxyphenyl) methyl) -1-piperazinyl) ethyl) -
sydnonimin;
N- (1,3-benzodioxol-5-ylcarbonyl) -3- (4- (2-pyrimidinyl) -1-
piperazinyl) -sydnonimine;
3- (4 - ((2,3-Dihydro-1,4-benzodioxin-2-yl) methyl) -1-piperazinyl) -
N- (1-oxopropyl) -sydnonimine;
3- (4- (2-methoxyphenyl) -1-piperazinyl) - (1-oxopropyl) -sydnonimine;
3- (2- (4- (1,3-Benzodioxol-5-ylmethyl) -1-piperazinyl) ethyl) -
sydnonimin;
3- (4 - ((2,3,4-Trimethoxyphenyl) methyl) -1-piperazinyl) -
sydnonimin;
N - ((phenylamino) carbonyl) -3- (4- (2-pyrimidinyl) -1-piperazinyl) -
sydnonimin;
3- (4- (2-methoxyphenyl) -1-piperazinyl) - (1-oxybutyl) sydnonimine;
N- (1-oxopropyl) -3- (4- (2-pyridinyl) -1-piperazinyl) -sydnonimine;
N- (1-oxobutyl) -3- (4- (2-pyrimidinyl) -1-piperazinyl) -sydnonimine;
3- (4 - ((2,3-Dihydro-1,4-benzodioxin-2-yl) methyl) -1-piperazinyl) -
sydnonimin;
3- (2- (4- (2-methoxyphenyl) -1-piperazinyl) ethyl) -sydnonimine;
N- (2,2-dimethyl-1-oxopropyl) -3- (4- (2-pyrimidinyl) -1-
piperazinyl) -sydnonimine;
3- (4- (1,3-Benzodioxol-5-yl) -1-piperazinyl) -N- (1-oxopropyl)
sydnonimin;
3- (4- (1,3-Benzodioxol-5-ylmethyl) -1-piperazinyl) -sydnonimine;
3- (2- (4- (2-pyridinyl) -1-piperazinyl) ethyl) -sydnonimine;
N- (1-oxopropyl) -3- (4- (2-pyrimidinyl) -1-piperazinyl) -sydnonimine;
3- (4- (2-methoxyphenyl) -1-piperazinyl) sydnonimine;
3- (2- (4- (2-pyrimidinyl) -1-piperazinyl) ethyl) -sydnonimine;
3- (4- (2-pyridinyl) -1-piperazinyl) sydnonimine;
3- (4- (2-pyrimidinyl) -1-piperazinyl) sydnonimine;
3-phenyl-N- (trichloroacetyl) -sydnonimine;
3- (2- (3,4-dimethoxyphenyl) ethyl) -sydnonimine;
3- (2- (4-methoxyphenyl) ethyl) -sydnonimine;
3- (2- (4-Hydroxyphenyl) ethyl) -sydnonimine;
3- (2- (4-hydroxyphenyl) methyl) -sydnonimine;
N-benzoyl-3- (2-phenylethyl) sydnonimine;
3- (3-phenylpropyl) -N- (2,3,4-trimethoxybenzoyl) sydnonimine;
3- (2-phenylethyl) -N- (2,3,4-trimethoxybenzoyl) sydnonimine;
3- (2- (3,4-Dimethoxyphenyl) ethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
N-acetyl-3- (2- (3,4-dimethoxyphenyl) ethyl) -sydnonimine;
4-phenyl-3- (2-phenylethyl) sydnonimine;
4-methyl-3- (2-phenylethyl) sydnonimine;
3- (2-ethoxy-2-oxoethyl) -N- (1-oxopropyl) -sydnonimine;
N-acetyl-3- (2-ethoxy-2-oxoethyl) sydnonimine;
3- (2-phenyl-1- (phenylmethyl) ethyl) -sydnonimine;
N, N'-diformyl-3,3'-dimethyl-4,4'-bisydnonimine;
N, N'-dicarboxy-3,3'-diphenyl-4,4'-bisydnonimine;
N, N'-dicarboxy-3,3'-dimethyl-4,4'-bisydnonimine;
N, N'-dibenzoyl-3,3'-dimethyl-4,4'-bisydnonimine;
3- (5-carboxypentyl) -sydnonimine;
3- (5-carboxypentyl) -4-methyl-sydnonimine;
3- (5-carboxypentyl) -N-nitroso-sydnonimine;
3- (1-methyl-2-phenylethyl) -N - ((phenylamino) carbonyl) -
sydnonimin;
3-acetoxy-4-propyl-sydnonimine;
3-acetoxy-N-methyl-4-propyl-sydnonimine;
N- (phenylcarbamoyl) -3 - ((phenylcarbamoyl) oxy) -4-propyl-
sydnonimin;
3 - ((phenylcarbamoyl) oxy) -4-propyl-sydnonimine;
3-acetoxy-N-acetyl-4-propyl-sydnonimine;
4- (carboxymethyl) -N- (methylcarbamoyl) -3-phenyl-sydnonimine-
ethyl ester;
3- (m - ((Cyanomethyl) nitrosamino) phenyl) -sydnonimine;
3-benzyl-4- (m-nitrophenyl) -sydnonimine;
3,3'-p-phenylenedisydnonimine;
3,3 '- (1,2-ethanediyl) bis-sydnonimine;
3-morpholino-N- (3,4,5-trimethoxybenzoyl) sydnonimine;
3- (dibenzylamino) -4-methyl-sydnonimine;
3- (dimethylamino) -4-methyl-sydnonimine;
N-benzoyl-3- (2-methyl-1-piperidinyl) sydnonimine;
N-benzoyl-3- (1-piperidinyl) -sydnonimine;
3- (dimethylamino) -N-nitroso-sydnonimine;
3- (dimethylamino) -N- (ethoxycarbonyl) -sydnonimine;
N-carboxy-3-morpholino-sydnonimine-3,3,5-trimethylcyclohexyl
ester;
N-carboxy-3-morpholinosydnonimine-2- (p-tolylsulfonyl) ethyl
ester;
N-carboxy-3-morpholino-sydnonimine ethyl ester;
N- (N-carboxyalanyl) -3-morpholinosydnonimine benzyl ester;
3- (4-morpholinyl) -N- (phenoxyacetyl) -sydnonimine;
N-acetyl-3- (4-morpholinyl) -sydnonimine;
3- (carboxymethyl) -4-phenyl-sydnonimine ethyl ester;
N-acetyl-3-butyl-4-phenyl-sydnonimine;
N-acetyl-3-phenyl-sydnonimine;
N-acetyl-3-benzyl-sydnonimine;
3-benzyl-4-phenyl-sydnonimine;
3-phenyl-sydnonimine;
3-benzyl-sydnonimine;
3 - (((2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-
azabicyc1o (3.2.0) hept-6-yl) carbamoyl) methyl) -N - ((o-
chlorphenyl) carbamoyl) -sydnonimine;
N-acetyl-3- (carbamoylmethyl) -sydnonimine;
4- (carbamoylmethyl) -3-methyl-N- (phenylcarbamoyl) -sydnonimine;
4- (carboxymethyl) -3-methyl-N- (phenylcarbamoyl) -sydnonimine-
ethyl ester;
N- (benzylcarbamoyl) -3- (carboxymethyl) -sydnonimine ethyl ester;
3- (carboxymethyl) -N- (methylcarbamoyl) -4-phenyl-sydnonimine-
ethyl ester;
3- (α-methylphenethyl) -sydnonimine;
3,3 ′ - (3,3-dinitro-1,5-pentanediyl) bis-sydnonimine;
N-benzoyl-3- (carboxymethyl) -sydnonimine ethyl ester;
3-isopropyl-4-phenyl-sydnonimine;
N-benzoyl-3- (carbamoylmethyl) -4-phenyl-sydnonimine;
3- (carbamoylmethyl) -4-phenyl-N- (phenylthiocarbamoyl) -
sydnonimin;
3- (α-carbamoyl-p-tolyl) -N- (methylcarbamoyl) -sydnonimine;
N- (benzylcarbamoyl) -3- (carbamoylmethyl) -sydnonimine;
4- (carbamoylmethyl) -3-methyl-N- (methylcarbamoyl) sydnonimine;
3 - (((2-hydroxyethyl) carbamoyl) methyl) -4-phenyl-N-
(phenylcarbamoyl) -sydnonimine;
3- (carbamoylmethyl) -N - ((o-chlorophenyl) carbamoyl) -sydnonimine;
3- (carbamoylmethyl) -4-methyl-N- (phenylthiocarbamoyl) -
sydnonimin;
3- (carbamoylmethyl) -4-phenyl-N- (phenylcarbamoyl) -sydnonimine;
3- (carbamoylmethyl) -N- (methyl carbamoyl) -4-phenyl-sydnonimine;
3- (α-carboxy-p-tolyl) -N - ((o-chlorophenyl) carbamoyl) -sydnonimine-
ethyl ester;
3- (α-carboxy-p-tolyl) -N- (methylcarbamoyl) -sydnonimine-
ethyl ester;
3- (o-carboxyphenyl) -N- (methylcarbamoyl) -sydnonimine;
3-benzyl-4 (carboxymethyl) -N- (methylcarbamoyl) -sydnonimine-
ethyl ester;
4- (2-ethoxy-2-oxoethyl) -3-methyl-N - ((methylamino) carbonyl) -
sydnonimin;
3- (carboxymethyl) -4-methyl-N- (phenylthiocarbamoyl) -sydnonimine-
ethyl ester;
3- (carboxymethyl) -4-phenyl-N- (phenylthiocarbamoyl) -sydnonimine-
ethyl ester;
3- (carboxymethyl) -4-phenyl-N- (phenylcarbamoyl) -sydnonimine-
ethyl ester;
3- (carboxymethyl) -N- (methylcarbamoyl) -sydnonimine ethyl ester;
3- (carboxymethyl) -N - ((o-chlorophenyl) carbamoyl) -sydnonimine-
ethyl ester;
N-benzoyl-3- (carboxymethyl) -4-phenyl-sydnonimine ethyl ester;
N-benzoyl-3- (carboxymethyl) -sydnonimine;
3- (carboxymethyl) -sydnonimine;
4- (carboxymethyl) -3-methyl -N- (phenylcarbamoyl) -sydnonimine;
3- (α-carboxy-p-tolyl) -N - ((o-chlorophenyl) carbamoyl) -sydnonimine;
3- (α-carboxy-p-tolyl) -N- (methylcarbamoyl) -sydnonimine;
4- (carboxymethyl) -3-methyl-N- (methylcarbamoyl) sydnonimine;
N- (benzylcarbamoyl) -3- (carboxymethyl) -sydnonimine;
3- (carboxymethyl) -4-phenyl-N- (phenylthiocarbamoyl) sydnonimine;
3- (carboxymethyl) -4-phenyl-N- (phenylcarbamoyl) -sydnonimine;
3- (carboxymethyl) -N - ((o-chlorophenyl) carbamoyl) -sydnonimine;
3- (α-carboxy-p-tolyl) -sydnonimine ethyl ester;
3- (o-carboxyphenyl) -sydnonimine;
3-benzyl-4- (carboxymethyl) -sydnonimine ethyl ester;
4- (carboxymethyl) -3-methyl-sydnonimine ethyl ester;
3- (2-ethoxy-2-oxoethyl) sydnonimine;
3- (methoxyphenyl) -sydnonimine;
N-acetyl-3-cyclohexyl-sydnonimine;
N-formyl-3-morpholinosydnonimine;
3-cyclohexyl-4-isopropyl-sydnonimine;
4-methyl-3-morpholinosydnonimine;
4-methyl-3- (1-methyl-2-phenylethyl) sydnonimine;
3- (3-piperidinopropyl) -sydnonimine;
3- (3- (Dimethylamino) propyl) -sydnonimine;
3- (2- (diethylamino) ethyl) -sydnonimine;
3- (2- (dimethylamino) ethyl) -sydnonimine;
3-cyclohexyl-4-methyl-sydnonimine;
4-bromo-N-carboxy-3-morpholino-sydnonimine phenyl ester;
N-carboxy-3- (dimethylamino) -sydnonimine benzyl ester;
4-bromo-N- (methoxycarbonyl) -3- (methyl (1-phenylethyl) amino) -
sydnonimin;
N-carboxy-4-chloro-3- (dimethylamino) -sydnonimine allyl ester;
N-carboxy-3- (dimethylamino) -sydnonimine allyl ester;
N-carboxy-3- (methyl (α-methylbenzyl) amino) -sydnonimine-
methyl ester;
4-bromo-N- (butoxycarbonyl) -3- (hexahydro-1H-azepin-1-yl)
sydnonimin;
N-carboxy-3- (hexahydro-1H-azepin-1-yl) -sydnonimine-butyl ester;
4-bromo-N-carboxy-3- (4-methyl-1-piperazinyl) -sydnonimine-
phenyl ester;
N-carboxy-3- (4-methyl-1-piperazinyl) sydnonimine phenyl ester;
N-carboxy-4-chloro-3- (dimethylamino) -sydnonimine-benzyl ester;
4-bromo-N-carboxy-3- (dimethylamino) -sydnonimine-benzyl ester;
N- (ethoxycarbonyl) -4-iodo-3- (4-morpholinyl) -sydnonimine;
4-bromo-N-carboxy-3-morpholino-sydnonimine ethyl ester;
4-bromo-N- (ethoxycarbonyl) -3- (4-morpholinyl) -sydnonimine;
N-carboxy-4-chloro-3-morpholino-sydnonimine ethyl ester;
N-acetyl-4-bromo-3- (methyl (α-methylbenzyl) amino) -sydnonimine;
N-acetyl-4-bromo-3- (3,4-dihydro-2 (1H) -isoquinolyl) -sydnonimine;
3- (methylpiperonylamino) -sydnonimine;
3-acetyl-N-morpholinosydnonimine;
N-nitroso-3- (1-piperidinyl) -sydnonimine;
3- (4-morpholinyl) -N - ((phenylamino) carbonyl) -sydnonimine;
3- (4-methyl-1-piperazinyl) -N-nitroso-sydnonimine;
3- (bis (phenylmethyl) amino) -4-methyl-N-nitrososydnonimine;
3,3 ′ - (1,4-piperazinediyl) bis (N-nitroso-sydnonimine);
3- (2-methyl-1-piperidinyl) -N-nitroso-sydnonimine;
N-nitroso-3- (1-pyrrolidinyl) -sydnonimine;
3- (dibutylamino) -N-nitroso-sydnonimine;
N - ((4- (acetylamino) phenyl) sulfonyl) -3- (4-morpholinyl) -
sydnonimin;
3- (4-morpholinyl) -N- (3-pyridinylcarbonyl) -sydnonimine;
3- (4morpholinyl) -N- (1-oxo-2 - (((phenylmethoxy) carbonyl) -
amino) propyl) -sydnonimine;
N- (1,3-dioxobutyl) -3- (4-morpholinyl) -sydnonimine;
N-benzoyl-3- (dimethylamino) -4-methyl-sydnonimine;
3- (4-morpholinyl) -N - ((phenylmethoxy) carbonyl) -sydnonimine;
N-benzoyl-3- (dimethylamino) -sydnonimine;
3- (4-morpholinyl) -N- (1-oxo-3-phenyl-2-propenyl) -sydnonimine;
3- (4-morpholinyl) -N- (1-oxo-3-phenylpropyl) sydnonimine;
3- (4-morpholinyl) -N- (1-oxopropyl) -sydnonimine;
3- (4-morpholinyl) -N- (trichloroacetyl) -sydnonimine;
N- (dichloroacetyl) -3- (4-morpholinyl) -sydnonimine;
N- (chloroacetyl) -3- (4-morpholinyl) -sydnonimine;
N-formyl-3- (4-morpholinyl) -sydnonimine;
3- (4-morpholinyl) -N- (trifluoroacetyl) -sydnonimine;
3- (4-morpholinyl) -N-nitroso-sydnonimine;
3- (4-morpholinyl) -N - ((phenylamino) carbonyl) -sydnonimine;
N - ((4-chlorophenyl) sulfonyl) -3- (4-morpholinyl) -sydnonimine;
N-benzoyl-3- (4-morpholinyl) -sydnonimine;
3 - (((2-carboxy-3- (hydroxymethyl) -8-oxo-5-thia-1-
azabicyclo (4.2.0) oct-2-en-7-yl) carbamoyl) methyl) N - ((o-
chlorphenyl) carbamoyl) -sydnonimine acetate;
N-benzoyl-3 - (((2-carboxy-3- (hydroxymethyl) -8-oxo-5-thia-1-
azabicyclo (4.2.0) oct-2-en-7-yl) carbamoyl) methyl) -
sydnonimine acetate;
3 - (((2-carboxy-3- (hydroxymethyl) -8-oxo-5-thia-1-
azabicyclo (4.2.0) oct-2-en-7-yl) carbamoyl) methyl) -N-
(methylcarbamoyl) -sydnonimine acetate;
3-sec-octyl-sydnonimine;
4-chloro-3- (dimethylamino) -N-nicotinoyl-sydnonimine;
4-chloro-N- (cyclohexylcarbonyl) -3- (4-morpholinyl) -sydnonimine;
4-bromo-N- (2-chlorobenzoyl) -3- (methyl (phenylmethyl) amino) -
sydnonimin;
N-acetyl-4-bromo-3- (3,4-dihydro-2 (1H) -isoquinolinyl) -sydnonimine;
N-acetyl-4-bromo-3- (1-piperidinyl) -sydnonimine;
N- (cyclohexylcarbonyl) -4-iodo-3- (4-morpholinyl) -sydnonimine;
4-chloro-N- (ethoxycarbonyl) -3- (1-piperidinyl) -sydnonimine;
N-acetyl-4-chloro-3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
4-chloro-3- (4-morpholinyl) -sydnonimine;
4-bromo-N- (ethoxycarbonyl) -3- (1-piperidinyl) -sydnonimine;
N-benzoyl-4-bromo-3- (dimethylamino) -sydnonimine;
4-bromo-3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
N-acetyl-4-bromo-3- (methyl (1-phenylethyl) amino) -sydnonimine;
4-bromo-3- (dimethylamino) -N- (3-pyridinylcarbonyl) -sydnonimine;
4-bromo-3- (4-morpholinyl) -sydnonimine;
4-bromo-N- (cyclohexylcarbonyl) -3- (4-morpholinyl) -sydnonimine;
N-acetyl-3- (3,4-dihydro-2 (1H) -isoquinolyl) -sydnonimine;
4-bromo-3- (1-piperidinyl) -sydnonimine;
4-bromo-3- (dimethylamino) -sydnonimine;
3-piperidino-4-propyl-sydnonimine;
3-amino-sydnonimine;
N- (cyclohexylcarbonyl) -3- (4-morpholinyl) -sydnonimine;
3- (allylmethylamino) -sydnonimine;
N- (2-chlorobenzoyl) -3- (hexahydro-lH-azepin-1-yl) -sydnonimine;
3- (di-2-propenylamino) -4-methyl-N - ((5-nitro-2-
thienyl) carbonyl) -sydnonimine;
N- (2-chlorobenzoyl) -3- (methyl (phenylmethyl) amino) -sydnonimine;
N- (cyclohexylcarbonyl) -3- (methyl (phenylmethyl) amino) -
sydnonimin;
N- (Cyclohexylcarbonyl) -3- (3,4-dihydro-2 (1H) -isoquinolinyl) -
sydnonimin;
N- (o-chlorobenzoyl) -3- (3,4-dihydro-2 (1H) -isoquinolyl) -
sydnonimin;
N- (2-methylbenzoyl) -3- (4-morpholinyl) -sydnonimine;
N- (2-chlorobenzoyl) -3- (4-morpholinyl) -sydnonimine;
N-acetyl-3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
N- (cyclohexylcarbonyl) -3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
3- (hexahydro-1H-azepin-1-yl) -N- (2-methylbenzoyl) sydnonimine;
3- (dimethylamino) -N- (5-nitro-2-furoyl) -sydnonimine;
3- (dimethylamino) -N - ((5-nitro-2-thienyl) carbonyl) -sydnonimine;
3- (methyl (2-pyridylmethyl) amino) -sydnonimine;
N- (ethoxycarbonyl) -3- (4-morpholinyl) -sydnonimine;
3- (diallylamino) -4-ethyl-sydnonimine;
3- (diallylamino) -4-methyl-sydnonimine;
3- (diallylamino) -4-phenethyl-sydnonimine;
3- (methyl (2-propynyl) amino) -sydnonimine;
3- (methyl (phenylmethyl) amino) -sydnonimine;
3- (diallylamino) -sydnonimine;
N- (cyclopropylcarbonyl) -3- (dimethylamino) -sydnonimine;
N-carboxy-3- (dimethylamino) -sydnonimine ethyl ester;
3- (diethylamino) -sydnonimine;
3 - ((p-chlorobenzyl) propylamino) -sydnonimine;
3- (methylphenethylamino) -sydnonimine;
3- (methyl (piperidinomethyl) amino) -sydnonimine;
3- (methyl (α-methylbenzyl) amino) -sydnonimine;
3- (2-phenylpiperidino) sydnonimine;
3- (bis (phenylmethyl) amino) -sydnonimine;
3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
3- (4-methyl-1-piperazinyl) sydnonimine;
3- (3,4-dihydro-2 (1H) -isoquinolinyl) -sydnonimine;
N-acetyl-3- (dimethylamino) -sydnonimine;
3- (dimethylamino) -N- (3,3-dimethylbutyryl) -sydnonimine;
3- (dimethylamino) -N-nicotinoyl-sydnonimine;
N- (cyclohexylcarbonyl) -3- (dimethylamino) -sydnonimine;
3- (dimethylamino) -N-o-toluoyl-sydnonimine;
N- (p-chlorobenzoyl) -3- (dimethylamino) -sydnonimine;
N- (o-chlorobenzoyl) -3- (dimethylamino) -sydnonimine;
N-benzoyl-3- (dimethylamino) -sydnonimine;
N-acetyl-3- (4-acetylhexahydro-1H-1,4-diazepin-1-yl) -sydnonimine;
N-acetyl-3-piperidinosydnonimine;
N-carboxy-3- (diallylamino) -4-ethyl-sydnonimine ethyl ester;
N-carboxy-3-piperidino-sydnonimine ethyl ester;
3- (dimethylamino) -N-hydrocinnamoyl-sydnonimine;
3- (methyl (α-methylbenzyl) amino) -N-nicotinoyl-sydnonimine;
N-benzoyl-3- (hexahydro-1H-azepin-1-yl) -sydnonimine;
N-acetyl-3- (diallylamino) -sydnonimine;
3- (dimethylamino) -N- (5-nitro-2-furoyl) -sydnonimine;
3- (4-benzyl-3-phenyl-1-piperazinyl) sydnonimine;
3- (4-benzyl-1-piperazinyl) -4-methyl-sydnonimine;
3- (4-benzyl-1-piperazinyl) sydnonimine;
3- (4-methyl-1-piperazinyl) sydnonimine;
3- (4- (p-chlorophenyl) -1-piperazinyl) sydnonimine;
3- (2-phenoxyethyl) sydnonimine;
3- (2-hydroxyethyl) -sydnonimine;
3- (1-methyl-2-phenylethyl) sydnonimine;
3-phenethyl-sydnonimine;
3- (α-methylbenzyl) -sydnonimine;
3- (2-methylpropyl) sydnonimine;
4-ethyl-3- (2-methylpropyl) -N-nitroso-sydnonimine;
3- (3-chlorophenyl) -N-nitroso-sydnonimine;
3- (2-hydroxyethyl) -sydnonimine acetate;
3- (3-carboxypropyl) -sydnonimine;
3-methyl-4-nonyl-sydnonimine;
3- (2,2-diphenylethyl) -N - ((phenylamino) carbonyl) -sydnonimine;
3- (2,2-diphenylethyl) -N-nitroso-sydnonimine;
N- (methoxycarbonyl) -3-phenyl-sydnonimine;
3-benzyl-5- (carboxyamino) -1,2,3-oxadiazolium hydroxide
methyl ester;
3-butyl-N- (methoxycarbonyl) -sydnonimine;
N-benzoyl-3-butyl-sydnonimine;
N-acetyl-3-butyl-sydnonimine;
N-acetyl-3- (1-methylethyl) -sydnonimine;
3-sec-butyl-sydnonimine;
3- (1-methylheptyl) hydnonimine;
3-m-tolyl-sydnonimine;
3- (2-phenylethyl) -sydnonimine;
3- (1-methylpropyl) -sydnonimine;
3- (1-methyl-2,2-diphenylethyl) sydnonimine;
3- (2,2-diphenylethyl) -sydnonimine;
3- (2-hydroxy-1-methyl-2-phenylethyl) sydnonimine;
3- (1-methyl-2-phenylethyl) -N-nitroso-4-phenyl-sydnonimine;
3-cyclohexyl-4 - ((diethylamino) methyl) -N-nitroso-sydnonimine;
3- (1-methylethyl) -N-nitrososydnonimine;
3-ethyl-N-nitroso-sydnonimine;
3-methyl-N-nitroso-sydnonimine;
3- (α-methylphenethyl) -sydnonimine;
3- (p-ethoxyphenyl) -N-nitroso-sydnonimine;
3- (p-ethoxyphenyl) -sydnonimine;
3- (1-methyl-2-phenylethyl) -N-nitroso-4- (1-piperidinylmethyl) -
sydnonimin;
4 - ((dimethylamino) methyl) -3- (1-methyl-2-phenylethyl) -N-nitroso-
sydnonimin;
N-benzoyl-3- (α-methylphenethyl) -4- (piperidinomethyl) -
sydnonimin;
N-benzoyl-3-cyclohexyl-4 - ((diethylamino) methyl) -sydnonimine;
4 - ((diethylamino) methyl) -3- (α-methylphenethyl) sydnonimine;
4 - ((Dimethylamino) methyl) -3- (αmethylphenethyl) -sydnonimine;
4 - ((diethylamino) methyl) -3-isopropyl-sydnonimine;
3-cyclohexyl-4 - ((diethylamino) methyl) -sydnonimine;
3-cyclohexyl-4- (nitromethyl) -N-nitroso-sydnonimine;
4- (nitromethyl) -N-nitroso-3- (phenylmethyl) -sydnonimine;
3-cyclohexyl-4- (nitromethyl) -N-nitroso-sydnonimine;
3- (1-methylethyl) -4- (nitromethyl) -N-nitrososydnonimine;
4- (chloromethyl) -3-isobutyl-sydnonimine;
3-benzyl-4- (chloromethyl) sydnonimine;
3- (α-methylphenethyl) -N- (phenylthiocarbamoyl) sydnonimine;
N - ((m-chlorophenyl) carbamoyl) -3- (α-methylphenethyl) -sydnonimine;
3- (2- (diethylamino) ethyl) -N- (phenylcarbamoyl) -sydnonimine;
N - ((phenylamino) carbonyl) -3- (2-phenylethyl) -sydnonimine;
3- (α-methylbenzyl) -N- (phenylcarbamoyl) -sydnonimine;
3-benzyl-N- (phenylcarbamoyl) -sydnonimine;
N- (aminocarbonyl) -3- (1-methyl-2-phenylethyl) sydnonimine;
3- (α-methylphenethyl) -N-nicotinoyl-sydnonimine;
3- (α-methylphenethyl) -N- (phenylacetyl) -sydnonimine;
3-phenethyl-N- (phenylacetyl) -sydnonimine;
N-carboxy-3- (α-methylphenethyl) -sydnonimine methyl ester;
N-carboxy-3-phenethyl-sydnonimine methyl ester;
N-carboxy-3-methyl-sydnonimine methyl ester;
4- (p-methoxyphenyl) -3- (α-methylphenethyl) sydnonimine;
3- (1-methyl-2-phenylethyl) -4-phenyl-sydnonimine;
3- (2-hydroxy-1-methyl-2-phenylethyl) sydnonimine;
3- (2-phenoxyethyl) sydnonimine;
3,3 ′ - (1,2-ethanediyl) bis (N-nitroso) sydnonimine;
4-methyl-N-nitroso-3- (phenylmethyl) -sydnonimine;
4-bromo-N-nitroso-3-phenyl-sydnonimine;
3- (4-chlorophenyl) -N-nitroso-sydnonimine;
3- (4-ethoxyphenyl) -N-nitroso-sydnonimine;
3- (4-methoxyphenyl) -N-nitroso-sydnonimine;
N-nitroso-3-phenyl-sydnonimine;
3-cyclohexyl-N-nitroso-sydnonimine;
N-nitroso-3- (phenylmethyl) -sydnonimine;
N-nitroso-3- (2-phenylethyl) -sydnonimine;
3- (1-methyl-2-phenylethyl) -N-nitroso-sydnonimine;
3-cycloheptyl-sydnonimine;
3-cyclopentyl-sydnonimine;
3- (allylmethylamino) -sydnonimine;
3,3 ′ - (1,4-piperazinediyl) disydnonimine;
4-methyl-3- (1-piperidinyl) sydnonimine;
3- (dibutylamino) -sydnonimine;
3- (2-methyl-1-piperidinyl) sydnonimine;
3- (dimethylamino) -sydnonimine;
3- (1-pyrrolidinyl) -sydnonimine;
3- (1-piperidinyl) -sydnonimine;
3- (p-fluorophenyl) -sydnonimine;
3- (m-fluorophenyl) -sydnonimine;
4-methyl-3-piperonyl-sydnonimine;
N-carbamoyl-3-phenyl-sydnonimine;
N-benzoyl-4-bromo-3- (2-methylpropyl) sydnonimine;
N- (ethoxycarbonyl) -3,4-diphenyl-sydnonimine;
N-acetyl-3,4-diphenyl-sydnonimine;
3-p-tolyl-sydnonimine;
4- (4- (1-methylethyl) phenyl) -N-nitroso-3- (phenylmethyl) -
sydnonimin;
3- (1-methyl-2-phenylethyl) -N- (phenylsulfonyl) -sydnonimine;
4- (3-nitrophenyl) -N-nitroso-3- (phenylmethyl) -sydnonimine;
4- (chloromethyl) -3-isopropyl-sydnonimine;
3-benzyl-4- (p- (dimethylamino) phenyl) -sydnonimine;
3-isopropyl-4-methyl-sydnonimine;
3- (1-methylethyl) -sydnonimine;
4-bromo-3- (α-methylphenethyl) -N- (phenylsulfonyl) -sydnonimine;
N-nitroso-4-phenyl-3- (phenylmethyl) -sydnonimine;
3-benzyl-4- (4-hydroxy-3-methoxyphenyl) sydnonimine;
3-benzyl-4-p-cumenyl-sydnonimine;
4- (4-methoxyphenyl) -N-nitroso-3- (phenylmethyl) -sydnonimine;
4- (4- (dimethylamino) phenyl) -N-nitroso-3- (phenylmethyl) -
sydnonimin;
3-benzyl-4- (m-nitrophenyl) -sydnonimine;
4- (3-nitrophenyl) -3- (phenylmethyl) -sydnonimine;
3-benzyl-4- (4-hydroxy-3-methoxyphenyl) sydnonimine;
4- (4-methoxyphenyl) -N-nitroso-3- (phenylmethyl) -sydnonimine;
N-acetyl-3-benzyl-4-phenyl-sydnonimine;
N-benzoyl-3-benzyl-4-phenyl-sydnonimine;
3- (1,3-benzodioxol-5-ylmethyl) -sydnonimine;
N- (N-acetylsulfanilyl) -3-piperonyl-sydnonimine;
3,4-diphenyl-sydnonimine;
3-isopropyl-4-methyl-sydnonimine;
3- (2-chloroethyl) sydnonimine;
3- (1-methylethyl) -sydnonimine;
4- (chloromethyl) -3-isopropyl-sydnonimine;
3-cyclohexyl-sydnonimine;
3-methyl-sydnonimine;
3-ethyl-sydnonimine;
3-butyl-sydnonimine;
4-methyl-3- (α-methylphenethyl) sydnonimine;
3,4-diphenyl-sydnonimine;
4-methyl-3-phenyl-sydnonimine;
3- (2-carboxyethyl) sydnonimine;
4-phenyl-3-p-tolylsydnonimine;
3- (o-methoxyphenyl) -sydnonimine;
3- (1-methyl-2-phenylethyl) sydnonimine;
3- (2-methylpropyl) sydnonimine;
3- (2-hydroxyethyl) -sydnonimine;
3- (3-methoxy-3-oxopropyl) -sydnonimine;
N-benzoyl-3- (2-methylpropyl) sydnonimine;
N-benzoyl-4-methyl-3- (phenylmethyl) -sydnonimine;
N- (dichlorophosphinyl) -3- (1-methylethyl) -sydnonimine;
N- (dichlorophosphinyl) -4-methyl-3-phenyl-sydnonimine;
3- (1-phenylethyl) -sydnonimine;
4-phenyl-3- (phenylmethyl) -sydnonimine;
4-methyl-3- (phenylmethyl) -sydnonimine;
3 - ((4-chlorophenyl) methyl) -sydnonimine;
3- (phenylmethyl) -sydnonimine;
N-carboxy-3- (p-ethoxyphenyl) -sydnonimine methyl ester;
N-carboxy-3- (p-methoxyphenyl) -sydnonimine methyl ester;
N-carboxy-3- (p-chlorophenyl) -sydnonimine methyl ester;
N-carboxy-3-p-tolyl-sydnonimine methyl ester;
N-carboxy-3- (m-chlorophenyl) -sydnonimine methyl ester;
and their pharmacologically acceptable salts.
Die Salze werden in üblicher Weise durch Neutralisation der Base mit anorganischen oder organischen Säuren erhalten.The salts are neutralized in the usual way Obtain base with inorganic or organic acids.
Als anorganische Säuren kommen zum Beispiel Salzsäure, Schwefelsäure, Phosphorsäure oder Bromwasserstoffsäure, als organische Säuren zum Beispiel Carbon-, Sulfo- oder Sulfonsäuren wie Essigsäure, Weinsäure, Milchsäure, Propionsäure, Glykolsäure, Malonsäure, Maleinsäure, Fumarsäure, Gerbsäure, Succinsäure, Alginsäure, Benzoesäure, 2-Phenoxybenzoesäure, 2-Acetoxybenzoesäure, Zimtsäure, Mandelsäure, Zitronensäure, Äpfelsäure, Salicylsäure, 3-Aminosalicylsäure, Ascorbinsäure, Embonsäure, Nicotinsäure, Isonicotinsäure, Oxalsäure, Aminosäuren, Methansulfonsäure, Ethansulfonsäure, 2-Hydroxyethansulfonsäure, Ethan-1,2- disulfonsäure, Benzolsulfonsäure, 4-Methylbenzolsulfonsäure oder Naphthalin-2-sulfonsäure in Frage.Examples of inorganic acids are hydrochloric acid, Sulfuric acid, phosphoric acid or hydrobromic acid, as organic acids for example carbon, sulfo or Sulfonic acids such as acetic acid, tartaric acid, lactic acid, Propionic acid, glycolic acid, malonic acid, maleic acid, fumaric acid, Tannic acid, succinic acid, alginic acid, benzoic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, cinnamic acid, Mandelic acid, citric acid, malic acid, salicylic acid, 3-aminosalicylic acid, ascorbic acid, embonic acid, nicotinic acid, Isonicotinic acid, oxalic acid, amino acids, methanesulfonic acid, Ethanesulfonic acid, 2-hydroxyethanesulfonic acid, ethane-1,2- disulfonic acid, benzenesulfonic acid, 4-methylbenzenesulfonic acid or naphthalene-2-sulfonic acid in question.
Die erfindungsgemäß verwendeten Arzneimittel enthalten neben den üblichen Hilfs-, Träger- und Zusatzstoffen eine wirksame Dosis von Verbindungen der allgemeinen Formel I oder eines seiner Salze zur Behandlung der genannten Dysfunktionen. Die Dosierung ist abhängig von Spezies, Körpergewicht, Alter, individuellem Zustand und Applikationsart.The medicaments used according to the invention contain in addition the usual auxiliaries, carriers and additives are effective Dose of compounds of general formula I or one its salts for the treatment of the mentioned dysfunctions. The Dosage depends on species, body weight, age, individual condition and type of application.
Als Applikationsformen kommen sowohl parenterale als auch topische Zubereitungen wie beispielsweise Lotionen, Cremes, Lösungen, Gele, Sprays, elastische Flüssig-Pflaster, transdermale Systeme oder Beschichtungen für Kondome in Frage.Both parenteral and also come as application forms topical preparations such as lotions, creams, Solutions, gels, sprays, elastic liquid plasters, transdermal systems or coatings for condoms in question.
Bevorzugt ist eine parenterale Applikation, da sie die sicherste Form ist, eine gezielte Wirkstoffmenge direkt ohne weitere Verfälschung durch andere Faktoren gezielt einzusetzen.Parenteral administration is preferred since it is the The safest form is a targeted amount of active ingredient directly without use further adulteration by other factors in a targeted manner.
Besonders bevorzugt zur vereinfachten Anwendung ist auch eine sterile Applikationssatz zur einmaligen Anwendung, welcher neben sterilen, mit Desinfektionslösungen versehenen Tupfern und der zugehörigen Benutzungsinformation Einmalspritzen zur vereinfachten Anwendung mit einer Dosiseinheit einer wirksamen Menge eines erektionsfördernden Mittels, bevorzugt einer parenteralen Zubereitungsform von Linsidomin, enthält. Die genannten Einmal-Fertigspritzen sind vorzugsweise vom Typ Ultrafein, wie sie beispielsweise in der Insulintherapie zur Anwendung kommen. Bevorzugt sind auch Spritzen in der Art von Autoinjektoren, die noch einfacher in ihrer Handhabung sind. Die Fertigspritzen sind in bevorzugter Form in lichtundurchlässiger ausgeführt, da sich dadurch der Zusatz von Photostabilisatoren zu den parenteralen Zubereitungen erübrigt. Sie können jedoch auch so ausgebildet sein daß Wirkstoff und zugehöriges Injektionslösungsmittel erst direkt vor der Injektion gemischt werden. Dies kann zum Beispiel in Zwei- Behältnis-Ampullen bzw. -Spritzen geschehen. Dadurch kann sich dann ein gegebenenfalls erforderlicher Photostabilisatorzusatz ebenfalls erübrigen.One is also particularly preferred for simplified application sterile application set for single use, which in addition to sterile swabs provided with disinfectant solutions and the associated usage information disposable syringes for simplified application with a unit dose of an effective Amount of an erection-promoting agent, preferably one parenteral preparation of linsidomine, contains. The disposable syringes mentioned are preferably of the type Ultra-fine, such as those used in insulin therapy Application come. Syringes of the type of are also preferred Auto injectors that are even easier to use. The pre-filled syringes are in preferred form designed to be more opaque, since this adds Photo stabilizers for the parenteral preparations are unnecessary. However, they can also be designed so that active ingredient and associated injection solvent just before the Injection. For example, this can be done in two Container ampoules or syringes happen. This can then a photostabilizer additive that may be required also superfluous.
Die sterilen Tupfer zur Desinfektion enthalten die üblichen Mittel zur Haut-Desinfektion wie beispielsweise Ethanol. Sie können jedoch auch noch zusätzlich erektionsfördernde Mittel in einer topisch applizierbaren Form zur Steigerung bzw. Verlängerung der Wirkung enthalten.The sterile swabs for disinfection contain the usual ones Skin disinfectants such as ethanol. they However, erection-promoting agents can also be used in a topically applicable form for increasing or Extension of effect included.
Zubereitungen zur parenteralen Applikation enthalten 0,1 bis 5 mg, bevorzugt 0,1 bis 2 mg der Verbindungen der Formel I pro Dosiseinheit und können in separaten Dosiseinheitsformen wie z. B. Ampullen oder Vials vorliegen. Vorzugsweise werden Lösungen des Wirkstoffes verwendet, bevorzugt wäßrige Lösungen und vor allem isotonische Lösungen, aber auch Suspensionen. Diese Injektionsformen können als Fertigpräparat zur Verfügung gestellt werden oder erst direkt vor der Anwendung durch Mischen der wirksamen Verbindung, zum Beispiel des Lyophilisats, gegebenenfalls mit weiteren festen Trägerstoffen, mit dem gewünschten Lösungs- oder Suspensionsmittel zubereitet werden. Für topische Applikationsformen ist selbstverständlich eine höhere Wirkstoffkonzentration als die für parenterale Zubereitungen genannte angezeigt.Preparations for parenteral administration contain 0.1 to 5 mg, preferably 0.1 to 2 mg of the compounds of the formula I per Dose unit and can be in separate dosage unit forms such. B. There are ampoules or vials. Solutions are preferred of the active ingredient used, preferably aqueous solutions and before all isotonic solutions, but also suspensions. These Injection forms can be available as a finished product provided or only immediately before use Mixing the active compound, for example the Lyophilisates, optionally with other solid carriers, prepared with the desired solvent or suspending agent will. For topical application forms is a matter of course a higher drug concentration than that for parenteral Preparations mentioned appear.
Parenterale wie topische Formen können sterilisiert sein und/oder gegebenenfalls Hilfsstoffe wie Konservierungsmittel, Stabilisatoren, Netzmittel, Penetrationsmittel, Emulgatoren, Spreitmittel, Lösungsvermittler, Salze zur Regelung des osmotischen Drucks oder zur Pufferung und/oder Viskositätsregulatoren enthalten.Parenteral and topical forms can be sterilized and / or optionally auxiliary substances such as preservatives, Stabilizers, wetting agents, penetrants, emulsifiers, Spreading agents, solubilizers, salts for regulating the osmotic pressure or for buffering and / or Viscosity regulators included.
Derartige Zusätze sind zum Beispiel Tartrat- und Citrat-Puffer, Ethanol, Komplexbildner (wie Äthylendiamin-tetraessigsäure und deren nicht-toxische Salze). Zur Regelung der Viskosität kommen hochmolekulare Polymere in Frage wie beispielweise flüssiges Polyethylenoxid, Carboxymethylcellulosen, Polyvinylpyrrolidone, Dextrane oder Gelatine. Feste Trägerstoffe sind zum Beispiel Stärke, Lactose, Mannit, Methylcellulose, Talkum, hochdisperse Kieselsäuren, höhermolekulare Fettsäuren (wie Stearinsäure), Gelatine, Agar-Agar, Calciumphosphat, Magnesiumstearat, tierische und pflanzliche Fette, feste hochmolekulare Polymere (wie Polyethylenglykol.Such additives are, for example, tartrate and citrate buffers, Ethanol, complexing agents (such as ethylenediamine tetraacetic acid and their non-toxic salts). Come to regulate the viscosity high molecular polymers such as liquid Polyethylene oxide, carboxymethyl celluloses, polyvinyl pyrrolidones, Dextrans or gelatin. Solid carriers are for example Starch, lactose, mannitol, methyl cellulose, talc, highly disperse Silicas, higher molecular fatty acids (such as stearic acid), Gelatin, agar-agar, calcium phosphate, magnesium stearate, animal and vegetable fats, solid high-molecular polymers (like polyethylene glycol.
Ölige Suspensionen für parenterale oder topische Anwendungen können vegetabile synthetische oder semisynthetische Öle wie beispielsweise flüssige Fettsäureester mit jeweils 8 bis 22 C-Atomen in den Fettsäureketten, zum Beispiel Palmitin-, Laurin-, Tridecyl-, Margarin-, Stearin-, Arachin-, Myristin-, Behen-, pentadecyl-, Linol-, Elaidin-, Brasidin-, Eruca- oder Ölsäure, die mit ein- bis dreiwertigen Alkoholen mit 1 bis 6 C-Atomen wie beispielsweise Methanol, Ethanol, Propanol, Butanol, Pentanol oder deren Isomere, Glycol oder Glycerol verestert sein. Derartige Fettsäureester sind beispielsweise handelsübliche Miglyole, Isopropylmyristat, Isopropylpalmitat, Isopropylstearat, PEG 6-Caprinsäure, Capryl/Caprinsäureester von gesättigten Fettalkoholen, Polyoxyethylenglyceroltrioleate, Ethyloleat, wachsartige Fettsäureester wie künstliches Entenbürzeldrüsenfett, Kokosfettsäure-isopropylester, Ölsäureoleylester, Ölsäuredecylester, Milchsäureethylester, Dibuthylphthalat, Adipinsäurediisopropylester, Polyol- Fettsäureester u. a. Ebenso geeignet sind Silikonöle verschiedener Viskosität oder Fettalkohole wie Isotridexylalkohol, 2-Octyldodecanol, Cetylstearyl-Alkohol oder Oleylalkohol, Fettsäuren wie beispielsweise Ölsäure. Weiterhin können vegetabile Öle wie Rizinusöl, Mandelöl, Olivenöl, Sesamöl, Baumwollsaatöl, Erdnußöl oder Sojabohnenöl Verwendung finden. Die genannten Stoffe haben zudem die Eigenschaften eines Spreitmittels, das heißt es erfolgt eine besonders gute Verteilung auf der Haut.Oily suspensions for parenteral or topical applications can be vegetable synthetic or semi synthetic oils like for example liquid fatty acid esters with 8 to 22 carbon atoms each in the fatty acid chains, for example palmitin, laurin, Tridecyl, margarine, stearin, arachine, myristic, behen, pentadecyl, linoleic, elaidic, brasidine, erucic or oleic acid, those with monohydric to trihydric alcohols with 1 to 6 carbon atoms such as methanol, ethanol, propanol, butanol, Pentanol or its isomers, glycol or glycerol esterified be. Such fatty acid esters are, for example commercially available miglyols, isopropyl myristate, isopropyl palmitate, Isopropyl stearate, PEG 6-capric acid, caprylic / capric acid ester of saturated fatty alcohols, polyoxyethylene glycerol trioleates, Ethyl oleate, waxy fatty acid esters such as artificial Duckling glandular fat, isopropyl coconut fatty acid, Oleic acid oleyl ester, oleic acid decyl ester, lactic acid ethyl ester, Dibuthyl phthalate, diisopropyl adipate, polyol Fatty acid esters a. Silicone oils are also suitable different viscosity or fatty alcohols like Isotridexyl alcohol, 2-octyldodecanol, cetylstearyl alcohol or Oleyl alcohol, fatty acids such as oleic acid. Farther Vegetable oils such as castor oil, almond oil, olive oil, Use sesame oil, cottonseed oil, peanut oil or soybean oil Find. The substances mentioned also have the properties a spreading agent, that is to say a particularly good one Distribution on the skin.
Als Lösungsmittel, Gelbildner und Lösungsvermittler kommen in Frage Wasser oder mit Wasser mischbare Lösungsmittel. Geeignet sind zum Beispiel Alkohole wie beispielsweise Ethanol oder Isopropylalkohol, Benzylalkohol, 2-Octyldodecanol, Polyethylenglykole, Phthalate, Adipate, Propylenglyklol, Glycerin, Di- oder Tripropylenglykol, Wachse, Methylcellosolve, Cellosolve, Ester, Morpholine, Dioxan, Dimethylsulfoxid, Dimethylformamid, Tetrahydrofuran, Cyclohexanon etc.As solvents, gelling agents and solubilizers come in Question water or water-miscible solvents. Suitable are, for example, alcohols such as ethanol or Isopropyl alcohol, benzyl alcohol, 2-octyldodecanol, Polyethylene glycols, phthalates, adipates, propylene glycol, Glycerin, di- or tripropylene glycol, waxes, Methyl cellosolve, cellosolve, ester, morpholine, dioxane, Dimethyl sulfoxide, dimethylformamide, tetrahydrofuran, Cyclohexanone etc.
Als Filmbildner können Celluloseether verwendet werden, die sich sowohl in Wasser als auch in organischen Lösungsmitteln lösen bzw. anquellen können und nach dem Trocknen eine Art Film bilden, wie beispielsweise Hydroxypropylcellulose, Methylcellulose, Ethylcellulose oder lösliche Stärken.Cellulose ethers can be used as film formers in both water and organic solvents can dissolve or swell and after drying a kind of film form, such as hydroxypropyl cellulose, Methyl cellulose, ethyl cellulose or soluble starches.
Mischformen zwischen Gel- und Filmbildnern sind durchaus ebenfalls möglich. Hier kommen vor allem ionische Makromoleküle zur Anwendung, wie beispielsweise Natriumcarboxymethylcellulose, Polyacrylsäure, Polymethacrylsäure und deren Salze, Natriumamylopektinsemiglykolat, Alginsäure oder Propylenglykol- Alginat als Natriumsalz, Gummi arabicum, Xanthan-Gummi, Guar- Gummi oder Carrageenan.Mixed forms between gel and film formers are quite also possible. Ionic macromolecules in particular come here to use, such as Sodium carboxymethyl cellulose, polyacrylic acid, Polymethacrylic acid and its salts, Sodium amylopectin semiglycolate, alginic acid or propylene glycol Alginate as sodium salt, gum arabic, xanthan gum, guar Gum or carrageenan.
Als weitere Formulierungshilfsmittel können eingesetzt werden:
Glycerin, Paraffin unterschiedlicher Viskosität,
Triethanolamin, Collagen, Allantoin, Novantisolsäure,
Parfümöle.The following can be used as additional formulation aids:
Glycerin, paraffin of different viscosities, triethanolamine, collagen, allantoin, novantisol acid, perfume oils.
Auch die Verwendung von Tensiden, Emulgatoren oder Netzmitteln kann zur Formulierung notwendig sein, wie zum Beispiel von Na- Laurylsulfat, Fettalkoholethersulfaten, Di-Na-N-lauryl-β- iminodipropionat, polyoxyethyliertes Rizinusöl oder Sorbitan- Monooleat, Sorbitan-Monostearat, Cetylakohol, Lecithin, Glycerinmonostearat, Polyoxyethylenstearat, Alkylphenolpolyglykolether, Cetyltrimethylammoniumchlorid oder Mono-/Dialkylpolyglykolether-orthophosphorsäure monoethanolaminsalze.Also the use of surfactants, emulsifiers or wetting agents may be necessary for the formulation, such as Na- Lauryl sulfate, fatty alcohol ether sulfates, di-Na-N-lauryl-β- iminodipropionate, polyoxyethylated castor oil or sorbitan Monooleate, sorbitan monostearate, cetylic alcohol, lecithin, Glycerol monostearate, polyoxyethylene stearate, Alkylphenol polyglycol ether, cetyltrimethylammonium chloride or Mono / dialkyl polyglycol ether orthophosphoric acid monoethanolamine salts.
Stabilisatoren wie Montmorillonite oder kolloidale Kieselsäuren zur Stabilisierung von Emulsionen oder zur Verhinderung des Abbaus der aktiven Substanzen wie Antioxidantien, beispielsweise Tocopherole oder Butylhydroxyanisol, oder Konservierungsmittel, wie p-Hydroxybenzoesäureester, können ebenfalls zur Zubereitung der gewünschten Formulierungen gegebenenfalls erforderlich sein.Stabilizers such as montmorillonites or colloidal silicas to stabilize emulsions or to prevent the Breakdown of active substances such as antioxidants, for example tocopherols or butylated hydroxyanisole, or Preservatives, such as p-hydroxybenzoic acid esters, can also for the preparation of the desired formulations may be required.
Zur Förderung der Penetration enthalten transdermale Formulierungen vorzugsweise organische, gut hautverträgliche Lösungsmittel wie Ethanol, Methylpyrrolidon, Polyethylenglykol, Oleylalkohol, Octanol, Linolsäure, Triacetin, Propylenglykol, Glycerin, Solketal oder Dimethylsulfoxid.To promote penetration contain transdermal Formulations preferably organic, well tolerated by the skin Solvents such as ethanol, methylpyrrolidone, polyethylene glycol, Oleyl alcohol, octanol, linoleic acid, triacetin, propylene glycol, Glycerin, Solketal or Dimethylsulfoxid.
Infolge der Lichtempfindlichkeit der Verbindungen der allgemeinen Formel I ist es angezeigt, den Darreichungsformen Photostabilisatoren zuzusetzen oder sie in entsprechend lichtschützenden Verpackungen bereitzustellen, wie beispielsweise in lichtundurchlässigen Einmal-Fertigspritzen.Due to the photosensitivity of the compounds of the general formula I it is appropriate to the dosage forms Add photo stabilizers or put them in accordingly to provide light-protecting packaging, such as for example in opaque, disposable pre-filled syringes.
Als Photostabilisatoren kommen Verbindungen in Frage wie Chinoline, z. B. 8-Hydroxychinolin oder Chinolingelb; geeignete Lebensmittelfarbstoffe; Flavanoide wie z. B. Hesperidin, Hesperidin-methylchalcon, Hesperidinphosphat, Hesperitin, Quercetin, Quercitrin, Rutin, Rutinsulfat, Naringenin, Kämpferol, Kämpferol-7,4′-dimethylether, Morin, Apigetrin, Luteolin und sein 7-Glycosid, oder Troxerutin. Sie werden dem Linsidomin im Mengenverhältnis 0,001 : 1 bis 50 : 1, vorzugsweise 0,1 : 1 bis 20 : 1 zugesetzt.Compounds such as can be used as photostabilizers Quinolines, e.g. B. 8-hydroxyquinoline or quinoline yellow; suitable Food coloring; Flavanoids such as B. hesperidin, Hesperidin-methylchalcon, hesperidin phosphate, hesperitin, Quercetin, Quercitrin, Rutin, Rutinsulfat, Naringenin, Kaempferol, kaempferol-7,4'-dimethylether, Luteolin and its 7-glycoside, or troxerutin. They will Linsidomine in a quantity ratio of 0.001: 1 to 50: 1, preferably 0.1: 1 to 20: 1 added.
Die Herstellung, Abfüllung und die Verschließung der Präparate erfolgt unter den üblichen antimikrobiellen und aseptischen Bedingungen. Auch für topischen beziehungsweise transdermalen Einsatz erfolgt eine Abpackung möglichst in separaten Dosiseinheiten zur Erleichterung der Handhabung, auch hier wie bei parenteralen Formen gegebenenfalls aus Stabilitätsgründen durch separate Abpackung der Wirkstoffe beziehungweise deren Kombinationen als Lyophilisat, gegebenenfalls mit festen Trägerstoffen, und den erforderlichen Lösungsmitteln etc.The manufacture, filling and sealing of the preparations takes place under the usual antimicrobial and aseptic Conditions. Also for topical or transdermal If possible, they are packaged in separate packages Dose units to facilitate handling, also here how in the case of parenteral forms, if necessary for reasons of stability by separate packaging of the active ingredients or their Combinations as a lyophilisate, optionally with solid ones Carriers, and the necessary solvents etc.
Ein weiterer Aspekt der Erfindung ist die Verwendung von Verbindungen der allgemeinen Formel I in Kombination mit synergistisch wirkenden Substanzen wie Adenosin, Vitaminen, zum Beispiel Vitamin A oder H, Prostaglandinen, zum Beispiel E1, mit Peptiden wie z. B. Calcitonine gene related peptides (CGRP), mit Calcium-Antagonisten wie Nifedipin, Verapamil, Diltiazem, Gallopamil, Niludipin, Nimodipin, Nicardipin, Prenylamin, Fendilin, Terodilin, Nisaldipin, Nitrendipin oder Perhexilin. Weitere Kombinationsmöglichkeiten bestehen mit α-Rezeptorenblockern, beispielsweise Phentolaminmethansulfonat, Phenoxybenzamin oder Minoxidil, oder Relaxantien der glatten Muskulatur wie Papaverin, Trinitroglycerin, Natriumnitroprussid oder S-nitroso-N-acetylpenicillamin.Another aspect of the invention is the use of compounds of general formula I in combination with synergistic substances such as adenosine, vitamins, for example vitamin A or H, prostaglandins, for example E 1 , with peptides such as. B. Calcitonine gene related peptides (CGRP), with calcium antagonists such as nifedipine, verapamil, diltiazem, gallopamil, niludipine, nimodipine, nicardipine, prenylamine, fendiline, terodiline, nisaldipine, nitrendipine or perhexiline. There are further possible combinations with α-receptor blockers, for example phentolamine methanesulfonate, phenoxybenzamine or minoxidil, or smooth muscle relaxants such as papaverine, trinitroglycerin, sodium nitroprusside or S-nitroso-N-acetylpenicillamine.
Claims (1)
R1 Wasserstoff, C1-C5-Alkyl oder Halogen
R2 Wasserstoff, -NO, -COR4 oder -SO2R5,
R3 einen der Reste bedeuten, wobei A für Sauerstoff oder eine der Gruppen
<S(O)m, <N-R11, <N-COOR8 oder <N-SO2R9 und
m für 0, 1 oder 2 und
n für 2, 3, 4, oder 5 stehen,
R4 Wasserstoff, einen aliphatischen Rest mit 1 bis 6 C-Atomen, der auch durch Alkoxy 1 bis 6 C-Atomen oder Aryloxy mit 6 bis 12 C-Atomen substituiert sein kann, einen cycloaliphatischen Rest mit 7 bis 14 C-Atomen, einen tricycloaliphatischen Rest mit 7 bis 16 C-Atomen, Aryl mit 6 bis 12 C-Atomen, das auch durch Halogen und/oder Alkyl mit 1 bis 4 C-Atomen und/oder Alkoxy mit 1 bis 4 C-Atomen mono-, di- oder trisubstituiert sein kann, Aralkyl oder Aralkenyl mit 7 bis 13 C-Atomen, Alkoxy mit 1 bis 6 C-Atomen, Cycloalkoxy mit 5 bis 8 C-Atomen, Bicycloalkoxy mit 7 bis 12 C-Atomen, Tricycloalkoxy mit 7 bis 16 C-Atomen, Aryloxy mit 6 bis 12 C-Atomen, Pyridyl, Pyrrolyl, Imidazolyl, Pyrazolyl, Pyrazinyl, Pyrimidinyl, Pyridazinyl, Alkoxycarbonyl mit insgesamt 2 bis 7 C-Atomen,
R5 Alkyl mit 1 bis 6 C-Atomen, Aryl mit 6 bis 12 C-Atomen, das auch durch Methyl oder Halogen substituiert sein kann, oder eine Dialkylaminogruppe mit 1 bis 4 C-Atomen in jedem der Alkylreste,
R6 und R7 unabhängig voneinander Alkyl mit 1 bis 6 C-Atomen, Alkenyl mit 3 bis 6 C-Atomen, Cycloalkyl mit 5 bis 8 C-Atomen, Bicycloalkyl mit 7 bis 14 C-Atomen, Tricycloalkyl mit 7 bis 16 C-Atomen, Aralkyl mit 7 bis 9 C-Atomen, wobei die Aralkylgruppe durch Methyl oder Halogen substituiert sein kann, oder einen über eine Alkylenkette an das Stickstoffatom der 3-Aminogruppe gebundenen heterocyclischen Ring bedeuten und
R6 zusätzlich Wasserstoff und
R7 zusätzlich ein Rest der Formeln sein kann,
R8 Alkyl mit 1 bis 4 C-Atomen,
R9 Alkyl mit 1 bis 6 C-Atomen, Aryl mit 6 bis 12 C-Atomen, das auch durch Methyl oder Halogen substituiert sein kann, oder eine Dialkylaminogruppe mit 1 bis 4 C-Atomen in jedem der Alkylreste,
R10 Alkyl mit 1 bis 4 C-Atomen und
R11 Alkyl mit 1 bis 6 C-Atomen bedeuten,
sowie deren pharmakologisch verträglichen Salze mit Ausnahme von Linsidomin (3-Morpholinosydnonimin) zur Herstellung von Arzneimitteln zur Behandlung erektiler Dysfunktionen bei Säugetieren und Menschen.Use of sydnonimines of the general formula I wherein
R 1 is hydrogen, C 1 -C 5 alkyl or halogen
R 2 is hydrogen, -NO, -COR 4 or -SO 2 R 5 ,
R 3 one of the residues mean, where A is oxygen or one of the groups
<S (O) m , <NR 11 , <N-COOR 8 or <N-SO 2 R 9 and
m for 0, 1 or 2 and
n stands for 2, 3, 4 or 5,
R 4 is hydrogen, an aliphatic radical with 1 to 6 C atoms, which can also be substituted by alkoxy 1 to 6 C atoms or aryloxy with 6 to 12 C atoms, a cycloaliphatic radical with 7 to 14 C atoms, one tricycloaliphatic radical with 7 to 16 carbon atoms, aryl with 6 to 12 carbon atoms, which is also mono-, di- by halogen and / or alkyl with 1 to 4 carbon atoms and / or alkoxy with 1 to 4 carbon atoms or can be trisubstituted, aralkyl or aralkenyl with 7 to 13 carbon atoms, alkoxy with 1 to 6 carbon atoms, cycloalkoxy with 5 to 8 carbon atoms, bicycloalkoxy with 7 to 12 carbon atoms, tricycloalkoxy with 7 to 16 carbon atoms Atoms, aryloxy with 6 to 12 carbon atoms, pyridyl, pyrrolyl, imidazolyl, pyrazolyl, pyrazinyl, pyrimidinyl, pyridazinyl, alkoxycarbonyl with a total of 2 to 7 carbon atoms,
R 5 is alkyl with 1 to 6 C atoms, aryl with 6 to 12 C atoms, which can also be substituted by methyl or halogen, or a dialkylamino group with 1 to 4 C atoms in each of the alkyl radicals,
R 6 and R 7 independently of one another alkyl with 1 to 6 C atoms, alkenyl with 3 to 6 C atoms, cycloalkyl with 5 to 8 C atoms, bicycloalkyl with 7 to 14 C atoms, tricycloalkyl with 7 to 16 C atoms Atoms, aralkyl having 7 to 9 carbon atoms, where the aralkyl group can be substituted by methyl or halogen, or a heterocyclic ring bonded via an alkylene chain to the nitrogen atom of the 3-amino group and
R 6 additionally hydrogen and
R 7 additionally a rest of the formulas can be,
R 8 alkyl with 1 to 4 carbon atoms,
R 9 is alkyl having 1 to 6 carbon atoms, aryl having 6 to 12 carbon atoms, which can also be substituted by methyl or halogen, or a dialkylamino group having 1 to 4 carbon atoms in each of the alkyl radicals,
R 10 alkyl with 1 to 4 carbon atoms and
R 11 is alkyl with 1 to 6 carbon atoms,
and their pharmacologically acceptable salts with the exception of linsidomine (3-morpholinosydnonimine) for the manufacture of medicaments for the treatment of erectile dysfunctions in mammals and humans.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19924213338 DE4213338A1 (en) | 1992-04-23 | 1992-04-23 | Treatment of impotence |
| PCT/EP1993/000546 WO1993018767A1 (en) | 1992-03-24 | 1993-03-10 | Use of sydnonimines to treat erectile dysfunction |
| AU36323/93A AU3632393A (en) | 1992-03-24 | 1993-03-10 | Use of sydnonimines to treat erectile dysfunction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19924213338 DE4213338A1 (en) | 1992-04-23 | 1992-04-23 | Treatment of impotence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE4213338A1 true DE4213338A1 (en) | 1993-10-28 |
Family
ID=6457308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19924213338 Withdrawn DE4213338A1 (en) | 1992-03-24 | 1992-04-23 | Treatment of impotence |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE4213338A1 (en) |
-
1992
- 1992-04-23 DE DE19924213338 patent/DE4213338A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4117249C2 (en) | Linsidomine used to treat erectile dysfunction | |
| AU736100B2 (en) | Process for controlling myiasis in cattle and sheep livestock and compositions for carrying out this process | |
| EP0470117B1 (en) | Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions | |
| EP0660711B1 (en) | Novel use of inhibitors of phosphodiestersase iv | |
| DE2523998A1 (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF SCHIZOPHRENIA | |
| DE4036706A1 (en) | METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA | |
| DE102004032651A1 (en) | Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting | |
| DE69921008T2 (en) | Treatment of spinal cord injury induced impotence | |
| DE2611183C2 (en) | Stabilized formulation of PGE-type prostaglandin-like drugs | |
| DE60316297T2 (en) | COMPOUNDS USEFUL FOR TREATING DISEASES AFFORDING ANTIANGIOGENIC THERAPY | |
| DE69326840T2 (en) | Emedastine containing ophthalmic compositions and their use in the treatment of allergic conjunctivitis | |
| DE69003924T2 (en) | Prevention of withdrawal symptoms. | |
| DE4223800A1 (en) | Use of 1.2.5-oxadiazole-2-oxides for the treatment of erectile dysfunctions | |
| WO1998016224A1 (en) | Pyrazolinones to treat disturbances of potency | |
| WO1993018767A1 (en) | Use of sydnonimines to treat erectile dysfunction | |
| DE4213338A1 (en) | Treatment of impotence | |
| DE68907976T2 (en) | Use of a thromboxane A2 receptor antagonist for the manufacture of a medicament for the treatment of pulmonary hypertension caused by protamine-induced neutralization of heparin. | |
| DE3855121T2 (en) | Anxiolytic piperazine derivatives | |
| DE4338948A1 (en) | Treating erectile dysfunction without causing side-effects | |
| DE4230755A1 (en) | Phosphodiesterase IV inhibitors for kidney and ureter disease treatment - with eg (4-(3-(cyclopentyl oxy) 4-methoxyphenyl-2-pyrrolidinone) being specific for kidney and ureter tissue relaxation | |
| DE10111516A1 (en) | Use of sydnonimines for the specific diagnosis of erectile dysfunction | |
| WO2000032199A1 (en) | Use of galanthamine and galanthamine derivatives in the case of acute functional brain damage | |
| DE3136031A1 (en) | PHARMACEUTICAL COMPOSITIONS, EFFECTIVE AGAINST CORONARY HEART DISEASES AND HIGH BLOOD PRESSURE | |
| DE4209462A1 (en) | Treatment of impotence | |
| EP0342617A2 (en) | Use of trequinsin and cosmetic preparations based on same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |